UNITED STATES
 SECURITIES AND EXCHANGE COMMISSION
 WASHINGTON, D.C. 20549

 FORM 10-K

 x
 ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 For the fiscal year ended December 31, 2024

 OR

 TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 For the transition period from to

 Commission File Number 1-10258

 TREDEGAR CORPORATION
 (Exact name of registrant as specified in its charter)

 Virginia
 54-1497771

 (State or other jurisdiction
of incorporation or organization)
 (I.R.S. Employer
Identification No.)

 1100 Boulders Parkway,

 Richmond,
 Virginia
 23225

 (Address of principal executive offices)
 (Zip Code)

 Registrant's telephone number, including area code: 804 - 330-1000
 Securities registered pursuant to Section 12(b) of the Act:

 Title of each class
 Trading Symbol
 Name of each exchange on which registered

 Common Stock
 TG
 New York Stock Exchange

 Securities registered pursuant to Section 12(g) of the Act:
 None

 (Title of class)

 Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes No x
 Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes No x
 Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No
 Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes x No
 Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company" and "emerging growth company" in Rule 12b-2 of the Exchange Act.

 Large accelerated filer
 o
 Accelerated filer
 x
 Smaller reporting company
 x

 Non-accelerated filer
 o

 Emerging growth company
 o

 If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
 Indicate by check mark whether the registrant has filed a report on and attestation to its management's assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. x
 If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements.
 Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant's executive officers during the relevant recovery period pursuant to §240.10D-1(b).
 Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes No x
 Aggregate market value of voting and non-voting common equity held by non-affiliates of the registrant as of June 28, 2024 (the last business day of the registrant's most recently completed second fiscal quarter): $ 130,091,356 *
 Number of shares of Common Stock outstanding as of March 7, 2025: 34,676,675

 *
 In determining this figure, an aggregate of 7,325,946 shares of Common Stock beneficially owned by John D. Gottwald, William M. Gottwald, James T. Gottwald, and Residual 10-year CLAT UA FDGJR Living Trust and the members of their immediate families has been excluded because the shares are deemed to be held by affiliates. The aggregate market value has been computed based on the closing price in the New York Stock Exchange on June 28, 2024.

 Documents Incorporated by Reference
 Portions of the Tredegar Corporation Proxy Statement for the 2025 Annual Meeting of Shareholders (the "Proxy Statement") are incorporated by reference into Part III of this Form 10-K.

 Index to Annual Report on Form 10-K
 Year Ended December 31, 2024

 Page

 Item 1.

 Business

 Item 1A.

 Risk Factors

 Item 1B.

 Unresolved Staff Comments

 Item 1C.

 Cybersecurity

 Item 2.

 Properties

 Item 3.

 Legal Proceedings

 Item 4.

 Mine Safety Disclosures

 Item 5.

 Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities

 Item 6.

 [RESERVED]

 Item 7.

 Management's Discussion and Analysis of Financial Condition and Results of Operations

 Item 7A.

 Quantitative and Qualitative Disclosures About Market Risk

 Item 8.

 Financial Statements and Supplementary Data

 Item 9.

 Changes In and Disagreements with Accountants on Accounting and Financial Disclosure

 Item 9A.

 Controls and Procedures

 Item 9B.

 Other Information

 Item 9C.

 Disclosure Regarding Foreign Jurisdictions that Prevent Inspections

 Item 10.

 Directors, Executive Officers and Corporate Governance

 Item 11.

 Executive Compensation

 Item 12.

 Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters

 Item 13.

 Certain Relationships and Related Transactions, and Director Independence

 Item 14.

 Principal Accountant Fees and Services

 Item 15.

 Exhibits and Financial Statement Schedules

 Item 16.

 Form 10-K Summary

 Item 1. BUSINESS
 Description of Business
 Tredegar Corporation is engaged, through its subsidiaries, in the manufacture of aluminum extrusions and polyethylene and polypropylene ("PE") plastic films. Unless the context requires otherwise, all references herein to "Tredegar," "the Company," "we," "us" or "our" are to Tredegar Corporation and its consolidated subsidiaries.
 The Company's reportable business segments are Aluminum Extrusions and PE Films.
 On November 1, 2024, the Company completed the sale of its flexible packaging films business (also referred to as "Terphane") headquartered in Brazil to Oben Group ("Oben"). Commencing in the fourth quarter of 2024, all historical results for Terphane have been presented as discontinued operations. For more information on this transaction, see Note 16. "Divestitures" to the Consolidated Financial Statements included in Item 15. "Exhibits and Financial Statement Schedules" of this Form 10-K ("Item 15").
 Aluminum Extrusions, also referred to as Bonnell Aluminum, produces high-quality, soft and medium strength alloyed aluminum extrusions, custom fabricated and finished, for the building and construction, automotive and transportation, consumer durables goods, machinery and equipment, electrical and renewable energy, and distribution markets. Bonnell Aluminum has manufacturing facilities located in the United States ("U.S.").
 Aluminum Extrusions manufactures mill (unfinished), machined, anodized and painted, and thermally improved aluminum extrusions for sale directly to fabricators and distributors. It also manufactures and sells branded product lines: Futura TransitionsTM by Bonnell Aluminum (flooring trims) and TSLOTSTM by Bonnell Aluminum (structural aluminum framing systems). Aluminum Extrusions competes primarily on the basis of product quality, service and price. Sales are made predominantly in the U.S. The end-use markets for Aluminum Extrusions are cyclical and seasonal in nature.
 The end-uses in each of Aluminum Extrusions' primary market segments include:
 Major Markets
 End-Uses

 Building & construction ("B&C") - nonresidential

 Commercial windows and doors, curtain walls, storefronts and entrances, automatic entry doors, walkway covers, ducts, louvers and vents, office wall panels, partitions and interior enclosures, acoustical walls and ceilings, point of purchase displays, pre-engineered structures, and flooring trims (Futura TransitionsTM by Bonnell Aluminum)

 B&C - residential
 Residential windows and doors, shower and tub enclosures, railing and support systems, venetian blinds, and swimming pools

 Automotive & transportation

 Automotive and light truck structural components, battery enclosures for electric vehicles, after-market automotive accessories, grills for heavy trucks, travel trailers and recreation vehicles

 Consumer durables

 Office furniture, pleasure boats, refrigerators and freezers, appliances and sporting goods

 Machinery & equipment

 Material handling equipment, conveyor systems, medical equipment, industrial fans and aluminum framing systems (TSLOTSTM by Bonnell Aluminum)

 Distribution (metal service centers specializing in stock and release programs and custom fabrications to small manufacturers)

 Various custom profiles including storm shutters, pleasure boat accessories, theater set structures and various standard profiles (including rod, bar, tube and pipe)

 Electrical & renewable energy

 Lighting fixtures, electronic apparatus, solar panel brackets and rigid and flexible conduits

 Aluminum Extrusions' net sales (sales less freight) by market segment for the years ended December 31, 2024, 2023 and 2022 is shown below:
 % of Aluminum Extrusions Net Sales1 by Market Segment

 2024
 2023
 2022

 B&C:

 Nonresidential
 56%
 57%
 55%

 Residential
 8%
 8%
 10%

 Automotive
 8%
 10%
 8%

 Specialty:

 Consumer durables
 7%
 8%
 9%

 Machinery & equipment
 11%
 9%
 9%

 Electrical
 8%
 5%
 5%

 Distribution
 2%
 3%
 4%

 Total
 100%
 100%
 100%

 1. The Company uses net sales as its measure of revenues from external customers at the segment level. For more business segment information, see Note 12 "Business Segments" to the Consolidated Financial Statements included in Item 15 of this Form 10-K.

 In 2024, 2023 and 2022, Aluminum Extrusions net sales accounted for approximately 82%, 86% and 87% of Tredegar's consolidated net sales, respectively.
 Open Orders. Overall open orders in Aluminum Extrusions were approximately $55.0 million, or 17 million pounds, at December 31, 2024 compared to approximately $48.0 million, or 14 million pounds, at December 31, 2023, an increase of $7.0 million, or approximately 15%. This level is below the quarterly range of 21 to 27 million pounds in 2019 before pandemic-related disruptions that resulted in long lead times, driving a peak in open orders of approximately 100 million pounds during the first quarter of 2022. Sales volume for Aluminum Extrusions, which the Company believes is cyclical and seasonal in nature due to its end-use markets, was 139.2 million pounds in 2024, 138.5 million pounds in 2023 and 174.7 million pounds in 2022.
 Raw Materials. The primary raw materials used by Aluminum Extrusions consist of aluminum ingot, aluminum scrap and various alloys, which are purchased from domestic and foreign producers in open-market purchases and under annual contracts. Refer to Item 7A. "Quantitative and Qualitative Disclosures About Market Risk" of this Form 10-K ("Item 7A") for additional information on aluminum price trends. Aluminum Extrusions believes that it has adequate supply agreements for aluminum and other product cost components in 2025.
 PE Films produces surface protection films, polyethylene overwrap films and films for other markets. Tredegar's Surface Protection unit produces single- and multi-layer surface protection films sold under the UltraMask, ForceField, ForceField PEARL, Pearl A and Obsidian brand names. These films, which are manufactured at facilities in the U.S. and China, support manufacturers of optical and other specialty substrates used in high-technology applications, most notably protecting high-value components of flat panel and flexible displays used in televisions, monitors, notebooks, smartphones, tablets, e-readers, electronic shelf labels and automobiles during the manufacturing and transportation processes. The Obsidian series of products is designed for usage in automotive applications. In 2024, 2023 and 2022, PE Films accounted for approximately 18%, 14% and 13% of Tredegar's consolidated net sales, respectively.
 Raw Materials. The primary raw materials used by PE Films are polyethylene and polypropylene resins. These raw materials are obtained from domestic and foreign suppliers at competitive prices. Refer to Item 7A for additional information on resin price trends. PE Films believes that there will be an adequate supply of polyethylene and polypropylene resins in the foreseeable future.
 Customers. PE Films' products are sold primarily in the U.S. and Asia, with the top four customers, collectively, comprising 88% of its net sales in 2024, 87% in 2023 and 88% in 2022. No single PE Films customer exceeds 10% of Tredegar's consolidated net sales. For additional information, see Item 1A. "Risk Factors" of this Form 10-K ("Item 1A").
 General
 Intellectual Property. Tredegar considers patents, licenses and trademarks to be material to PE Films. On December 31, 2024, PE Films held 32 patents (including 6 U.S. patents), and 35 registered trademarks (including 9 U.S. registered trademarks). As of December 31, 2024, these patents had remaining terms of 5 to 16 years.

 Government Regulation. The Company's operations are subject to various local, state, federal and foreign government regulations, including environmental, privacy and anti-corruption and anti-bribery laws and regulations.
 U.S. laws concerning the environment to which the Company's domestic operations are or may be subject to include the Clean Water Act, the Clean Air Act, the Resource Conservation and Recovery Act, the Occupational Safety and Health Act, the National Environmental Policy Act, the Toxic Substances Control Act, the Comprehensive Environmental Response, Compensation and Liability Act ("CERCLA"), regulations promulgated under these acts, and other federal, state or local laws or regulations governing environmental matters. Compliance with these laws is an important consideration because Tredegar uses hazardous materials in some of its operations, is a generator of hazardous waste, and wastewater from the Company's operations is discharged to various types of wastewater management systems. Under CERCLA and other laws, Tredegar may be subject to financial exposure for costs associated with waste management and disposal, even if the Company fully complies with applicable environmental laws.
 The U.S. Environmental Protection Agency has adopted regulations under the Clean Air Act relating to emissions of carbon dioxide and other greenhouse gases ("GHG"), including mandatory reporting and permitting requirements. Several of the Company's manufacturing operations result in emissions of carbon dioxide or GHG and are subject to the current GHG regulations. The Company's compliance with environmental regulations has yet to require significant capital expenditures; however, environmental standards tend to become more stringent over time. Therefore, in order to comply with current or future environmental legislation or regulations, the Company may be subject to additional capital expenditures, operating expenses or other compliance costs, the amounts and timing of which are not presently determinable, but which could be significant, including constructing new facilities or modifying existing facilities.
 Like environmental regulations, current or future workplace safety, privacy and anti-corruption and anti-bribery legislation or regulations may subject the Company to additional capital expenditures, operating expenses or other compliance costs, the amounts and timing of which are not presently determinable but could be significant. Any failure to comply with current or future laws and regulations, including environmental, workplace safety, privacy and anti-corruption and anti-bribery laws and regulations, could subject Tredegar to substantial penalties, fines, costs and expenses. For further discussion regarding certain environmental, health and safety, privacy and anti-corruption and anti-bribery laws and regulations to which the Company is subject, see Item 1A below.
 Human Capital Management.
 Overview
 Tredegar had approximately 1,500 employees at December 31, 2024 located in the U.S. and Asia, of which 96% are located in the U.S. Approximately 20% of the Company's employees are represented by labor unions located in the U.S. under two collective bargaining agreements with varying durations and expiration dates. The labor union representing employees at Bonnell Aluminum's Newnan Plant ratified a new collective bargaining agreement in January 2025. Tredegar will negotiate with the labor union representing employees in PE Films's Pottsville Plant later in 2025.
 Health and Safety
 Tredegar has continuously exceeded the industry standards for safety in each of its respective manufacturing sectors. The Company uses various forms of employee safety metrics to assess the health and safety performance of its Aluminum Extrusion and PE Films operations, including employee safety data which is available on the Company's website at www.tredegar.com/about-tredegar/our-broader-commitments/committed-to-our-employees/.
 Additionally, Aluminum Extrusions has on-site health clinics at its Carthage and Clearfield facilities. These clinics allow Aluminum Extrusions to invest in its people, provide more personal and more thorough healthcare to employees, and enhance the employer-employee relationship. Collectively, the Carthage and Clearfield clinics serve over 600 employees.
 Talent and Development
 The Company believes its employees are its most valuable asset and are critical to the success of the Company. The Company seeks to retain employees by offering competitive wages, benefits and training opportunities. The objectives of our executive compensation programs are to attract, motivate and retain highly qualified executive officers. To accomplish these objectives, the Company relies on a pay strategy that emphasizes performance-based compensation through annual and long-term incentives. The Company believes that this pay strategy creates a strong link between pay and performance and aligns with our business strategy of generating strong operating results and shareholder value creation while controlling fixed costs.
 The Company is committed to holistically supporting our employees both at work and in their communities by:
 • Strictly following all applicable health, safety and non-discrimination laws in each country;
 • Promoting the highest standards for employee health and safety through innovative programs; and

 • Providing opportunities for community outreach and supporting programs that enhance the lives of children and families.
 Tredegar strictly complies with all applicable federal, state, local and international laws governing non-discrimination in employment in every location where Tredegar and its businesses have facilities to ensure healthy and positive working conditions. This applies to all terms and conditions of employment, including recruiting, hiring, job assignments, promotion, termination, layoff, recall, transfer, leaves of absence, compensation and training. All applicants and employees are treated with the same high level of respect regardless of their race, creed, color, religion, sex, sexual orientation, gender identity, age, pregnancy, national origin, ethnicity, political affiliation, union membership, family status, citizenship status, veteran status, disability or other protected category. Employees who experience or witness discriminatory behavior are encouraged to report such behavior to their supervisor, Human Resources or Tredegar's toll-free anonymous reporting hotline. Additionally, the Company spends significant resources in developing its employees. Among the five core principles of the "The Tredegar Way" that the Company uses to guide its organization, the "Leadership" principle is focused on building a team of motivated and engaged leaders at every level of the Company. Each business unit has identified specific action plans to promote the Leadership principle among its employees. Action plans include talent development, skills training, reinforcement of strong cultural values, and robust systems to ensure a safe working environment.
 Information About Our Executive Officers. See Item 10. "Directors, Executive Officers and Corporate Governance" of this Form 10-K.
 Available Information and Corporate Governance Documents. Tredegar's website address is www.tredegar.com. The Company makes available, through its website, its annual report on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K and amendments to those reports filed or furnished pursuant to Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), as soon as reasonably practicable after such documents are electronically filed with, or furnished to, the Securities and Exchange Commission ("SEC"). Information filed electronically with the SEC can be accessed on its website at www.sec.gov. In addition, the Company's Corporate Governance Guidelines, Code of Conduct, the charters of the Audit, Executive Compensation, Nominating and Governance Committees and Climate Change Risk Assessment and many other corporate policies are available on Tredegar's website and are available in print to any shareholder upon request by contacting Tredegar's Corporate Secretary at 1100 Boulders Parkway, Richmond, Virginia 23225. The information on or that can be accessed through the Company's website is not, and shall not be deemed to be, a part of this Form 10-K or incorporated into other filings it makes with the SEC.

 Forward-looking and Cautionary Statements
 Some of the information contained in this Form 10-K may constitute "forward-looking statements" within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. When the Company uses the words "believe," "estimate," "anticipate," "appear to," "expect," "project," "plan," "likely," "may" and similar expressions, it does so to identify forward-looking statements. Such statements are based on the Company's then current expectations and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those addressed in the forward-looking statements. It is possible that the Company's actual results and financial condition may differ, possibly materially, from the anticipated results and financial condition indicated in or implied by these forward-looking statements. Accordingly, you should not place undue reliance on these forward-looking statements. For risks and important factors that could cause actual results to differ from expectations, refer to the reports that Tredegar files with or furnishes the SEC from time-to-time, including the risks and important factors set forth in Item 1A. Readers are urged to review and consider carefully the disclosures Tredegar makes in the reports Tredegar files with or furnishes to the SEC. Tredegar does not undertake, and expressly disclaims any duty, to update any forward-looking statement to reflect any change in management's expectations or any change in conditions, assumptions or circumstances on which such statements are based, except as required by applicable law.

 Item 1A. RISK FACTORS
 There are a number of risks and uncertainties that could have a material adverse effect on the Company's businesses and its consolidated financial condition, results of operations or cash flows. The following risk factors should be considered, in addition to the other information included in this Form 10-K, when evaluating Tredegar and its businesses.
 Risks Related to All of Tredegar's Businesses
 • Ongoing macroeconomic factors, including inflation, high interest rates and recession risks could cause downturns in key markets and create other commercial disruptions, which could adversely impact our businesses. Products sold to key end-use markets, including the B&C and consumer electronics markets, represent a significant portion of our revenue. Because these markets are tied closely to overall economic performance, macroeconomic factors could cause changes to demand for our products. These factors include: (i) inflation; (ii) high interest rates; (iii) recession risks; and (iv) other interruptions of international and regional commerce. Price erosion may occur as competitors become more aggressive in

 pricing practices. To the extent that these factors reduce demand for our products, our business, financial position, results of operations and cash flows could be adversely impacted.
 • Tredegar's performance is influenced by costs incurred by its operating companies, including the cost of raw materials and energy. These costs include the cost of aluminum (the raw material on which Aluminum Extrusions primarily depends), resin (the raw material on which PE Films primarily depends), natural gas (the principal fuel necessary for Aluminum Extrusions' plants to operate), electricity, diesel fuel, chemicals and paint. Aluminum, resin and natural gas prices are volatile as shown in the charts in Item 7A. The Company attempts to mitigate the effects of increased costs through price increases and contractual pass-through provisions, but there are no assurances that higher prices can effectively be passed through to customers or that Tredegar will be able to offset fully or on a timely basis the effects of higher costs. Further, the Company's cost control efforts may not be sufficient to offset any increases in raw materials, energy or other costs.
 • Noncompliance with any of the covenants in the Company's $125 million asset-based revolving credit facility ("ABL Facility"), which matures on June 30, 2026, could result in all debt outstanding thereunder becoming due and limiting the Company's borrowing capacity, which could have a material adverse effect on its consolidated financial condition and liquidity. The credit agreement governing Tredegar's ABL Facility contains restrictions and financial covenants that, if violated, could restrict the Company's operational and financial flexibility. Failure to comply with these covenants could result in an event of default, which if not cured or waived, would result in all outstanding debt under the credit facility at such time becoming due, which could have a material adverse effect on the Company's consolidated financial condition and liquidity.
 • Our failure to continue to attract, develop and retain certain key officers or employees could adversely affect our businesses. Our success depends upon the efforts and abilities of key personnel, many of whom are longstanding employees. The loss of any of these key personnel could deplete our institutional knowledge base and negatively affect our ability to efficiently operate our businesses. Certain roles have experienced high turnover in recent years, and we are experiencing an increasingly competitive labor market. Increased employee turnover could hinder our ability to execute our business strategy and adversely affect our business, financial condition, results of operations and cash flows.
 • Disruptions at one of the Company's major manufacturing facilities could negatively impact financial results. Tredegar believes it has implemented measures to minimize the risks of disruption at its facilities. However, a disruption could occur as a result of any number of events: an equipment failure with repairs requiring long lead times, labor stoppages or shortages, cybersecurity attacks, utility disruptions, constraints on the supply or delivery of critical raw materials, and severe weather conditions, including potential flooding at the Aluminum Extrusions facility located in Carthage, TN, which is located in a 50-year flood plain. A material disruption in one of the Company's operating locations could negatively impact production and the Company's consolidated financial condition, results of operations and cash flows.
 • A failure in the Company's information technology systems as a result of cybersecurity attacks or other causes could negatively affect Tredegar's business. The Company depends on information technology ("IT") to record and process customer orders, manufacture and ship products in a timely manner, secure its production processes and know-how, maintain the financial accuracy of its business records and maintain personally identifiable information of its employees. An IT system failure due to computer viruses, internal or external security breaches, cybersecurity attacks or other malicious causes could disrupt our operations and prevent us from being able to process transactions with our customers, operate our manufacturing facilities and properly report transactions in a timely manner. Increased global IT security threats and cyber-crime pose a potential risk to the security and availability of the Company's IT systems, networks and services, including those that are managed, hosted, provided or used by third parties, as well as to the confidentiality, availability and integrity of the Company's data. Additionally, increased cybersecurity risk arises due to certain employees working remotely. To date, interruptions of the Company's IT systems have been infrequent, and Tredegar has not experienced a material cybersecurity incident. A significant prolonged failure of or security breach of the IT systems, networks or service providers the Company relies upon, or a loss or disclosure of business or other sensitive information, or personally identifiable information, as a result of a cybersecurity incident or other cause, could result in substantial costs to the Company, damage to the Company's reputation, regulatory enforcement actions and lawsuits and could adversely affect the Company's business, results of operations, financial condition or cash flows.
 • Trade policies could cause an increase in the cost of our products or otherwise negatively impact the Company. The primary raw materials used by Aluminum Extrusions consist of aluminum ingot, aluminum scrap and various alloys, which are purchased from domestic and foreign producers in open-market purchases and under short-term contracts. PE Film's Surface Protection business involves imports to and from the U.S. and other countries where the Company produces and sells its products, including China. Trade tensions have been rising between the U.S. and other countries. An increase in tariffs and other trade barriers between the U.S. and other countries could cause disruption to supply chains

 and an increase in the cost of Aluminum Extrusions' and PE Films' products or otherwise negatively impact the production and sale of the Company's products in world markets.
 • The Company's results of operations, financial condition and cash flows have been and could be impacted by the macroeconomic effects of a pandemic. The COVID-19 pandemic had multiple adverse effects on the global economy, including short-term impacts affecting labor supply and causing supply chain disruptions which led to inflationary pressures. In addition, the pandemic resulted in certain after-shocks and structural shifts, which have adversely impacted Tredegar's markets.
 In the event of a future pandemic, Tredegar's businesses, our suppliers, contractors and third-party logistic providers could experience conditions similar to those associated with the COVID-19 pandemic, including facility closures, labor constraints, supply chain disruptions and other challenges. These challenges could impact our ability to maintain sufficient inventory and to accurately predict demand or lead times, which could inhibit our ability to service customer demand. Additionally, a future pandemic could heighten other risks described herein.
 • Tredegar is subject to current and future government regulations, including environmental laws and regulations, and could become exposed to liabilities and costs associated with such regulations. The Company is subject to regulation by local, state, federal and foreign governmental authorities. New laws and regulations, or changes to existing laws, including those relating to environmental matters (including global climate change and plastic products), and privacy matters, could subject Tredegar to significant additional capital expenditures, operating expenses or other compliance costs. Moreover, future developments in federal, state, local and international laws and regulations, including environmental laws, are difficult to predict. Environmental laws and privacy restrictions have become and are expected to continue to become increasingly strict. As a result, Tredegar expects to be subject to new environmental and privacy laws and regulations. However, any such changes are uncertain and, therefore, it is not possible for the Company to predict with certainty the amount of additional capital expenditures or operating expenses that could be necessary for compliance with respect to any such changes.
 The Company is subject to the U.S. Foreign Corrupt Practices Act, anti-corruption laws and similar anti-bribery laws in other jurisdictions, which generally prohibit companies and their intermediaries from making improper payments to foreign officials for the purpose of obtaining or retaining business. Although we have policies and procedures designed to facilitate compliance with these laws and regulations, our employees, contractors and agents may take actions in violation of our policies. Any such violation, even if prohibited by our policies, could adversely affect our business and/or our reputation.
 Risks Related to Aluminum Extrusions
 • Sales volume and profitability of Aluminum Extrusions is cyclical and seasonal and highly dependent on economic conditions of end-use markets in the U.S., particularly in the construction sector. Aluminum Extrusions' end-use markets can be cyclical and subject to seasonal swings in volume. In addition, changes in architectural design, demographic, and remote work trends could negatively impact the overall commercial construction industry. Because of the capital-intensive nature and level of fixed costs inherent in the aluminum extrusions business, the percentage drop in earnings before interest, taxes, depreciation and amortization ("EBITDA") from ongoing operations in a cyclical downturn will likely exceed the percentage drop in volume. In addition, during an economic slowdown, excess industry capacity often drives increased pricing pressure in many end-use markets as competitors seek to maintain or increase their position with key customers. Benefits associated with cost reductions and productivity improvements may not be sufficient to offset the adverse effects on profitability from pricing and margin pressure and higher bad debts (including a greater chance of loss associated with customers defaulting on fixed-price forward sales contracts) that usually accompany a downturn.
 • Unfairly traded imports of aluminum extrusions could injure or threaten with injury America's domestic aluminum extrusions industry, which could have an adverse effect on the financial condition, results of operations and cash flows of Aluminum Extrusions. Chinese and other foreign manufacturers continue to try to evade the antidumping and countervailing orders to avoid duties. In October, 2022, the U.S. International Trade Commission ("ITC") extended the antidumping and countervailing duty orders against aluminum extrusions from China for a period of five years.
 In March 2018, the U.S. imposed tariffs of 10% on aluminum ingot and semi-finished aluminum imported into the U.S. from certain countries ("Section 232 tariffs"). In December 2020, the Department of Commerce ("USDOC") introduced a tariff exclusion process, allowing importers to bypass individual exclusion requests and import items without Section 232 tariffs.
 The Company participated as a member of the U.S. Aluminum Extruders Coalition which filed a trade case with the USDOC and the U.S. International Trade Commission ("USITC") against 15 countries in response to alleged large and increasing volumes of unfairly priced imports of aluminum extrusions since 2019. In November 2023, the USITC found that there is a reasonable indication that the American aluminum extrusions industry is materially injured or threatened

 with injury due to imports from 14 countries, including China. In September 2024, the USDOC announced its final determinations that aluminum extrusion producers and exporters in 14 countries, including China, sold aluminum extrusions at less-than-fair value in the U.S. In October 2024, the USITC found that U.S. producers had not been materially injured by reason of the subject imports, despite the USDOC findings of less-than-fair value pricing by those imports. The coalition has appealed the decision.
 The USITC negative determination in October did not impact the existing duties on aluminum extrusions from China.
 On February 10, 2025, the Section 232 tariffs on all aluminum imports were increased from 10% to 25%, effective March 12, 2025, and certain country-specific and product-specific exclusions from the tariffs were revoked. This action also expands the scope of the tariffs to include downstream products, including certain finished aluminum goods. These measures, which apply in addition to existing antidumping and countervailing duties, are intended to prevent the circumvention of duties through the importation of downstream products. The actual level and timing of the tariffs remains a fluid situation. A failure by, or the inability of, U.S. trade officials to restore the import tariff in its full format could have an adverse effect on the businesses, financial condition, results of operations and cash flows of Aluminum Extrusions.
 • The markets for Aluminum Extrusions' products are highly competitive with product quality, service, delivery performance and price being the principal competitive factors. Aluminum Extrusions has approximately 1,100 customers that are in a variety of end-use markets within the broad categories of building and construction, automotive, transportation, consumer durables, electrical, renewable energy, machinery and equipment, and distribution. No single Aluminum Extrusions' customer exceeds 2% of consolidated net sales. Future success and prospects depend on Aluminum Extrusions' ability to provide superior service, high quality products, timely delivery and competitive pricing to retain existing customers and participate in overall industry cross-cycle growth. Failure in any of these areas could lead to a loss of customers, which could have an adverse effect on the business, financial condition, results of operations and cash flows of Aluminum Extrusions.
 • The failure to successfully implement the new enterprise resource planning and manufacturing execution systems could adversely impact the Aluminum Extrusions business and results of operations. In January 2022, Aluminum Extrusions commenced the implementation of new enterprise resource planning and manufacturing execution systems ("ERP/MES") across all locations of the Aluminum Extrusions business. The implementation of these systems is a major undertaking from a financial, management, and personnel perspective. The implementations have been more difficult, time-consuming and costly (approximately $21 million of spending to date) than expected. This project has been reorganized with the timing for the go-live date being uncertain. There can be no assurance that these systems will be beneficial to the extent anticipated. Conversely, our existing systems could become obsolete, fail to function properly or otherwise fail to address our needs. Any additional disruptions, delays or deficiencies in the design and implementation of the new systems could adversely affect our financial position, results of operations and cash flows.
 Risks Related to PE Films
 • PE Films is highly dependent on sales associated with relatively few large customers. PE Films' top four customers comprised in total approximately 16%, 12% and 12% of Tredegar's consolidated net sales in 2024, 2023 and 2022, respectively. The loss or significant reduction of sales associated with one or more of these customers without replacement by new business could have an adverse effect on the Company.
 While PE Films is undertaking efforts to expand its customer base, there can be no assurance that such efforts will be successful, or that they will offset any loss of sales and profits associated with large customer declines.
 • The failure of PE Films' customers to achieve success or maintain market share could adversely impact PE Films' sales and operating margins. PE Films' specialized protection and polyethylene overwrap films are used in the production of various consumer products sold worldwide. Our customers' ability to successfully develop, manufacture and market those products is integral to PE Films' success. Cyclical downturns and changing consumer preferences, particularly those driven by changes in technology, may negatively affect businesses that use PE Films' film products, which could adversely affect sales and operating margins. Other factors that could adversely affect the business include (i) failure by a key customer to achieve success or maintain share in markets in which they sell products containing PE Films' materials, including as a result of customer preferences for products other than films, (ii) key customers using products developed by others that replace PE Films' business with such customers, (iii) delays in a key customer rolling out products utilizing new technologies developed by PE Films, and (iv) operational decisions by a key customer that result in component substitution, inventory reductions and similar changes.
 • The Company's inability to protect its intellectual property rights or its infringement of the intellectual property rights of others could have an adverse impact on PE Films. The continued success of PE Films' business depends on its ability not only to protect its own technologies and trade secrets, but also to develop and sell new products that do not infringe upon existing patents. Intellectual property litigation is very costly and could result in substantial expense and diversions

 of Company resources, both of which could adversely affect its consolidated financial condition, results of operations and cash flows. In addition, there may be no effective legal recourse against infringement of the Company's intellectual property by third parties, whether due to limitations on enforcement of rights in foreign jurisdictions or as a result of other factors.

 Item 1B. UNRESOLVED STAFF COMMENTS
 None.

 Item 1C. CYBERSECURITY
 Tredegar's business model depends on the efficiency and reliability of its information systems, networks, and essential assets, with a portion of these systems and networks being administered by third-party service providers. Tredegar's Cybersecurity Program (the "Program"), which was designed utilizing a risk-based approach, was developed to not only prevent, identify, investigate, resolve, and mitigate potential cybersecurity vulnerabilities within Tredegar but also to enhance the information security posture of Tredegar's operations involving third-party service providers.
 Tredegar entrusts its third-party service providers with the responsibility to institute security measure protocols that are appropriately and proportionally tailored to the corresponding risks. However, Tredegar also periodically conducts assessments of the third-party service providers' security frameworks to verify the implementation of adequate security measures, to safeguard Tredegar against potential vulnerabilities.
 The Program leverages a blend of automated systems, manual operations, and external evaluations to proactively identify and mitigate potential cybersecurity threats. Key components of the Program include Tredegar's Cybersecurity Incident Response Plan and Cyber Crisis Management Plan. These plans encompass a strategic approach that includes: (i) detection of threats, thorough analysis of cybersecurity incidents to determine whether timely notification to Tredegar's Board of Directors ("Board") is necessary; (ii) containment of incidents; (iii) eradication or mitigation of threats; (iv) recovery processes; and (v) a comprehensive post-incident review.
 To further strengthen its cybersecurity posture, Tredegar employs third-party consultants who work with the internal audit and information technology ("IT") functions to assess Tredegar's information security program and practices, including incident management, service continuity, and information security compliance programs, and identify areas for improvement. The results of such an assessment are regularly presented to the Audit Committee. Notably, these assessments include periodic penetration tests, which allow Tredegar to identify vulnerabilities, refine procedures, and enhance its crisis management and recovery capabilities. The Program is also supported by an organizational structure, involving collaboration across various business sectors and an interdisciplinary Global Data Protection and Cybersecurity Oversight Team that meets regularly to identify information security risks and appropriate risk mitigation strategies. Additionally, because Tredegar recognizes the significant role that its employees play in information security, it provides annual formal information security training to all of its employees that covers critical topics such as phishing and email security best practices. Furthermore, periodic simulated phishing exercises are conducted to reinforce these practices.
 Tredegar's IT Director and Bonnell's Director of Information Security are responsible for managing the Program, including the prevention, mitigation, detection and remediation of cybersecurity incidents. Tredegar's IT Director has over 10 years of cybersecurity expertise, including working in similar roles at other companies, has cybersecurity certifications from EC-Council and ODU Global and holds a degree in Computer Science from Universidade Catolica de Pernambuco and an MBA in IT Management from Universidade Federal de Pernambuco. Bonnell's Director of Information Security has over 30 years of cybersecurity experience, including working in similar roles at other companies, has cybersecurity certifications from EC-Council and ISC^2 and holds a degree in Mechanical Engineering from the Georgia Institute of Technology. Tredegar's IT Director and Bonnell's Director of Information Security also regularly collaborate closely with key management, including the Chief Financial Officer, General Counsel, Compliance Manager, and Human Resources Executive Director, to foster effective communication regarding the Program within Tredegar.
 The Board is responsible for risk management, with specific oversight of cybersecurity risks being delegated to the Audit Committee. The Audit Committee receives updates from Tredegar's and Bonnell's IT Directors at each of its quarterly meetings. These updates encompass an assessment of Tredegar's cybersecurity risk profile, including the efficacy of Tredegar's cybersecurity policies, procedures, strategies, and areas of emerging risk. Additionally, the Board receives annual, but often more frequent, updates on Tredegar's cybersecurity systems.
 Based on the information we have as of the date of this Form 10-K, we do not believe any risks from cybersecurity threats, including as a result of any previous cybersecurity incidents, have materially affected us, including our business strategy, results of operations or financial condition. See Item 1A. Risk Factors for further information.

 Item 2. PROPERTIES

 General
 Most of the improved real property and the other assets used in the Company's operations are owned. Certain of the owned property is subject to an encumbrance under the ABL Facility. See Note 7 "Debt and Credit Agreements" to the Consolidated Financial Statements in Item 15 for more information.
 Tredegar considers the manufacturing facilities, warehouses and other properties and assets that it owns or leases to be in generally good condition. Capacity utilization at its various manufacturing facilities can vary with product mix and normal fluctuations in sales levels. The Company believes that its Bonnell Aluminum and PE Films manufacturing facilities have sufficient capacity to meet current production requirements. Tredegar's corporate headquarters, which is leased, is located at 1100 Boulders Parkway, Richmond, Virginia 23225.
 The Company's principal manufacturing plants and facilities as of December 31, 2024 are listed below:

 Locations in the U.S.

 Locations Outside the U.S.

 Principal Operations

 Carthage, Tennessee
Clearfield, Utah (leased)
Elkhart, Indiana
Newnan, Georgia
Niles, Michigan

 None

 Production of aluminum extrusions, fabrication and finishing

 Locations in the U.S.

 Locations Outside the U.S.

 Principal Operations

 Pottsville, Pennsylvania

 Guangzhou, China

 Production of plastic films

 Item 3. LEGAL PROCEEDINGS
 The information required by this Item 3 is set forth in Note 15 "Contingencies" to the Consolidated Financial Statements in Item 15 and is hereby incorporated herein by reference.

 Item 4. MINE SAFETY DISCLOSURES
 None.

 Item 5. MARKET FOR REGISTRANT'S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES
 Tredegar's common stock is traded on the New York Stock Exchange ("NYSE") under the ticker symbol "TG". There were 34,676,675 shares of common stock held by 1,498 shareholders of record on March 7, 2025. The shares of common stock held includes voting and dividend-participating unvested restricted stock granted to employees of 772,116 shares.
 Dividend Information
 Prior to the third quarter of 2023, Tredegar paid a regular cash dividend every quarter since becoming a public company in July 1989. All decisions with respect to the declaration and payment for future dividends will be made by the Board in its sole discretion based upon earnings, financial condition, anticipated cash needs, compliance with the covenants under the ABL Facility and other such considerations as the Board deems relevant.
 Issuer Purchases of Equity Securities
 In January 2008, Tredegar announced that the Board approved a share repurchase program whereby management is authorized at its discretion to purchase, in the open market or in privately negotiated transactions, up to 5 million shares of the Company's outstanding common stock. The authorization has no time limit. Tredegar did not repurchase any shares in the open market or otherwise in 2024, 2023 or 2022 under this standing authorization. The maximum number of shares remaining under this standing authorization was 1,732,003 at December 31, 2024. All decisions with respect to the declaration and payment for future share repurchases will be made by the Board in its sole discretion based upon earnings, financial condition, anticipated cash needs, compliance with the covenants under the ABL Facility and other such considerations as the Board deems relevant.

 Stock Performance Graph
 The following graph compares cumulative total shareholder returns for Tredegar, the S&P SmallCap 600 Stock Index (an index comprised of companies with market capitalizations similar to Tredegar) and the Russell 2000 Index for the five years ended December 31, 2024. Tredegar is part of both the S&P SmallCap 600 Index and Russell 2000 Index.

 COMPARISON OF 5 YEAR CUMULATIVE TOTAL RETURN*
 Among Tredegar Corporation, the S&P SmallCap 600 Index, and the Russell 2000 Index

 *$100 invested on 12/31/19 in stock or index, including reinvestment of dividends.
 Fiscal year ending December 31.

 Copyright 2025 Standard & Poor's, a division of S&P Global. All rights reserved.
 Copyright 2025 Russell Investment Group. All rights reserved.

 Item 6. [RESERVED]

 Item 7. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
 The following discussion and analysis of our financial condition and results of operations focuses on and is intended to clarify the results of our operations, certain changes in our financial position, liquidity, capital structure and business developments for the periods covered by the consolidated financial statements included in this Form 10-K. This discussion should be read in conjunction with, and is qualified by reference to, the other related information including, but not limited to, the audited consolidated financial statements (including the notes thereto) and the description of our business, all as set forth in this Form 10-K, as well as the risk factors discussed above in Item 1A.
 This section provides discussion and a year-to-year comparison for the years ended December 31, 2024 and 2023 and for the years ended December 31, 2023 and 2022.

 Business Overview
 General
 Tredegar Corporation is an industrial manufacturer with two primary businesses: custom aluminum extrusions for the B&C, automotive and specialty end-use markets in the United States through its Aluminum Extrusions segment (with exports comprising less than 5% of total sales volume) and surface protection films for high-technology applications in the global electronics industry through its PE Films segment. With approximately 1,500 employees, the Company operates manufacturing facilities in the U.S. and China.
 EBITDA from ongoing operations is the measure of segment profit and loss used by Tredegar's chief operating decision maker ("CODM") for purposes of assessing financial performance. The Company uses sales less freight ("net sales") as its measure of revenues from external customers at the segment level. This measure is separately included in the financial information regularly provided to the CODM.
 Earnings before interest and taxes ("EBIT") from ongoing operations is a non-GAAP financial measure included in the reconciliation of segment financial information to consolidated results for the Company in the Segment Operations Review section below. EBIT is not intended to represent the stand-alone results for Tredegar's ongoing operations under GAAP and should not be considered as an alternative to net income (loss) as defined by GAAP. We believe that EBIT is a widely understood and utilized metric that is meaningful to certain investors and that including this financial metric in the reconciliation of management's performance metric, EBITDA from ongoing operations, provides useful information to those investors that primarily utilize EBIT to analyze the Company's core operations.
 Sales were $598.0 million in 2024 compared to $573.3 million in 2023. Net income (loss) from continuing operations was $1.0 million ($0.03 per diluted share) in 2024, compared with net income (loss) from continuing operations of $(99.2) million ($(2.91) per diluted share) in 2023.
 2024 Financial Results Highlights
 • EBITDA from ongoing operations for Aluminum Extrusions of $41.4 million was $3.4 million higher than the year of 2023.
 • EBITDA from ongoing operations for PE Films of $30.5 million was $19.3 million higher than the year of 2023.
 Gains and losses associated with exit and disposal activities, plant shutdowns, asset impairments, restructurings and other items are described in Results of Operations below.

 Results of Operations
 2024 versus 2023
 The following table presents a bridge of consolidated net income (loss) from continuing operations from the year of 2023 to the year of 2024 with related management's discussion and analysis below the table.

 Net income (loss) from continuing operations for the year ended December 31, 2023

 $
 (99,165)

 (51,300)

 Income (loss) from continuing operations before income taxes for the year ended December 31, 2023

 (150,465)

 Change in income (loss) from increases (decreases) in the following items:

 Sales
 24,702

 Other income (expense), net
 1,197

 Total
 25,899

 Change in income (loss) from (increases) decreases in the following items:

 Cost of goods sold
 (518)

 Freight

 Selling, general and administrative
 (7,582)

 Research and development
 2,183

 Pension and postretirement benefits
 10,627

 1,652

 Asset impairments and costs associated with exit and disposal
activities, net of adjustments
 4,447

 21,620

 Other
 (20)

 Total
 125,446

 Income (loss) from continuing operations before income taxes for the year ended December 31, 2024

 (165)

 Net income (loss) from continuing operations for the year ended December 31, 2024

 $
 1,045

 Sales in 2024 increased by 4.3% compared with 2023. Net sales were relatively flat in Aluminum Extrusions primarily due to flat sales volume and the pass-through of higher metal costs, partially offset by a lower average conversion price add-on to metal costs associated with a shift in sales mix. Net sales increased 37.0% in PE Films primarily due to higher net sales and volume in Surface Protection, with extremely high sales in the first half of 2024 associated with the restocking of Surface Protection customers' inventories. Overwrap films volume increased 14% versus 2023, primarily due to volume increases associated with lower margin business. For more information on changes in net sales and volume, see the Segment Operations Review section below.
 Other income (expense), net was $(1.0) million in 2024 compared to $(2.1) million in 2023. The amount in other income (expense), net for 2024 was primarily related to $1.3 million of deferred and discretionary incentive payments made in 2024 subsequent to the sale of Terphane. The amount in other income (expense), net for 2023 was primarily related to a $2.0 million charge to adjust the initial purchase price of the nonparticipating single premium group annuity contract as a result of the routine administrative process to transition the pension plan.
 Consolidated gross profit (sales minus cost of goods sold and freight) as a percentage of sales (gross profit margin) was 16.1% in 2024 versus 12.4% in 2023.
 • The gross profit margin in Aluminum Extrusions increased primarily due to favorable variable manufacturing costs, higher labor productivity and higher volume, partially offset by higher labor and employee-related costs and lower spread (the difference between selling prices and metal costs) associated with a shift in sales mix. Additionally, inventories accounted for under the last-in first-out ("LIFO") inventory method resulted in a charge of $1.2 million in 2024 versus a benefit of $0.9 million in 2023. The timing of the flow-through under the first-in first-out ("FIFO") method of aluminum raw material costs, which were previously acquired in a quickly changing commodity pricing environment, causing a temporary mismatch in the change in the cost of raw materials included in variable costs and

 the pass through to customers included in sales, resulted in a benefit of $1.4 million in 2024 versus a charge of $1.0 million in 2023.
 • The gross profit margin in PE Films increased primarily due to higher contribution margin (net sales less variable costs) from Surface Protection associated with substantially higher volume, favorable pricing, operating efficiencies and variable cost savings in 2024 versus 2023. Inventories accounted for under the LIFO method resulted in a benefit of $0.2 million in 2024 versus a benefit of $1.3 million in 2023, and the pass-through lag associated with resin costs resulted in a charge of $1.0 million in 2024 versus a charge of $0.5 million in 2023.
 For more information on changes in operating costs and expenses, see the Segment Operations Review section below.
 As a percentage of sales, selling, general and administrative ("SG&A") and R&D expenses were 12.3% in 2024 compared with 11.9% in 2023. While SG&A expense increased 11.6% and R&D decreased 75.4% year-over-year, sales increased $24.7 million or 4.3% compared with the prior year period. Higher SG&A spending was primarily due to higher employee-related compensation and higher professional fees associated with business development activities. Lower R&D spending was primarily due to lower costs associated with the closure of the PE Films technical center in Richmond, VA in 2023.
 Pension and postretirement benefits was $0.2 million in 2024 compared to $10.8 million in 2023. The change in pension and postretirement benefits was primarily due to lower pension expense as a result of the pension plan termination completed in 2023. During 2023, the Company settled the pension plan, which resulted in a pre-tax pension settlement loss in the consolidated results of operation of $92.3 million. On November 3, 2023, the pension plan termination and settlement process was completed, and the Company's relevant pension plan obligation was transferred to Massachusetts Mutual Life Insurance Company. See Note 8 "Retirement Plans and Other Postretirement Benefits" to the Consolidated Financial Statements in Item 15 for more information.
 During 2024, a non-cash goodwill impairment of $13.3 million was recognized associated with the Clearfield, Utah operation reporting unit in Aluminum Extrusions. During 2023, a non-cash partial goodwill impairment of $34.9 million was recognized associated with the Surface Protection reporting unit in PE Films. See Note 1 "Nature of Operations and Summary of Significant Accounting Policies" to the Consolidated Financial Statements in Item 15 for more information.
 The effective tax rate used to compute income taxes from continuing operations for the year of 2024 was (18.8)%, compared to 34.1% in 2023. The decrease in the effective tax rate is primarily due to pre-tax income from continuing operations in 2024 versus a pre-tax loss from continuing operations in 2023. The tax rate in 2023 was significantly impacted by tax benefits previously recorded in other comprehensive income (loss) that were released in 2023 as a result of the pension plan termination. The stranded taxes released with the termination of the pension plan represent the effect of the change in federal and state tax rates on pension-related deferred tax items initially recorded in other comprehensive income. The related stranded taxes were released in full in 2023. See Note 11 "Income Taxes" to the Consolidated Financial Statements in Item 15 for additional information.
 Pre-tax gains and losses associated with plant shutdowns, asset impairments, restructurings and other items in 2024 detailed below are shown in the reconciliation of net sales and EBITDA from ongoing operations by segment in the Segment Operations Review below and are included in "Asset impairments and costs associated with exit and disposal activities, net of adjustments" in the consolidated statements of income, unless otherwise noted.

 ($ in millions)
 Q1
 Q2
 Q3
 Q4
 2024

 Aluminum Extrusions:

 (Gains) losses associated with plant shutdowns, asset impairments and restructurings:

 Production equipment asset impairment
 $
 —
 $
 —
 $
 —
 $
 0.2
 $
 0.2

 (Gains) losses from sale of assets, investment writedowns and other items:

 Consulting expenses for ERP/MES project1

 0.6
 0.8
 0.7
 0.5
 2.6

 Storm damage to the Newnan, Georgia plant1

 0.1
 0.2
 —
 (0.7)
 (0.4)

 Legal fees associated with the Aluminum Extruders Trade Case and other matters1

 0.2
 0.3
 0.4
 0.3
 1.2

 Resolution of customer quality complaint3

 —
 —
 0.8
 (0.1)
 0.7

 Goodwill impairment4

 —
 —
 —
 13.3
 13.3

 Total for Aluminum Extrusions
 $
 0.9
 $
 1.3
 $
 1.9
 $
 13.5
 $
 17.6

 PE Films:

 (Gains) losses associated with plant shutdowns, asset impairments and restructurings:

 Richmond, Virginia Technical Center closure expenses, including severance4

 $
 0.2
 $
 0.1
 $
 —
 $
 (0.1)
 $
 0.2

 Richmond, Virginia Technical Center lease modification4

 0.3
 —
 —
 (0.1)
 0.2

 Total for PE Films
 $
 0.5
 $
 0.1
 $
 —
 $
 (0.2)
 $
 0.4

 Corporate:

 (Gain) losses from sale of assets, investment writedowns and other items:

 Professional fees associated with business development activities1

 $
 0.2
 $
 —
 $
 0.1
 $
 0.3
 $
 0.6

 Professional fees associated with remediation activities related to internal control over financial reporting1

 0.9
 0.4
 0.3
 0.2
 1.8

 Professional fees associated with the transition to the ABL Facility1

 0.2
 —
 0.1
 0.1
 0.4

 Deferred and discretionary incentive payments made subsequent to the sale of Terphane2

 —
 —
 —
 1.3
 1.3

 Group annuity contract premium adjustment2,5

 —
 (0.2)
 —
 (0.1)
 (0.3)

 Total for Corporate
 $
 1.3
 $
 0.2
 $
 0.5
 $
 1.8
 $
 3.8

 1.Included in "Selling, general and administrative expenses" in the consolidated statements of income.
 2.Included in "Other income (expense), net" in the consolidated statements of income.
 3.Included in "Sales" in the consolidated statements of income.
 4.For more information, see Note 1 "Nature of Operations and Summary of Significant Accounting Policies" to the Consolidated Financial Statements in Item 15.
 5.For more information, see Note 8 "Retirement Plans and Other Postretirement Benefits" to the Consolidated Financial Statements in Item 15.

 Average total debt outstanding and interest rates were as follows:

 (In millions, except percentages)
 2024
 2023

 Floating-rate debt with interest charged on a rollover basis plus a credit spread:

 Average total outstanding debt balance
 $
 117.7
 $
 148.9

 Average interest rate
 8.9
 %
 7.1
 %

 2023 versus 2022
 The following table presents a bridge of consolidated net income (loss) from the year of 2022 to the year of 2023 with related management's discussion and analysis below the table.

 Net income (loss) from continuing operations for the year ended December 31, 2022

 $
 12,585

 (3,021)

 Income (loss) from continuing operations before income taxes for the year ended December 31, 2022

 9,564

 Change in income (loss) from increases (decreases) in the following items:

 Sales
 (188,662)

 Other income (expense), net
 (3,209)

 Total
 (191,871)

 Change in income (loss) from (increases) decreases in the following items:

 Cost of goods sold
 150,109

 Freight
 4,785

 Selling, general and administrative
 4,223

 Research and development
 2,429

 (2,175)

 (92,291)

 (34,891)

 Other
 (347)

 Total
 31,842

 Income (loss) from continuing operations before income taxes for the year ended December 31, 2023

 (150,465)

 (51,300)

 Net income (loss) from continuing operations for the year ended December 31, 2023

 $
 (99,165)

 Sales in 2023 decreased by 24.8% compared with 2022. Net sales decreased 25.6% in Aluminum Extrusions primarily due to lower sales volume and the pass-through of lower metal costs. Net sales decreased 21.3% in PE Films primarily due to lower volume in Surface Protection, resulting from weak demand in the consumer electronics market and customer inventory corrections during 2023. For more information on changes in net sales and volume, see the Segment Operations Review section below.
 Other income (expense), net was $(2.1) million in 2023 compared to $1.1 million in 2022. The change in other income (expense), net was primarily due to a $2.0 million charge to adjust the initial purchase price of the nonparticipating single premium group annuity contract as a result of the routine administrative process to transition the pension plan. Also, there was cash consideration of $0.3 million received in January 2023 compared to $1.4 million received in May 2022 related to customary post-closing adjustments on the sale of the investment in kaleo, Inc., which was sold in December 2021.
 Consolidated gross profit (sales minus cost of goods sold and freight) as a percentage of sales (gross profit margin) was 12.4% in 2023 versus 13.8% in 2022.
 • The gross profit margin in Aluminum Extrusions decreased primarily due to lower volume, lower labor productivity in the first half of 2023, higher supply expense, including higher paint expense associated with a shift to more painted product throughout 2023 and inflationary costs for other supplies, partially offset by lower utility costs and unfavorable LIFO inventory adjustments. The timing of the flow through under the FIFO method of aluminum raw material costs, which were previously acquired in a quickly changing commodity pricing environment, causing a temporary mismatch in the change in the cost of raw materials included in variable costs and the pass through to customers included in sales, resulted in a charge of $1.0 million in 2023 versus a benefit of $0.1 million in 2022. There were lower fixed manufacturing costs primarily due to lower non-production utility costs, and lower employee compensation. In addition, the Company recorded an unfavorable out-of-period adjustment of $0.4 million related to inventory and accrued labor costs in 2022.
 • The gross profit margin in PE Films increased primarily due to higher overwrap films contribution margin associated with higher volume, favorable mix and favorable pricing, operating efficiencies and cost improvements and favorable LIFO inventory adjustments for both Surface Protection and overwrap films in 2023 versus 2022, partially offset by lower contribution margin for Surface Protection associated with a market slowdown, customer

 inventory corrections and for previously disclosed customer product transitions. In addition, fixed manufacturing costs were lower primarily due to employee compensation and fixed cost savings.
 For more information on changes in operating costs and expenses, see the Segment Operations Review section below.
 As a percentage of sales, SG&A and R&D expenses were 11.9% in 2023 compared with 9.8% in 2022. While SG&A and R&D expenses decreased 6.1% and 45.6% year-over-year, sales decreased $188.7 million or 24.8% compared with the prior year period. Lower SG&A spending was primarily due to lower employee-related compensation and lower stock-based compensation. Lower R&D spending was primarily due to the closure of the technical center in Richmond, VA.
 For more information on changes in interest expense, see the "Corporate Expenses, Interest and Other" section of the Segment Operations Review section below.
 During 2023, the Company settled the pension plan, which resulted in a pre-tax pension settlement loss in the consolidated results of operation of $92.3 million. On November 3, 2023, the pension plan termination and settlement process was completed, and the Company's relevant pension plan obligation was transferred to Massachusetts Mutual Life Insurance Company. See Note 8 "Retirement Plans and Other Postretirement Benefits" to the Consolidated Financial Statements in Item 15 for more information.
 During 2023, a non-cash partial goodwill impairment of $34.9 million was recognized associated with the Surface Protection reporting unit in PE Films, see Note 1 "Nature of Operations and Summary of Significant Accounting Policies" to the Consolidated Financial Statements in Item 15 for more information.
 The effective tax rate used to compute income taxes from continuing operations for the year of 2023 was 34.1%, compared to (31.6)% in 2022. The increase in the effective tax rate is primarily due to tax benefits previously recorded in other comprehensive income (loss) that were released as a result of the pension plan termination, partially offset by a reduction in Brazilian tax incentives as a percentage of income. The stranded taxes released with the termination of the pension plan represent the effect of the change in federal and state tax rates on pension-related deferred tax items initially recorded in other comprehensive income. The related stranded taxes were released in full in 2023. See Note 11 "Income Taxes" to the Consolidated Financial Statements in Item 15 for additional information.
 Pre-tax gains and losses associated with plant shutdowns, asset impairments, restructurings and other items in 2023 detailed below are shown in the reconciliation of net sales and EBITDA from ongoing operations by segment table in the Segment Operations Review below and are included in "Asset impairments and costs associated with exit and disposal activities, net of adjustments" in the consolidated statements of income, unless otherwise noted.

 ($ in millions)
 Q1
 Q2
 Q3
 Q4
 2023

 Aluminum Extrusions:

 (Gains) losses associated with plant shutdowns, asset impairments and restructurings:

 Other restructuring costs - severance
 $
 —
 $
 —
 $
 0.1
 $
 —
 $
 0.1

 (Gains) losses from sale of assets, investment writedowns and other items:

 Consulting expenses for ERP/MES project1

 —
 —
 1.2
 0.6
 1.8

 Storm damage to the Newnan, Georgia plant1

 0.6
 (0.2)
 0.1
 —
 0.5

 Legal fees associated with the Aluminum Extruders Trade Case1

 —
 —
 —
 0.5
 0.5

 Total for Aluminum Extrusions
 $
 0.6
 $
 (0.2)
 $
 1.4
 $
 1.1
 $
 2.9

 PE Films:

 (Gains) losses associated with plant shutdowns, asset impairments and restructurings:

 Impairment of Richmond, Virginia Technical Center assets3

 $
 —
 $
 —
 $
 3.4
 $
 0.1
 $
 3.5

 Richmond, Virginia Technical Center closure expenses, including severance3

 —
 —
 1.2
 0.1
 1.3

 Richmond, Virginia Technical Center accelerated depreciation3

 —
 —
 —
 0.3
 0.3

 Richmond, Virginia Technical Center lease modification3

 —
 —
 —
 (0.1)
 (0.1)

 Goodwill impairment3

 —
 15.4
 19.5
 —
 34.9

 Total for PE Films
 $
 —
 $
 15.4
 $
 24.1
 $
 0.4
 $
 39.9

 Corporate:

 (Gain) losses from sale of assets, investment writedowns and other items:

 Professional fees associated with business development activities1

 $
 (0.1)
 $
 (0.1)
 $
 0.1
 $
 0.3
 $
 0.2

 Professional fees associated with remediation activities related to internal control over financial reporting1

 0.5
 0.5
 0.2
 0.8
 2.0

 Write-down of investment in Harbinger Capital Partners Special Situations Fund2

 —
 0.2
 —
 —
 0.2

 Group annuity contract premium expense2

 —
 —
 —
 2.0
 2.0

 Net periodic benefit cost for the frozen defined benefit pension plan in process of termination4

 3.4
 3.4
 3.1
 0.9
 10.8

 Pension settlement loss4

 —
 —
 25.6
 66.7
 92.3

 Total for Corporate
 $
 3.8
 $
 4.0
 $
 29.0
 $
 70.7
 $
 107.5

 1.Included in "Selling, general and administrative expenses" in the consolidated statements of income.
 2.Included in "Other income (expense), net" in the consolidated statements of income.
 3.For more information, see Note 1 "Nature of Operations and Summary of Significant Accounting Policies" to the Consolidated Financial Statements in Item 15.
 4. For more information, see Note 8 "Retirement Plans and Other Postretirement Benefits" to the Consolidated Financial Statements in Item 15.

 Average total debt outstanding and interest rates were as follows:

 (In millions, except percentages)
 2023
 2022

 Floating-rate debt with interest charged on a rollover basis plus a credit spread:

 Average total outstanding debt balance
 $
 148.9
 $
 114.5

 Average interest rate
 7.1
 %
 3.5
 %

 Segment Operations Review
 2024 versus 2023
 A summary of operating results for 2024 versus 2023 for both of the Company's reporting segments is shown below.
 A summary of results for Aluminum Extrusions is provided below:

 Favorable/

 (Unfavorable)

 2024
 2023
 % Change

 Sales volume (lbs)
 139,152
 138,451
 0.5%

 Net sales
 $
 471,815
 $
 (0.6)%

 354,397
 365,320
 3.0%

 Last-in first-out inventory adjustment
 1,234
 (944)
 NM*

 Manufacturing fixed costs1

 40,123
 41,028
 2.2%

 Selling, general and administrative costs1

 33,638
 29,725
 (13.2)%

 Other2

 1,066
 1,698
 37.2%

 $
 41,357
 $
 37,976
 8.9%

 (17,722)
 (17,927)
 1.1%

 EBIT from ongoing operations3

 $
 23,635
 $
 20,049
 17.9%

 $
 10,097
 $
 20,339

 1.Excludes related depreciation and amortization
 2.Includes segment allocated employee compensation benefit expenses
 3.See the reconciliation below of this non-GAAP measure to the most comparable measure calculated in accordance with GAAP.
 *Not meaningful ("NM")

 Net sales in 2024 were relatively flat versus 2023 primarily due to flat sales volume and the pass-through of higher metal costs, partially offset by a lower average conversion price add-on to metal costs associated with a shift in sales mix.
 EBITDA from ongoing operations increased $3.4 million in 2024 versus 2023, primarily due to:
 • A $7.9 million increase in contribution margin associated with:
 Favorable variable manufacturing costs ($4.8 million), higher labor productivity ($2.5 million) and higher volume ($0.5 million), partially offset by higher labor and employee-related costs ($2.2 million) and lower spread associated with a shift in sales mix ($1.4 million); and
 The timing of the flow-through under the FIFO method of aluminum raw material costs, which were previously acquired in a quickly changing commodity pricing environment, causing a temporary mismatch in the change in the cost of raw materials included in variable costs and the pass through to customers included in sales, resulted in a benefit of $1.4 million in 2024 versus a charge of $1.0 million in 2023.
 • Inventories accounted for under the LIFO method resulted in a charge of $1.2 million in 2024 versus a benefit of $0.9 million in 2023;
 • Lower manufacturing fixed costs of $0.9 million primarily due to lower employee-related compensation and reduced outside services ($1.2 million); and
 • Higher SG&A expenses of $3.9 million primarily due to employee-related incentive compensation ($2.7 million) and headquarters rent expenses ($0.6 million).

 Aluminum Extrusions believes that it has adequate supply agreements for aluminum and other product cost components in 2025. See discussion of quantitative and qualitative disclosures about market risk in Item 7A in this Form 10-K for additional information on aluminum price trends.
 Goodwill Impairment at Bonnell
 During the fourth quarter of 2024, the Company recognized a non-cash write-off of goodwill of $13.3 million ($10.4 million after deferred income tax benefits) associated with the Clearfield, Utah operation ("Clearfield") acquired in February 2017 (formerly Futura). Clearfield exceeded expectations in performance, including exceptional customer service, from the date of acquisition until before pandemic-related disruptions that resulted in long lead times during periods of 2021 and 2022. Long lead times resulted in customers seeking supply from other sources to meet their demand, including imports. Some business lost at Clearfield during this time has been regained during the recovery underway, but not at the level that the Company previously anticipated would eventually replicate the EBITDA and net cash flow generation that existed prior to the pandemic-related disruptions. As a consequence, using projections that assume the continuation of lower sales and profitability, the estimated fair value of Clearfield during the fourth quarter of 2024 fell below its carrying value by more than the amount of goodwill causing the write-off.
 Projected Capital Expenditures and Depreciation & Amortization
 Capital expenditures for Bonnell Aluminum are projected to be $17 million in 2025, including $5 million for productivity projects and $12 million for capital expenditures required to support continuity of operations. Depreciation expense is projected to be $16 million in 2025. Amortization expense is projected to be $2 million in 2025.
 A summary of results for PE Films is provided below:

 Favorable/

 (Unfavorable)

 2024
 2023
 % Change

 Sales volume (lbs)
 39,324
 29,355
 34.0%

 Net sales
 $
 105,199
 $
 37.0%

 50,289
 40,824
 (23.2)%

 (174)
 (1,333)
 (86.9)%

 Manufacturing fixed costs1

 13,248
 13,793
 4.0%

 Selling, general and administrative costs1

 11,245
 12,106
 7.1%

 Other2

 32.7%

 $
 30,486
 $
 11,217
 171.8%

 (5,200)
 (6,522)
 20.3%

 EBIT from ongoing operations3

 $
 25,286
 $
 4,695
 NM*

 $
 1,761
 $
 1,772

 1.Excludes related depreciation and amortization
 2.Includes segment allocated employee compensation benefit expenses
 3.See the reconciliation below of this non-GAAP measure to the most comparable measure calculated in accordance with GAAP.
 *Not meaningful ("NM")

 Net sales in 2024 increased 37.0% versus 2023 due to higher net sales in Surface Protection. Sales volume in 2024 for surface protection films increased 57% versus 2023, with extremely high sales volumes in the first half of 2024 associated with the restocking of Surface Protection customers' inventories. Overwrap films volume increased 14% versus 2023, primarily due to volume increases associated with lower margin business.
 EBITDA from ongoing operations in 2024 increased $19.3 million versus 2023 primarily due to:
 • Higher contribution margin of $19.0 million resulting from:
 A $19.4 million increase from Surface Protection associated with substantially higher volume and favorable pricing ($13.4 million), and operating efficiencies and variable cost savings ($6.0 million);
 Relatively flat contribution margin from overwrap films, associated with a shift in sales mix and unfavorable pricing ($1.0 million), offset by operating efficiencies and variable cost savings ($1.0 million); and
 The pass-through lag associated with resin costs ($1.0 million charge in 2024 versus a charge of $0.5 million in 2023).

 • Inventories accounted for under the LIFO method that resulted in a benefit of $0.2 million in 2024 versus a benefit of $1.3 million in 2023.
 • Lower SG&A of $0.9 million primarily due to decreased research and development costs ($1.6 million), partially offset by increased employee-related incentive compensation ($1.2 million).
 See discussion of quantitative and qualitative disclosures about market risk in Item 7A in this Form 10-K for additional information on resin price trends.
 Projected Capital Expenditures and Depreciation & Amortization
 Capital expenditures for PE Films are projected to be $3 million in 2025, including $2 million for productivity projects and $1 million for capital expenditures required to support continuity of current operations. Depreciation expense is projected to be $5 million in 2025. There is no amortization expense for PE Films.
 Corporate Expenses and Interest
 Corporate expenses, net in 2024 decreased by $9.2 million compared to 2023, primarily due to lower pension expense as a result of the pension plan termination completed in 2023 ($10.7 million), a non-recurring charge in 2023 associated with the pension plan transition ($2.3 million) and lower software maintenance fees ($0.6 million), partially offset by higher employee-related incentive compensation ($4.7 million).
 Interest expense was $4.7 million in 2024 in comparison to $6.3 million in 2023, primarily due to lower weighted average total debt outstanding, partially offset by higher interest rates.
 2023 versus 2022
 A summary of operating results for 2023 versus 2022 for each of the Company's reporting segments is shown below.
 A summary of results for Aluminum Extrusions is provided below:

 Favorable/

 (Unfavorable)

 2023
 2022
 % Change

 Sales volume (lbs)
 138,451
 174,670
 (20.7)%

 Net sales
 $
 $
 637,872
 (25.6)%

 365,320
 503,374
 27.4%

 (944)
 (5,402)
 (82.5)%

 Manufacturing fixed costs1

 41,028
 43,073
 4.7%

 Selling, general and administrative costs1

 29,725
 31,641
 6.1%

 Other2

 1,698
 (1,614)
 NM*

 $
 37,976
 $
 66,800
 (43.1)%

 (17,927)
 (17,414)
 (2.9)%

 EBIT from ongoing operations3

 $
 20,049
 $
 49,386
 (59.4)%

 $
 20,339
 $
 23,664

 1.Excludes related depreciation and amortization
 2.Includes segment allocated employee compensation benefit expenses
 3.See the reconciliation below of this non-GAAP measure to the most comparable measure calculated in accordance with GAAP.
 *Not meaningful ("NM")

 Net sales in 2023 decreased 25.6% versus 2022 primarily due to lower sales volume and the pass-through of lower metal costs.
 EBITDA from ongoing operations decreased $28.8 million in 2023 versus 2022, primarily due to:
 • A 25.0 million decrease in contribution margin associated with:
 Lower volume ($27.6 million), lower labor productivity in the first half of 2023 ($0.9 million), higher supply expense, including higher paint expense associated with a shift to more painted product throughout 2023 and inflationary costs for other supplies ($1.6 million), partially offset by lower utility costs ($2.3 million);
 The timing of the flow-through under the FIFO method of aluminum raw material costs, which were previously acquired in a quickly changing commodity pricing environment, causing a temporary mismatch in

 the change in the cost of raw materials included in variable costs and the pass through to customers included in sales, resulted in a charge of $1.0 million in 2023 versus a benefit of $0.1 million in 2022; and
 • Inventories accounted for under the LIFO method resulted in a benefit of $0.9 million in 2023 versus a benefit of $5.4 million in 2022.
 • Lower manufacturing fixed costs of $2.0 million primarily due to lower non-production utility costs ($0.9 million) and lower employee-related compensation ($0.5 million). In addition, the Company recorded an unfavorable out-of-period adjustment of $0.4 million related to inventory and accrued labor costs in 2022.
 • Lower SG&A expenses of $1.9 million primarily due to lower employee incentive-based compensation ($2.5 million) and lower expense for allowance for bad debt ($0.8 million), partially offset by other employee-related compensation ($0.9 million) and increased information technology expenses ($0.4 million).
 A summary of results for PE Films is provided below:

 Favorable/

 (Unfavorable)

 2023
 2022
 % Change

 Sales volume (lbs)
 29,355
 32,873
 (10.7)%

 Net sales
 $
 $
 97,571
 (21.3)%

 40,824
 56,085
 27.2%

 (1,333)
 NM*

 Manufacturing fixed costs1

 13,793
 15,216
 9.4%

 Selling, general and administrative costs1

 12,106
 14,116
 14.2%

 Other2

 (316)
 NM*

 $
 11,217
 $
 11,949
 (6.1)%

 (6,522)
 (6,280)
 (3.9)%

 EBIT from ongoing operations3

 $
 4,695
 $
 5,669
 (17.2)%

 $
 1,772
 $
 3,289

 1.Excludes related depreciation and amortization
 2.Includes segment allocated employee compensation benefit expenses
 3.See the reconciliation below of this non-GAAP measure to the most comparable measure calculated in accordance with GAAP.
 *Not meaningful ("NM")

 Net sales in 2023 decreased 21.3% versus 2022, primarily due to lower volume in Surface Protection, resulting from weak demand in the consumer electronics market and customer inventory corrections during 2023. Sales volume in 2023 for surface protection films declined 22% and increased 2% for overwrap films versus 2022.
 EBITDA from ongoing operations in 2023 decreased $0.7 million versus 2022 primarily due to:
 • Lower contribution margin of $5.5 million resulting from:
 An $8.6 million decrease from Surface Protection associated with a market slowdown and customers' inventory corrections ($11.1 million) and for previously disclosed customer product transitions ($0.7 million), partially offset by favorable pricing ($0.5 million) and operating efficiencies ($2.6 million);
 A $4.5 million increase from overwrap films associated with higher volume, favorable mix and favorable pricing ($1.3 million) and operating efficiencies and cost improvements ($3.2 million); and
 The pass-through lag associated with resin costs (a charge of $0.5 million in 2023 versus a benefit of $0.9 million in 2022).
 • Inventories accounted for under the LIFO method, which resulted in a benefit of $1.3 million versus a charge of $0.5 million in 2022;
 • Lower fixed manufacturing costs of $1.4 million primarily due to employee compensation expenses ($1.0 million) and other fixed cost savings ($0.2 million).
 • Lower SG&A of $2.0 million primarily due to lower research and development ($2.0 million) from the closure of the technical center in Richmond, VA.

 Corporate Expenses and Interest
 Corporate expenses, net in 2023 decreased by $6.7 million compared to 2022, primarily due to lower pension expense as a result of the pension plan termination completed in 2023 ($3.7 million), lower accruals for employee-related compensation ($2.1 million), lower stock-based compensation ($1.3 million), lower professional fees associated with business development activities ($0.8 million), and lower external and internal audit fees ($1.0 million), partially offset by a charge to adjust the initial purchase price of the nonparticipating single premium group annuity contract as a result of the routine administrative process to transition the pension plan ($2.0 million).
 Interest expense was $6.3 million in 2023 in comparison to $4.1 million in 2022, primarily due to higher weighted average total debt outstanding and higher interest rates.

 Reconciliation of Net Sales and EBITDA from Ongoing Operations by Segment
 A reconciliation of segment financial information to consolidated results for the Company for the years ended December 31, 2024, 2023 and 2022 is shown below:

 2024
 2023
 2022

 $
 471,815
 $
 $
 637,872

 105,199
 97,571

 Total net sales
 577,014
 551,566
 735,443

 Add back freight
 21,011
 21,757
 26,542

 Sales as shown in the condensed consolidated statements of income
 $
 598,025
 $
 573,323
 $
 761,985

 EBITDA from Ongoing Operations

 Aluminum Extrusions:

 Ongoing operations:

 EBITDA
 $
 41,357
 $
 37,976
 $
 66,800

 (17,722)
 (17,927)
 (17,414)

 EBIT
 23,635
 20,049
 49,386

 Plant shutdowns, asset impairments, restructurings and other
 (5,346)
 (3,557)
 (310)

 (13,271)
 —
 —

 PE Films:

 Ongoing operations:

 EBITDA
 $
 30,486
 $
 11,217
 $
 11,949

 (5,200)
 (6,522)
 (6,280)

 EBIT
 25,286
 4,695
 5,669

 Plant shutdowns, asset impairments, restructurings and other
 (420)
 (4,972)
 (646)

 —
 (34,891)
 —

 Total
 29,884
 (18,676)
 54,099

 4,664
 6,316
 4,141

 Gain on investment in kaleo, Inc.
 1,406

 Stock option-based compensation costs
 —
 1,414

 —
 —

 Corporate expenses, net
 24,520
 33,727
 40,402

 Income (loss) from continuing operations before income taxes
 (150,465)
 9,564

 (165)
 (51,300)
 (3,021)

 1,045
 (99,165)
 12,585

 (65,610)
 (6,740)
 15,870

 $
 (64,565)
 $
 (105,905)
 $

 Liquidity and Capital Resources
 The Company continues to focus on working capital management. Measures such as days sales outstanding ("DSO"), days inventory outstanding ("DIO") and days payables outstanding ("DPO") are used to evaluate changes in working capital. Changes in operating assets and liabilities from December 31, 2023 to December 31, 2024 are summarized below. Cash flows for discontinued operations have not been separately disclosed in the consolidated statements of cash flows.
 • Accounts and other receivables increased $9.2 million or 16.5%.
 Accounts and other receivables in Aluminum Extrusions increased $8.3 million primarily due to higher sales volume and the pass-through of higher metal costs, partially offset by a lower average conversion price add-on to metal costs associated with a shift in sales mix in the fourth quarter of 2024 versus the fourth quarter of 2023. DSO (computed using trailing 12 months net sales and a rolling 12-month average of accounts and other receivables balances) was approximately 44.7 days in 2024 and 45.1 days in 2023.
 Accounts and other receivables in PE Films increased $0.9 million primarily due to higher sales volume in surface protection films. DSO was approximately 24.9 days in 2024 and 26.3 days in 2023.
 • Inventories increased $1.7 million or 3.5%.
 Inventories in Aluminum Extrusions remained consistent with prior year. DIO (computed using trailing 12 months costs of goods sold calculated on a FIFO basis and a rolling 12-month average of inventory balances calculated on the FIFO basis) was approximately 47.4 days in 2024 and 51.6 days in 2023.
 Inventories in PE Films increased $1.4 million due to higher raw materials costs and higher finished goods. The DIO was approximately 50.3 days in 2024 and 57.2 days in 2023.
 • Net property, plant and equipment decreased by $14.1 million or 9.3% primarily due to depreciation expense ($21.4 million), partially offset by capital expenditures ($8.3 million).
 • Identifiable intangible assets, net decreased by $1.8 million or 19.5% primarily due to amortization expense.
 • Deferred income tax assets, net increased $9.3 million or 40.1% primarily due to an increase in tax credit carryforwards offset by the utilization of net operating loss and interest limitation carryforwards. Deferred tax liabilities related to intangible amortization, depreciation and foregone tax credits on foreign branch income decreased $6.3 million while deferred taxes assets related to capitalized R&D and asset write-offs, divestitures and environmental accruals increased $4.3 million. See Note 11 "Income Taxes" to the Consolidated Financial Statements in Item 15 for additional information.
 • Accounts payable decreased by $4.6 million or 6.7%.
 Accounts payable in Aluminum Extrusions decreased $3.9 million, primarily due to the timing of payments. DPO (computed using trailing 12 months costs of goods sold calculated on a FIFO basis and a rolling 12-month average of accounts payable balances) was approximately 44.5 days in 2024 and 49.8 days in 2023.
 Accounts payable in PE Films remained relatively flat. The DPO was approximately 41.3 days in 2024 and 43.4 days for 2023.
 Net cash provided by operating activities was $25.5 million in 2024 compared to net cash provided by operating activities of $24.0 million in 2023. The change in operating activities is primarily due to an increase in EBITDA from ongoing operations of the Company's continuing business segments of $22.7 million, partially offset by a net increase in accounts and other receivables, inventories, prepaid expenses and other, and accounts payable of $18.9 million.
 Net cash provided by investing activities was $40.5 million in 2024 compared to net cash used in investing activities of $26.2 million in 2023. The change in investing activities is primarily due to net cash proceeds received for the sale of Terphane ($54.6 million) and lower capital expenditure spending ($12.1 million).
 Net cash used in financing activities was $65.0 million in 2024 compared to net cash used in financing activities of $4.5 million in 2023. The change in financing activities is primarily due to higher debt principal payments, net of borrowings ($72.8 million) under the ABL Facility (as defined below), lower dividends paid ($8.9 million) and lower debt financing fees ($3.4 million).
 At December 31, 2024, Tredegar had cash, cash equivalents and restricted cash of $7.1 million, including funds held in locations outside the U.S. of $1.6 million.

 Debt and Credit Agreements
 ABL Facility
 In December 2023, the Company entered into Amendment No. 3 to the Second Amended and Restated Credit Agreement ("the Credit Agreement"), which, prior to the ABL Adjustment Date (as defined below), provided the Company with a $180 million senior secured asset-based revolving credit facility. In April 2024, the Company entered into Amendment No. 4 to the Credit Agreement (as amended by Amendment No. 3 and Amendment No. 4, the "ABL Facility") that, among other items: (i) moved the ABL Adjustment Date (defined below) from March 31, 2025 to September 30, 2025 and (ii) required weekly reporting of the borrowing base financial covenant until the ABL Adjustment Date. The ABL Facility is secured by substantially all assets of the Company and its domestic subsidiaries, including equity in certain material first-tier foreign subsidiaries. Availability for borrowings under the ABL Facility is governed by a borrowing base, determined by the application of specified advance rates against eligible assets, including a portion of trade accounts receivable, inventory, cash and cash equivalents, owned real properties, and owned machinery and equipment. Upon the earlier of September 30, 2025 or the date the Company received the proceeds from the sale of Terphane (the "ABL Adjustment Date"), the $180 million ABL Facility was to be reduced to $125 million. On November 1, 2024, with the closing of the sale of Terphane, the ABL Adjustment Date occurred. The ABL Facility will expire on June 30, 2026.
 The financial covenant is a minimum fixed charge coverage ratio (as defined in the ABL Facility) of 1.00:1.00 that will be triggered in the event that availability is less than 10% of the $125 million commitment amount and continuing thereafter until availability is greater than 10% of the $125 million commitment amount for 30 consecutive days. As of December 31, 2024, funds available to borrow under the ABL Facility was $43.8 million, or 35.0% of the aggregate commitment of $125 million.

 The computation of Credit EBITDA, as defined in the ABL Facility, is presented below.

 Computations of Credit EBITDA (as defined in the ABL Facility) as of and for the
 Twelve Months Ended December 31, 2024 *

 Computations of Credit EBITDA for the twelve months ended December 31, 2024 (in thousands):

 $
 (64,565)

 Plus:

 After-tax losses related to discontinued operations
 65,610

 Total income tax expense for continuing operations
 —

 4,664

 Depreciation and amortization expense for continuing operations
 23,225

 All non-cash losses and expenses, plus cash losses and expenses not to exceed $10,000, for continuing operations that are classified as unusual, extraordinary or which are related to plant shutdowns, asset impairments and/or restructurings (cash-related of $8,590)
 22,321

 Charges related to stock option grants and awards accounted for under the fair value-based method
 —

 Losses related to the application of the equity method of accounting
 —

 Losses related to adjustments in the estimated fair value of assets accounted for under the fair value method of accounting
 —

 Fees, costs and expenses incurred in connection with the amendment process

 Terphane sale transaction costs in an amount not to exceed $10,000
 —

 Minus:

 After-tax income related to discontinued operations
 —

 Total income tax benefits for continuing operations
 (165)

 (36)

 All non-cash gains and income, plus cash gains and income in excess of $10,000, for continuing operations that are classified as unusual, extraordinary or which are related to plant shutdowns, asset impairments and/or restructurings
 —

 Income related to changes in estimates for stock option grants and awards accounted for under the fair value-based method
 —

 Income related to the application of the equity method of accounting
 —

 Income related to adjustments in the estimated fair value of assets accounted for under the fair value method of accounting
 (144)

 Plus cash dividends declared on investments in an amount not to exceed $10,000 for such period
 —

 Plus or minus, as applicable, pro forma EBITDA adjustments associated with acquisitions and asset dispositions
 —

 Plus or minus, as applicable, pro forma EBITDA adjustments to pension expense associated with the early payment of pension obligations
 (258)

 Credit EBITDA
 $
 51,111

 Fixed charge coverage ratio**:

 Credit EBITDA
 $
 51,111

 Unfinanced capital expenditures
 $
 11,858

 Fixed charges
 $
 5,034

 Fixed charge coverage ratio
 7.80

 *Credit EBITDA is not intended to represent net income (loss) or cash flow from operations as defined by GAAP and should not be considered as an alternative to either net income (loss) or to cash flow.
 ** Fixed Charge Coverage Ratio is computed as the ratio of (a) Credit EBITDA minus Unfinanced Capital Expenditures to (b) Fixed Charges.

 As of December 31, 2024, the Company was in compliance with all debt covenants.
 PE Films Guangzhou Loan
 In June 2024, PE Films' business location in Guangzhou, China, Guangzhou Tredegar Film Products Co., Ltd.("Guangzhou Tredegar"), entered into a 9.5 million Chinese Yuan, which is equivalent to $1.3 million as of December 31, 2024, revolving loan with the Industrial and Commercial Bank of China. The loan matures on July 3, 2025. The interest rate is the one-year loan prime rate published by the National Interbank Funding Center for the working day immediately preceding the drawdown date, minus 0.45%. As of December 31, 2024, the National Interbank Funding Center rate was 3.45%. The

 revolving loan is secured by a mortgage contract listing the Guangzhou Tredegar factory building as collateral. The mortgage contract has a maximum value of 30 million Chinese Yuan and is effective from June 25, 2024 through May 31, 2027. This loan was presented as current debt on the consolidated balance sheet for the year ended December 31, 2024.
 For more information on the ABL Facility and the PE Films Guangzhou Loan, see Note 7 "Debt and Credit Agreements" to the consolidated Financial Statements in Item 15.
 The Company believes that existing borrowing availability, current cash balances and cash flow from operations will be sufficient to satisfy short term material cash requirements related to working capital, capital expenditure, and debt repayments for at least the next 12 months. In the longer term, liquidity will depend on many factors, including the results of operations, the timing and extent of capital expenditures, changes in operating plans, or other events that would cause the Company to seek additional financing in future periods.
 Material Cash Requirements for Known Contractual and Other Obligations
 The Company's material cash requirements from known contractual and other obligations as of December 31, 2024 were as follows:
 Debt and interest payments
 As of December 31, 2024, the Company had outstanding debt under the ABL Facility of $60.6 million with contractual payments due in June 2026. Estimated future interest payments associated with the ABL Facility total $6.6 million, with $4.4 million payable within the next 12 months.
 As of December 31, 2024, PE Films had outstanding debt of $1.3 million under the PE Films Guangzhou Loan. Estimated future interest payments associated with the PE Films Guangzhou Loan payable within the next 12 months were immaterial.
 Capital expenditure commitments
 See "Projected Capital Expenditures and Depreciation & Amortization" within "Segment Operations Overview" above in this Item 7 for discussion of the Company's planned investment in capital expenditures in 2024, of which $0.4 million are contractual commitments that existed as of December 31, 2024.
 Operating Leases
 The Company enters into various operating leases primarily for real estate, office equipment and vehicles. See Note 4 "Leases" to the Consolidated Financial Statements in Item 15 for additional information.
 Uncertain Tax Positions
 As of December 31, 2024, unrecognized tax benefits on uncertain tax positions were $0.8 million. Tax payments resulting from the successful challenge by the taxing authority on uncertain tax positions taken by Tredegar would possibly result in the payment of interest and penalties of $0.2 million, which were accrued at December 31, 2024, if tax payments were made as a result of a successful challenge by the taxing authority on uncertain tax positions. Due to uncertainties in the timing of potential tax audits, the timing of the resolution of these positions is uncertain. Therefore, the Company is unable to make a reasonably reliable estimate of the timing of payments beyond 12 months. See Note 11 "Income Taxes" to the Consolidated Financial Statements in Item 15 for additional information.
 Off-Balance Sheet Arrangements
 The Company has no material off-balance sheet arrangements that have had or are reasonably likely to have a material current or future effect on its financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources.
 From time to time, the Company enters into transactions with third parties in connection with the sale of assets or businesses in which it agrees to indemnify the buyers or third parties involved in the transaction, or the sellers or third parties involved in the transaction agree to indemnify Tredegar, for certain liabilities or risks related to the assets or business. Also, in the ordinary course of business, the Company may enter into agreements with third parties for the sale of goods or services that may contain indemnification provisions. In the event that an indemnification claim is asserted, liability for indemnification would be subject to an assessment of the underlying facts and circumstances under the terms of the applicable agreement. Further, any indemnification payments may be limited or barred by a monetary cap, a time limitation, or a deductible or basket. For these reasons, the Company is unable to estimate the maximum potential amount of the potential future liability under the indemnity provisions of these agreements. Tredegar does, however, accrue for losses for any known contingent liability, including those that may arise from indemnification provisions, when future payment is probable and the amount is reasonably estimable. The Company discloses contingent liabilities if the probability of loss is reasonably possible and material.

 Critical Accounting Policies and Estimates
 The preparation of financial statements in accordance with GAAP requires the Company to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, expenses and related disclosures. Certain accounting policies, as described below, are considered "critical accounting policies" because they are particularly dependent on estimates made by management about matters that are inherently uncertain and could have a material impact on the Company's consolidated financial statements. Estimates and judgments are based on historical experience, forecasted events and various other assumptions that management believes are reasonable under the circumstances. Actual results could differ significantly from those estimates under different assumptions and conditions. A summary of all of our significant accounting policies is included in Note 1 "Nature of Operations and Summary of Significant Accounting Policies" to the Consolidated Financial Statements in Item 15.
 Impairment of Goodwill
 The Company assesses goodwill for impairment when events or circumstances indicate that the carrying value may not be recoverable, or, at a minimum, on an annual basis (December 1st of each year). When assessing goodwill for impairment, accounting guidance allows the Company to first perform a qualitative assessment ("Step 0 analysis"), which evaluates certain qualitative factors, including macroeconomic conditions, industry and market considerations, cost factors and overall financial performance, as well as company and reporting unit factors. If the Company's Step 0 analysis indicates that it is more likely than not that the fair value of a reporting unit is less than its carrying amount, then the Company would perform a quantitative impairment test ("Step 1 analysis").
 Domestic producers of aluminum extrusions in the U.S. continue to experience adverse conditions associated with economic uncertainty, including persistently high interest rates, tight lending standards and inflationary pressures, which negatively impact the non-residential B&C end-use market. These pandemic-related disruptions, which resulted in long lead times and a decline in industry capacity utilization, caused pricing pressure in the aluminum extrusions end-use markets. An influx of foreign imports at less-than-fair value pricing has also adversely impacted domestic producers.
 During 2024, customers of the Aluminum Extrusions' Clearfield, Utah operation ("Clearfield") acquired as "Futura" in February 2017 continued to seek supply from other sources to meet their demand, including imports. However, in 2024, Clearfield continued to experience a resurgence in customer volumes that had declined due to the pandemic, albeit not at the speed and profit level that was previously projected. The recovery has been slower than previously anticipated, and is not trending back to previous Company expectations to replicate the EBITDA and net cash flow generation that existed prior to the pandemic-related disruptions and influx of imports.
 As a consequence, the Company performed a goodwill impairment analysis during the fourth quarter of 2024 using Clearfield projections that assume the continuation of lower margin business. Since the estimated fair value of Clearfield fell below its carrying value by more than the amount of goodwill, the Company recognized a non-cash write-off of goodwill of $13.3 million ($10.4 million after deferred income tax benefits) associated with Clearfield.
 The Company estimated the fair value of Clearfield by: (i) computing an estimated enterprise value ("EV") utilizing the discounted cash flow method (the "DCF Method"), and (ii) adding cash and cash equivalents. Key financial assumptions utilized to determine the fair value of the reporting unit include sales volume and sales price growth projections. At December 31, 2024, the effect of a two percent increase per year in these growth projections would increase the reporting unit's fair value, however such sensitized fair value is still below Clearfield's carrying value by more than the amount of goodwill.
 As of December 31, 2024, the Company's remaining goodwill of $22.4 million was included in the Surface Protection reporting unit. See Note 1 "Nature of Operations and Summary of Significant Accounting Policies" to the Consolidated Financial Statements in Item 15 for additional information on the analysis of goodwill impairment.
 Income Taxes
 Current tax liabilities and assets are recognized for the estimated taxes payable or refundable, respectively, on the tax returns for the current year. Deferred tax assets and liabilities are determined based on differences between financial reporting and tax bases of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. Accordingly, accounting for income taxes represents the Company's best estimate of various events and transactions. Tax laws are often complex and may be subject to differing interpretations by the taxpayer and the relevant governmental taxing authorities. In establishing a provision for income tax expense, Tredegar must make judgments and interpretations about the application of tax laws. The Company must also make estimates about when in the future certain items will affect taxable income in the various taxing jurisdictions.
 A valuation allowance is recorded in the period when the Company determines that it is more likely than not that all or a portion of deferred income tax assets may not be realized. The establishment and removal of a valuation allowance requires the Company to consider all positive and negative evidence and make a judgmental decision regarding the amount of valuation allowance required as of a reporting date.

 Tredegar may be required to change its provision for income taxes when estimates used in determining valuation allowances on deferred tax assets significantly change, or when new information indicates the need for adjustment in valuation allowances. Additionally, future events, such as changes in tax laws, tax regulations, or interpretations of such laws or regulations, could have an impact on the provision for income tax and the effective tax rate. Any such changes could significantly affect the amounts reported in the financial statements in the year these changes occur.
 See Note 11 "Income Taxes" to the Consolidated Financial Statements in Item 15 for additional information on income taxes.

 Item 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 Tredegar has exposure to the volatility of interest rates, polyethylene resin prices, aluminum ingot and scrap prices, energy prices, foreign currencies and emerging markets. See Liquidity and Capital Resources regarding interest rate exposures related to borrowings under the ABL Facility.
 Profit margins in Aluminum Extrusions are sensitive to fluctuations in aluminum ingot and scrap prices as well as natural gas prices (natural gas is the principal energy source used to operate its casting furnaces). Changes in polyethylene resin prices and the timing of those changes could have a significant impact on profit margins in PE Films. There is no assurance of the Company's ability to pass through higher raw material and energy costs to its customers.
 The purchase price of raw materials fluctuates on a monthly basis; therefore, Aluminum Extrusions pricing policies generally allow the Company to pass the underlying index cost of aluminum and certain alloys through to the vast majority of our customers so that we remain substantially neutral to metal pricing. In the normal course of business, Aluminum Extrusions enters into fixed-price forward sales contracts with certain customers for the sale of fixed quantities of aluminum extrusions at scheduled intervals. In order to hedge its exposure to aluminum price volatility (see the chart below) under these fixed-price arrangements, which generally have a duration of not more than 12 months, the Company enters into a combination of forward purchase commitments and futures contracts to acquire or hedge aluminum, based on the scheduled deliveries. See Note 9 "Derivatives" to the Consolidated Financial Statements in Item 15 for additional information.
 The volatility of quarterly average aluminum prices is shown in the chart below.

 Source: Quarterly averages computed by the Company using daily Midwest average prices provided by Platts.

 The volatility of quarterly average natural gas prices is shown in the chart below.

 Source: Quarterly averages computed by Tredegar using monthly NYMEX settlement prices.

 The volatility of average quarterly prices of polyethylene resin in the U.S. (a primary raw material for PE Films products) is shown in the chart below:

 Source: Quarterly averages computed by Tredegar using monthly data provided by IHS, Inc. In February 2020, IHS reflected a 32 cents per pound non-market adjustment based on their estimate of the growth of discounts in prior periods. The 4th quarter 2019 average rate of $0.51 per pound is shown on a pro forma basis as if the non-market adjustment was made in the fourth quarter of 2019. In January 2023, IHS reflected a 41 cents per pound non-market adjustment based on their estimate of the growth of discounts in the prior periods. The 4th quarter 2022 average rate of $0.60 per pound is shown on a pro forma basis as if the non-market adjustment was made in the fourth quarter of 2022.

 The price of resin is driven by several factors, including supply and demand and the price of oil, ethylene and natural gas. Selling prices to customers are set considering numerous factors, including the expected volatility of resin prices. In certain situations, PE Films has index-based pass-through raw material cost arrangements with customers. However, under certain agreements, changes in resin prices are not passed through for a period of 90 days or more. In response to unprecedented cost increases and supply issues for polyethylene and polypropylene resin, Tredegar Surface Protection implemented a quarterly resin cost pass-through mechanism, effective July 1, 2021, for all products and customers not previously covered by such arrangements. Pricing on the remainder of the business is based upon raw material costs and supply/demand dynamics within the markets in which the Company competes.

 The Company sells to customers in foreign markets through its foreign operations and through exports from U.S. plants. The percentage of sales and total assets for manufacturing operations related to foreign markets for 2024, 2023 and 2022 are as follows:

 Tredegar Corporation
Percentage of Consolidated Net Sales and Total Assets Related to Foreign Markets

 2024
 2023
 2022

 % of Total
 % Total
Assets - Foreign Operations
 % of Total
 % Total
Assets - Foreign
Operations
 % of Total
 % Total
Assets -Foreign
Operations

 Exports
From
U.S.
 Foreign Operations
 Exports
From
U.S.
 Foreign Operations
 Exports
From
U.S.
 Foreign Operations

 Canada
 —
 —
 —
 —
 —
 —

 Latin America
 —
 —
 —
 —
 —
 —

 Asia
 —
 —
 —

 Total
 —
 —
 —

 Tredegar attempts to match the pricing and cost of its products in the same currency and generally views the volatility of foreign currencies and the corresponding impact on earnings and cash flow as part of the overall risk of operating in a global environment (for additional information, see trends for the Chinese Yuan in the chart below). Exports from the U.S. are generally denominated in U.S. Dollars. The Company's foreign currency exposure on income from continuing foreign operations relates to the Chinese Yuan.
 PE Films is generally able to match the currency of its sales and costs for its product lines. Tredegar estimates that the change in the value of foreign currencies relative to the U.S. Dollar on PE Films had an unfavorable impact on EBITDA from ongoing operations in PE Films of $0.1 million in 2024 compared to 2023.
 Trends for the Chinese Yuan are shown in the chart below:

 Source: Quarterly averages computed by Tredegar using daily closing data provided by Bloomberg.

 Item 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA
 The information required by this Item 8 is set forth in Item 15 and is hereby incorporated herein by reference.

 Item 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE
 None.

 Item 9A. CONTROLS AND PROCEDURES
 Evaluation of Disclosure Controls and Procedures
 In connection with the preparation of this Form 10-K, pursuant to Rule 13a-15(b) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), the Company carried out an evaluation with the participation of its management, including its Chief Executive Officer (principal executive officer) and Chief Financial Officer (principal financial officer), of the effectiveness of the design and operation of the Company's disclosure controls and procedures (as defined under Rule 13a-15(e) and 15d-15(e) under the Exchange Act) as of December 31, 2024.
 Based on the evaluation of our disclosure controls and procedures as of December 31, 2024, the Company's Chief Executive Officer and Chief Financial Officer concluded that, as of such date, our disclosure controls and procedures were effective.
 Management's Report on Internal Control over Financial Reporting
 The Company's management is responsible for establishing and maintaining an adequate system of internal control over financial reporting, as defined in the Exchange Act Rule 13a-15(f). Management conducted an assessment of the Company's internal control over financial reporting based on the framework established by the Committee of Sponsoring Organizations of the Treadway Commission in Internal Control — Integrated Framework (2013). Based on the assessment, management concluded that, as of December 31, 2024, the Company's internal control over financial reporting is effective. The Company's internal control over financial reporting as of December 31, 2024 has been audited by KPMG LLP, an independent registered public accounting firm, as stated in their report which is included herein, which expresses an unqualified opinion on the effectiveness of the Company's internal control over financial reporting as of December 31, 2024.
 Changes in Internal Control Over Financial Reporting
 There has been no change in the Company's internal control over financial reporting during the quarter ended December 31, 2024, that has materially affected, or is reasonably likely to materially affect, its internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act).

 Item 9B. OTHER INFORMATION
 Director and Officer Trading Arrangements
 During the three months ended December 31, 2024, no director or officer of the Company adopted or terminated a "Rule 10b5-1 trading arrangement" or "non-Rule 10b5-1 trading arrangement," as each term is defined in Item 408(a) of Regulation S-K.

 Item 9C. DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS
 None.

 Item 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE
 The information concerning directors and persons nominated to become directors of Tredegar to be included in the Proxy Statement under the headings "Proposal 1: Election of Directors" and "Tredegar's Board of Directors" is incorporated herein by reference.
 The information concerning corporate governance to be included in the Proxy Statement under the headings "Board Meetings, Meetings of Independent Directors and Board Committees" and "Corporate Governance and Risk Oversight" is incorporated herein by reference.
 Set forth below are the names, ages and titles of the Company's executive officers:

 Name
 Age
 Title

 John M. Steitz
 President and Chief Executive Officer

 D. Andrew Edwards
 Executive Vice President and Chief Financial Officer

 Kevin C. Donnelly
 Executive Vice President, General Counsel and Corporate Secretary

 John M. Steitz. Mr. Steitz was elected President and Chief Executive Officer effective March 19, 2019. He previously served as President and Chief Executive Officer of Addivant Corporation, a leading global supplier of antioxidants, intermediates, inhibitors, modifiers, UV stabilizers and other additives to the plastic and rubber industries, from March 2015 until January 2019, as President and Chief Operating Officer of PQ Corporation, a leading worldwide producer of specialty inorganic performance chemicals and catalysts, from October 2013 until March 2015, as President and Chief Executive Officer of Avantor Performance Materials, a global supplier of ultra-high-purity life sciences materials with strict regulatory and performance specifications, from September 2012 through September 2013, as President and Chief Operating Officer of Albemarle Corporation, a global specialty chemicals company, from March 2012 through August 2012, and as Chief Operating Officer and Executive Vice President of Albemarle from April 2007 until March 2012.
 D. Andrew Edwards. Mr. Edwards was named Executive Vice President and Chief Financial Officer effective August 6, 2020. Mr. Edwards served as Vice President and Chief Financial Officer from July 20, 2015 until August 2020. He previously served as the Chief Financial Officer of United Sporting Companies, Inc., a wholesale distributor of outdoor sporting goods, from February 2013 until July 2015 and as Vice President, Controller and Chief Accounting Officer of Owens & Minor, Inc., a distributor of acute medical products, from April 2010 to February 2013 and as Acting Chief Financial Officer of Owens & Minor, Inc. from March 2012 to February 2013. Mr. Edwards also served as Vice President, Finance, of Owens & Minor, Inc. from December 2009 until April 2010. Mr. Edwards previously served as the Company's Vice President, Chief Financial Officer and Treasurer from August 2003 to December 2009 and as the Company's Vice President, Finance from November 1998 to August 2003. Mr. Edwards also served as the Company's Treasurer from May 1997 to December 2009 and as the Company's Controller from October 1992 until July 2000.
 Kevin C. Donnelly. Mr. Donnelly was elected Executive Vice President, General Counsel and Corporate Secretary effective January 1, 2025. He joined Tredegar in 2010 as Assistant General Counsel. He was promoted to Associate General Counsel in 2013, and he served in that capacity until 2021, when he became Vice President, General Counsel and Corporate Secretary. Prior to joining Tredegar, Mr. Donnelly was an associate at Hunton & Williams LLP (now Hunton Andrews Kurth LLP). He received a B.A. degree from the University of Richmond and a J.D. from the University of Virginia.
 Tredegar has a Code of Conduct that applies to all of its directors, officers and employees (including its chief executive officer, chief financial officer and principal accounting officer) and has posted the Code of Conduct on its website. All amendments to or waivers from any provision of the Company's Code of Conduct applicable to the chief executive officer, chief financial officer or principal accounting officer or persons performing similar functions will be disclosed on the Company's website. The Company's internet address is www.tredegar.com.
 Tredegar has an insider trading policy governing the purchase, sale and other dispositions of Tredegar's securities that applies to all personnel of Tredegar and its subsidiaries, including directors, officers and employees and other covered persons. Tredegar believes that its insider trading policy is reasonably designed to promote compliance with insider trading laws, rules and regulations, as well as applicable listing standards. A copy of Tredegar's insider trading policy is filed as Exhibit 19 to this Form 10-K. In addition, with regard Tredegar's trading in its own securities, it is Tredegar's policy to comply with the federal securities laws and the applicable listing standards.

 Item 11. EXECUTIVE COMPENSATION
 The information to be included in the Proxy Statement under the headings "Compensation of Directors," "Compensation Discussion and Analysis," "Executive Compensation Committee Report" and "Compensation of Executive Officers" is incorporated herein by reference.

 Item 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS
 The information to be included in the Proxy Statement under the headings "Stock Ownership" and "Equity Compensation Plan Information" is incorporated herein by reference.

 Item 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE
 The information to be included in the Proxy Statement under the headings "Certain Relationships and Related Transactions," "Tredegar's Board of Directors" and "Board Meetings, Meetings of Independent Directors and Board Committees" is incorporated herein by reference.

 Item 14. PRINCIPAL ACCOUNTANT FEES AND SERVICES
 Our independent registered public accounting firm is KPMG LLP, Richmond, Virginia, Audit Firm ID: 185.
 The following is incorporated herein by reference:
 • Information on accounting fees and services to be included in the Proxy Statement under the heading "Audit and Non-Audit Fees;" and
 • Information on the Audit Committee's procedures for pre-approving certain audit and non-audit services to be included in the Proxy Statement under the heading "Audit and Non-Audit Fees."

 Item 15. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES

 (a)
 List of documents filed as a part of the report:

 (1)
 Financial statements:

 Tredegar Corporation

 Index to Financial Statements and Supplementary Data

 Page

 Auditors' Opinions:

 Report of Independent Registered Public Accounting Firm

 Opinion on Internal Control Over Financial Reporting

 Financial Statements:

 Consolidated Balance Sheets

 Consolidated Statements of Income (Loss)

 Consolidated Statements of Comprehensive Income (Loss)

 Consolidated Statements of Cash Flows

 Consolidated Statements of Shareholders' Equity

 Notes to Financial Statements

 (2)
 Financial statement schedules:

 None

 (3)
 Exhibit Index

 Report of Independent Registered Public Accounting Firm

 To the Shareholders and Board of Directors
 Tredegar Corporation:
 Opinion on the Consolidated Financial Statements
 We have audited the accompanying consolidated balance sheets of Tredegar Corporation and subsidiaries (the Company) as of December 31, 2024 and 2023, the related consolidated statements of income (loss), comprehensive income (loss), cash flows, and shareholders' equity for each of the years in the three-year period ended December 31, 2024, and the related notes (collectively, the consolidated financial statements). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2024 and 2023, and the results of its operations and its cash flows for each of the years in the three-year period ended December 31, 2024, in conformity with U.S. generally accepted accounting principles.
 We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the Company's internal control over financial reporting as of December 31, 2024, based on criteria established in Internal Control – Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission, and our report dated March 12, 2025 expressed an unqualified opinion on the effectiveness of the Company's internal control over financial reporting.
 Basis for Opinion
 These consolidated financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on these consolidated financial statements based on our audits. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
 We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud. Our audits included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. We believe that our audits provide a reasonable basis for our opinion.
 Critical Audit Matter
 The critical audit matter communicated below is a matter arising from the current period audit of the consolidated financial statements that was communicated or required to be communicated to the audit committee and that: (1) relates to accounts or disclosures that are material to the consolidated financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of a critical audit matter does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the accounts or disclosures to which it relates.
 Sufficiency of audit evidence over sales
 As discussed in Notes 1 and 12 to the consolidated financial statements, the Company recorded approximately $598,025 thousand of sales during the year ended December 31, 2024. Sales are recognized by the sale of finished products to customers. Those sales predominantly contain a single performance obligation and revenue is recognized at the point in time when control of the product is transferred to customers, along with the title, risk of loss and rewards of ownership. Depending on the arrangement with the customer, these criteria are met either at the time the product is shipped or when the product is made available or delivered to the destination specified in the agreement with the customer. The processing and recording of sales is decentralized across multiple locations and is reliant on multiple information technology (IT) systems.
 We identified the evaluation of the sufficiency of audit evidence over sales as a critical audit matter. Subjective auditor judgment was required to determine the nature and extent of procedures to be performed over the Company's locations because of the number of IT applications, the decentralized nature of the sales generating activities, and the need to involve IT professionals with specialized skills and knowledge.

 The following are the primary procedures we performed to address this critical audit matter. We applied auditor judgment to determine the nature and extent of procedures to be performed over sales, including determining the locations at which those procedures were to be performed. For each location where procedures were performed, we evaluated the design and tested the operating effectiveness of certain internal controls over the Company's revenue recognition processes, including the controls over the accurate recording of revenue transactions. We involved IT professionals with specialized skills and knowledge, who assisted in testing certain general IT controls and application controls, including IT system-generated reports used by the Company in its revenue recognition processes. At certain locations, we selected a sample of transactions and compared the amounts recognized to relevant cash receipts as well as underlying documentation such as contracts, purchase orders, shipping documents, or other third-party evidence. At certain locations, we performed software-assisted data analysis to test relationships among certain revenue transactions. At the locations we performed software-assisted data analysis, we also tested certain transactions and compared the amounts recognized by the Company to relevant cash receipts as well as underlying documentation such as contracts, purchase orders, shipping documents, or other third-party evidence. We evaluated the sufficiency of audit evidence obtained by assessing the results of procedures performed, including the appropriateness of the nature and extent of such evidence.
 /s/ KPMG LLP

 We have served as the Company's auditor since 2018.

 Richmond, Virginia
 March 12, 2025

 Report of Independent Registered Public Accounting Firm

 To the Shareholders and Board of Directors
 Tredegar Corporation:
 Opinion on Internal Control Over Financial Reporting
 We have audited Tredegar Corporation and subsidiaries' (the Company) internal control over financial reporting as of December 31, 2024, based on criteria established in Internal Control – Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission. In our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of December 31, 2024, based on criteria established in Internal Control – Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission.
 We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the consolidated balance sheets of the Company as of December 31, 2024 and 2023, the related consolidated statements of income (loss), comprehensive income (loss), cash flows, and shareholders' equity for each of the years in the three-year period ended December 31, 2024, and the related notes (collectively, the consolidated financial statements), and our report dated March 12, 2025 expressed an unqualified opinion on those consolidated financial statements.
 Basis for Opinion
 The Company's management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting, included in the accompanying Management's Report on Internal Control Over Financial Reporting. Our responsibility is to express an opinion on the Company's internal control over financial reporting based on our audit. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
 We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects. Our audit of internal control over financial reporting included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audit also included performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.
 Definition and Limitations of Internal Control Over Financial Reporting
 A company's internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company's internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company's assets that could have a material effect on the financial statements.
 Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.
 /s/ KPMG LLP
 Richmond, Virginia
 March 12, 2025

 CONSOLIDATED BALANCE SHEETS

 December 31

 2024
 2023

 (In thousands, except share data)

 Assets

 Current assets:

 Cash and cash equivalents
 $
 7,062
 $
 9,660

 Restricted cash
 —
 3,391

 Accounts and other receivables, net
 64,817
 55,615

 Income taxes recoverable
 —
 1,182

 Inventories
 51,381
 49,654

 Prepaid expenses and other
 16,567
 8,817

 Current assets of discontinued operations
 —
 48,358

 Total current assets
 139,827
 176,677

 Property, plant and equipment, at cost:

 Land and land improvements
 4,740
 4,740

 Buildings
 67,871
 65,465

 Machinery and equipment
 426,815
 426,097

 Total property, plant and equipment
 499,426
 496,302

 Less: accumulated depreciation
 ( 362,394)
 ( 345,145)

 Net property, plant and equipment
 137,032
 151,157

 Right-of-use leased assets
 14,635
 11,100

 Identifiable intangible assets, net
 7,326
 9,105

 Goodwill
 22,446
 35,717

 Deferred income tax assets
 32,517
 23,155

 Other assets
 2,448
 3,442

 Noncurrent assets of discontinued operations
 36,108

 Total assets
 $
 356,357
 $
 446,461

 Liabilities and Shareholders' Equity

 Current liabilities:

 Accounts payable
 $
 64,704
 $
 69,328

 Accrued expenses
 22,168
 18,606

 Lease liability, short-term
 2,453
 1,903

 Short-term debt
 1,322
 —

 ABL revolving facility
 —
 126,322

 Income taxes payable

 Current liabilities of discontinued operations
 32,762

 Total current liabilities
 91,708
 249,104

 Lease liability, long-term
 12,993
 10,396

 ABL revolving facility
 60,600
 —

 Pension and other postretirement benefit obligations, net
 5,914
 6,643

 Deferred income tax liabilities
 —

 Other non-current liabilities
 4,105
 3,862

 Noncurrent liabilities of discontinued operations
 —
 20,803

 Total liabilities
 175,389
 290,808

 Contingencies (Note 15)

 Shareholders' equity:

 Common stock, no par value (authorized 150,000,000 shares, issued and outstanding— 34,661,272 shares at December 31, 2024 and 34,408,638 at December 31, 2023)

 63,590
 61,606

 Common stock held in trust for savings restoration plan ( 118,543 shares at December 31, 2024 and December 31, 2023)

 ( 2,233)
 ( 2,233)

 Accumulated other comprehensive income (loss):

 Foreign currency translation adjustment
 5,105
 ( 83,037)

 Gain (loss) on derivative financial instruments

 Pension and other postretirement benefit adjustments

 Retained earnings
 113,412
 177,977

 Total shareholders' equity
 180,968
 155,653

 Total liabilities and shareholders' equity
 $
 356,357
 $
 446,461

 CONSOLIDATED STATEMENTS OF INCOME (LOSS)

 Years Ended December 31

 2024
 2023
 2022

 (In thousands, except share data)

 Revenues and other:

 Sales
 $
 598,025
 $
 573,323
 $
 761,985

 Other income (expense), net
 ( 952)
 ( 2,149)
 1,060

 597,073
 571,174
 763,045

 Costs and expenses:

 Cost of goods sold
 480,958
 480,440
 630,549

 Freight
 21,011
 21,757
 26,542

 Selling, general and administrative
 72,970
 65,388
 69,611

 Research and development
 2,894
 5,323

 Amortization of identifiable intangibles
 1,778
 1,758
 2,124

 Pension and postretirement benefits
 10,844
 14,569

 4,664
 6,316
 4,141

 Asset impairments and costs associated with exit and disposal activities, net of adjustments
 5,060

 —
 —

 34,891
 —

 Total
 596,193
 721,639
 753,481

 Income (loss) from continuing operations before income taxes
 ( 150,465)
 9,564

 ( 165)
 ( 51,300)
 ( 3,021)

 1,045
 ( 99,165)
 12,585

 ( 65,610)
 ( 6,740)
 15,870

 $
 $
 $

 Earnings (loss) per share:

 Basic

 $
 0.03
 $
 ( 2.91)
 $
 0.37

 ( 1.91)
 ( 0.19)
 0.47

 Basic earnings (loss) per share
 $
 ( 1.88)
 $
 ( 3.10)
 $
 0.84

 Diluted

 $
 0.03
 $
 ( 2.91)
 $
 0.37

 ( 1.91)
 ( 0.19)
 0.47

 Diluted earnings (loss) per share
 $
 ( 1.88)
 $
 ( 3.10)
 $
 0.84

 Shares used to compute earnings (loss) per share:

 Basic
 34,346
 34,133
 33,806

 Diluted
 34,346
 34,133
 33,826

 CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)

 Years Ended December 31

 2024
 2023
 2022

 $
 $
 $

 Other comprehensive income (loss):

 Unrealized foreign currency translation adjustment ($ 0 tax in 2024, net of tax expense of $ 469 in 2023 and net of tax expense of $ 290 in 2022)

 3,042

 Reclassification of foreign currency translation loss realized on the sale of Terphane (net of tax expense $ 601)

 88,437
 —
 —

 Derivative financial instruments adjustment (net of tax expense of $ 85 in 2024, net of tax expense of $ 933 in 2023 and net of tax benefit of $ 336 in 2022)

 3,281
 ( 3,381)

 Reclassification of derivative financial instruments loss realized on the sale of Terphane (net of tax benefit $ 1,209)

 ( 1,288)
 —
 —

 Pension & other postretirement benefit adjustments:

 Recognition in earnings of actuarial loss for pension settlement (net of tax expense of $ 41,294)

 —
 50,997
 —

 Net gains (losses) and prior service costs (net of tax expense of $ 109 in 2024, net of tax expense of $ 422 in 2023 and net of tax benefit of $ 1,400 in 2022)

 1,513
 ( 5,064)

 Amortization of prior service costs and net gains or losses (net of tax benefit of $ 31 in 2024, net of tax expense of $ 1,968 in 2023 and net of tax expense of $ 2,965 in 2022)

 ( 110)
 7,065
 10,641

 Other comprehensive income (loss)
 87,896
 65,898
 1,909

 Comprehensive income (loss)
 $
 23,331
 $
 ( 40,007)
 $
 30,364

 CONSOLIDATED STATEMENTS OF CASH FLOWS

 Years Ended December 31

 2024
 2023
 2022

 Cash flows from operating activities:

 $
 $
 $

 Adjustments for noncash items:

 Depreciation
 23,681
 25,786
 23,882

 Amortization of identifiable intangibles
 1,856
 1,897
 2,520

 34,891
 —

 Reduction of right-of-use lease asset
 2,259
 2,220
 2,098

 Deferred income taxes
 ( 8,202)
 ( 56,098)

 Accrued pension and postretirement benefits
 10,844
 14,602

 —
 —

 Stock-based compensation expense
 2,498
 1,978
 3,619

 Gain on investment in kal o
 ( 144)
 ( 262)
 ( 1,406)

 Loss on sale of divested business
 74,877
 —
 —

 Impairment of Richmond, Virginia Technical Center assets
 —
 3,454
 —

 Changes in assets and liabilities:

 Accounts and other receivables
 ( 14,785)
 17,400
 18,569

 Inventories
 ( 6,911)
 47,607
 ( 37,771)

 Income taxes recoverable/payable
 ( 406)
 ( 6,423)

 Prepaid expenses and other
 ( 7,174)
 1,204
 ( 2,526)

 Accounts payable and accrued expenses
 10,009
 ( 25,165)
 ( 14,916)

 Lease liability
 ( 2,749)
 ( 2,299)
 ( 2,301)

 Pension and postretirement benefit plan contributions
 ( 587)
 ( 28,269)
 ( 50,660)

 Other, net
 1,820
 2,827

 Net cash provided by (used in) operating activities
 25,508
 23,995
 ( 20,844)

 Cash flows from investing activities:

 ( 14,347)
 ( 26,446)
 ( 36,875)

 Proceeds from the sale of kal o
 1,406

 Net proceeds on sale of divested business (net of $ 20 million debt principal assumed by buyer)

 54,631
 —
 —

 Proceeds from the sale of assets
 —

 Net cash provided by (used in) investing activities
 40,511
 ( 26,184)
 ( 35,459)

 Cash flows from financing activities:

 Borrowings
 615,201
 116,134
 313,500

 Debt principal payments
 ( 679,590)
 ( 107,713)
 ( 249,500)

 Dividends paid
 —
 ( 8,884)
 ( 16,974)

 Debt financing costs
 ( 587)
 ( 4,021)
 ( 1,245)

 Other
 —
 —
 ( 396)

 Net cash provided by (used in) financing activities:
 ( 64,976)
 ( 4,484)
 45,385

 Effect of exchange rate changes on cash
 ( 7,436)
 ( 371)

 Increase (decrease) in cash, cash equivalents and restricted cash
 ( 6,393)
 ( 5,777)
 ( 11,289)

 Cash, cash equivalents and restricted cash at beginning of period
 13,455
 19,232
 30,521

 Cash, cash equivalents and restricted cash at end of period
 $
 7,062
 $
 13,455
 $
 19,232

 Supplemental cash flow information:

 Interest payments
 $
 13,524
 $
 10,499
 $
 4,423

 Income tax payments, net
 $
 12,228
 $
 2,282
 $
 10,814

 CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY

 Common Stock
 Retained
Earnings
 Trust for Savings Restoration Plan
 Accumulated Other Comprehensive Income (Loss)
 Total Shareholders' Equity

 (In thousands, except share and per-share data)
 Shares
 Amount

 Balance at January 1, 2022
 33,736,629
 $
 55,174
 $
 281,187
 $
 ( 2,135)
 $
 ( 149,504)
 $
 184,722

 —
 —
 —
 —

 Foreign currency translation adjustment
 —
 —
 —
 —

 Derivative financial instruments adjustment
 —
 —
 —
 —
 ( 3,381)
 ( 3,381)

 Net gains or (losses) and prior service costs
 —
 —
 —
 —
 ( 5,064)
 ( 5,064)

 Amortization of prior service costs and net gains or losses
 —
 —
 —
 —
 10,641
 10,641

 Cash dividends declared ($ 0.50 per share)

 —
 —
 ( 16,974)
 —
 —
 ( 16,974)

 Stock-based compensation expense
 294,764
 4,046
 —
 —
 —
 4,046

 Repurchase of employee common stock for tax withholdings
 ( 30,751)
 ( 396)
 —
 —
 —
 ( 396)

 Tredegar common stock purchased by trust for savings restoration plan
 —
 —
 ( 53)
 —
 —

 Balance at December 31, 2022
 34,000,642
 58,824
 292,721
 ( 2,188)
 ( 147,595)
 201,762

 —
 —
 —
 —

 Foreign currency translation adjustment
 —
 —
 —
 —
 3,042
 3,042

 Derivative financial instruments adjustment
 —
 —
 —
 —
 3,281
 3,281

 Net gains or (losses) and prior service costs
 —
 —
 —
 —
 1,513
 1,513

 Amortization of prior service costs and net gains or losses
 —
 —
 —
 —
 7,065
 7,065

 Recognition in earnings of net actuarial loss for pension settlement
 —
 —
 —
 —
 50,997
 50,997

 Cash dividends declared ($ 0.26 per share)

 —
 —
 ( 8,884)
 —
 —
 ( 8,884)

 Stock-based compensation expense
 407,996
 3,036
 —
 —
 —
 3,036

 Repurchase of employee common stock for tax withholdings
 —
 ( 254)
 —
 —
 —
 ( 254)

 Tredegar common stock purchased by trust for savings restoration plan
 —
 —
 ( 45)
 —
 —

 Balance at December 31, 2023
 34,408,638
 61,606
 177,977
 ( 2,233)
 ( 81,697)
 155,653

 —
 —
 —
 —

 Foreign currency translation adjustment
 —
 —
 —
 —

 Foreign currency translation loss realized on the sale of Terphane
 88,437
 88,437

 Derivative financial instruments adjustment
 —
 —
 —
 —

 Derivative financial instruments loss realized on the sale of Terphane
 ( 1,288)
 ( 1,288)

 Net gains or (losses) and prior service costs
 —
 —
 —
 —

 Amortization of prior service costs and net gains or losses
 —
 —
 —
 —
 ( 110)
 ( 110)

 Stock-based compensation expense
 252,634
 2,211
 —
 —
 —
 2,211

 Repurchase of employee common stock for tax withholdings
 —
 ( 227)
 —
 —
 —
 ( 227)

 Balance at December 31, 2024
 34,661,272
 $
 63,590
 $
 113,412
 $
 ( 2,233)
 $
 6,199
 $
 180,968

 NOTES TO FINANCIAL STATEMENTS

 1. NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
 Nature of Operations. Tredegar Corporation and subsidiaries (collectively "Tredegar," "the Company," "we," "us" or "our") is an industrial manufacturer with two primary businesses: custom aluminum extrusions for the North American building & construction, automotive and specialty end-use markets; and surface protection films for high-technology applications in the global electronics industry and polyethylene overwrap films used for bathroom tissue and paper towels. The Company's business segments are Aluminum Extrusions (also referred to as Bonnell Aluminum) and PE Films. More information on the Company's business segments is provided in Note 12.
 On November 1, 2024, the Company completed the sale of its flexible packaging films business (also referred to as "Terphane") headquartered in Brazil to Oben Group ("Oben"). Commencing in the fourth quarter of 2024, all historical results for Terphane have been presented as discontinued operations. For more information on this transaction, see Note 16.
 Basis of Presentation and Principles of Consolidation. The consolidated financial statements include the accounts and operations of the Company and have been prepared in accordance with U.S. generally accepted accounting principles ("GAAP"). Intercompany balances and transactions have been eliminated in consolidation. Certain amounts for the prior years have been reclassified to conform to current year presentation.
 Fiscal Year End. The Company operates on a calendar fiscal year except for the Aluminum Extrusions segment, which operates on a 52/53-week fiscal year basis. References to Aluminum Extrusions for 2024, 2023 and 2022 relate to the 52-week fiscal year ended December 29, 2024, 53-week fiscal year ended December 31, 2023 and 52-week fiscal year ended December 25, 2022, respectively. The Company does not believe the impact of reporting the results of this segment in this manner is material to the consolidated financial results. The Company may fund or receive cash from the Aluminum Extrusions segment based on Aluminum Extrusion's cash flows from operations during the intervening period from Aluminum Extrusion's fiscal year end to the Company's calendar year end. As a result, the Company's cash and cash equivalents declined by $ 3.6 million as of December 31, 2024 since the Company made payments to the Aluminum Extrusions segment to fund its working capital during the intervening period.
 Use of Estimates. The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue, expenses and disclosure of contingent assets and liabilities (if any). On an ongoing basis, the Company evaluates its estimates, including those related to provisions for transaction and credit losses, income taxes, pension, and the valuation of goodwill and intangible assets, among others. Tredegar bases its estimates on historical experience and various other assumptions which the Company believes to be reasonable under the circumstances. Actual results could differ from those estimates.
 Foreign Currency Translation. The financial statements of subsidiaries located outside the U.S., where the local currency is the functional currency, are translated into U.S. Dollars using exchange rates in effect at the period end for assets and liabilities and average exchange rates during each reporting period for results of operations. Adjustments resulting from the translation of these financial statements are reflected as a separate component of shareholders' equity. There are no operating subsidiaries located outside the U.S. where the U.S. Dollar is the functional currency. Transaction and remeasurement gains or losses included in income were losses of $ 0.3 million, $ 0.2 million and $ 0.8 million in 2024, 2023 and 2022, respectively.
 Cash, Cash Equivalents and Restricted cash. Cash, cash equivalents and restricted cash consist of cash on hand in excess of daily operating requirements and highly liquid investments with original maturities of three months or less. At December 31, 2024 and 2023, Tredegar had cash, cash equivalents and restricted cash of $ 7.1 million and $ 13.1 million, respectively, including funds held in locations outside the U.S. of $ 1.6 million and $ 0.8 million, respectively.
 The Company's policy permits investment of excess cash in marketable securities that have the highest credit ratings and maturities of less than one year. The primary objectives of the policy are safety of principal and liquidity.
 The following table provides a reconciliation of cash, cash equivalents and restricted cash to amounts shown in the consolidated statements of cash flows:

 2024
 2023

 Cash and cash equivalents
 $
 7,062
 $
 9,660

 Restricted cash
 —
 3,391

 Total cash, cash equivalents and restricted cash
 $
 7,062
 $
 13,051

 Restricted cash as of December 31, 2023 consists of $ 3.4 million of receipts that have not yet been applied to the ABL Facility (defined below). See Note 7 for additional information.
 Accounts and Other Receivables, net. Accounts receivables are stated at the amount invoiced to customers less allowances for doubtful accounts. Accounts receivables are non-interest bearing and arise from the sale of products to customers under typical industry trade terms. Notes receivables are immaterial. Past due amounts are determined based on established terms and charged-off when deemed uncollectible. The allowance for doubtful accounts is determined based on an assessment of probable losses taking into account past due amounts, customer credit profile, historical experience and current economic conditions. For receivables that do not have a specific allowance, the loss rate is computed by segment to apply to the remaining receivables balance, using each segment's historic loss rate. Other receivables include value-added taxes related to certain foreign subsidiaries and other miscellaneous receivables due within one year. For certain customers, the Company has arrangements in place with financial institutions whereby certain customer receivables are sold to the financial institution at a discount and without recourse. Upon sale, the associated receivable is unrecognized, and the discount is recognized. For more information on accounts and other receivables, net, see Note 2.
 Inventories. Inventories are stated at the lower of cost or market, with cost determined using the last in, first out ("LIFO") method, the weighted average cost or the first in, first out ("FIFO") method. Cost elements included in work-in-process and finished goods inventories are raw materials, direct labor and manufacturing overhead. Finished goods, work-in-process, raw materials and supplies, stores and other inventory are reviewed to determine if inventory quantities are in excess of forecasted usage or if they have become obsolete.
 Property, Plant and Equipment. Accounts include costs of assets constructed or purchased, related delivery and installation costs and interest incurred on significant capital projects during their construction periods. Expenditures for renewals and betterments also are capitalized, but expenditures for repairs and maintenance are expensed as incurred. The cost and accumulated depreciation applicable to assets retired or sold are removed from the respective accounts, and gains or losses thereon are included in income. Capital expenditures for property, plant and equipment include capitalized interest. Capitalized interest included in capital expenditures for property, plant and equipment was immaterial. Depreciation is computed primarily by the straight-line method based on the estimated useful lives of the assets that generally range from 5 to 40 years for buildings and land improvements and 2 to 20 years for machinery and equipment.
 Goodwill and Identifiable Intangibles. The excess of the purchase price over the fair value of identifiable net assets of acquired companies is allocated to goodwill. The Company assesses goodwill for impairment when events or circumstances indicate that the carrying value may not be recoverable, or, at a minimum, on an annual basis (December 1st of each year). When assessing goodwill for impairment, accounting guidance allows the Company to first perform a qualitative assessment ("Step 0 analysis"), which evaluates certain qualitative factors, including macroeconomic conditions, industry and market considerations, cost factors and overall financial performance, as well as company and reporting unit factors. If the Company's Step 0 analysis indicates that it is more likely than not that the fair value of a reporting unit is less than its carrying amount, then the Company would perform a quantitative impairment test ("Step 1 analysis").
 Domestic producers of aluminum extrusions in the U.S. continue to experience adverse conditions associated with economic uncertainty, including persistently high interest rates, tight lending standards and inflationary pressures, which negatively impact the non-residential B&C end-use market. These pandemic-related disruptions, which resulted in long lead times and a decline in industry capacity utilization, caused pricing pressure in the aluminum extrusions end-use markets. An influx of foreign imports at less-than-fair value pricing has also adversely impacted domestic producers.
 During 2024, customers of the Aluminum Extrusions' Clearfield, Utah operation ("Clearfield") acquired as "Futura" in February 2017 continued to seek supply from other sources to meet their demand, including imports. However, in 2024, Clearfield continued to experience a resurgence in customer volumes that had declined due to the pandemic, albeit not at the speed and profit level that was previously projected. The recovery has been slower than previously anticipated, and is not trending back to previous Company expectations to replicate the EBITDA and net cash flow generation that existed prior to the pandemic-related disruptions and influx of imports.
 As a consequence, the Company performed a goodwill impairment analysis during the fourth quarter of 2024 using Clearfield projections that assume the continuation of lower margin business. Since the estimated fair value of Clearfield fell below its carrying value by more than the amount of goodwill, the Company recognized a non-cash write-off of goodwill of $ 13.3 million ($ 10.4 million after deferred income tax benefits) associated with Clearfield.
 The Company estimated the fair value of Clearfield by: (i) computing an estimated enterprise value ("EV") utilizing the discounted cash flow method (the "DCF Method"), and (ii) adding cash and cash equivalents. Key financial assumptions utilized to determine the fair value of the reporting unit include sales volume and sales price growth projections.
 As of December 31, 2024, the Company's remaining goodwill of $ 22.4 million was included in the Surface Protection reporting unit.

 During 2023, uncertainty about the timing of a recovery in the consumer electronics market persisted, and manufacturers in the supply chain for consumer electronics continued to experience reduced capacity utilization and inventory corrections. In light of the limited visibility on the timing of a recovery and the expected adverse future impact to the Surface Protection business, coupled with a cautious outlook on new product development opportunities, the Company performed a Step 1 goodwill impairment analysis, as of June 30, 2023 and September 30, 2023, of the Surface Protection component of PE Films. The analyses concluded that the fair value of Surface Protection was less than its carrying value, thus a non-cash partial goodwill impairment of $ 34.9 million ($ 27.0 million after deferred income tax benefits) was recognized during 2023.
 The Company estimated the fair value of Surface Protection by: (i) computing an estimated EV utilizing the DCF Method, (ii) applying adjustments for any surplus or deficient working capital, (iii) adding cash and cash equivalents, and (iv) subtracting interest-bearing debt. The DCF Method was used, incorporating Surface Protection's latest projections, which reflect updated expected market recovery levels, feasibility of launching new product applications, competitive pricing and cash flows associated with production efficiencies, as well as consideration of cost savings and inventory corrections.
 For more information on goodwill and identifiable intangibles, see Note 5.
 Impairment of Long-Lived Assets. The Company reviews long-lived assets for possible impairment when events indicate that an impairment may exist. For assets that are held and used in operations, if events indicate that an asset may be impaired, the Company estimates the future unlevered pre-tax cash flows expected to result from the use of the asset and its eventual disposition. Assets are grouped for this purpose at the lowest level for which there are identifiable and independent cash flows. If the sum of these undiscounted pre-tax cash flows is less than the carrying amount of the asset group, an impairment loss is calculated. Measurement of the impairment loss is the amount by which the carrying amount exceeds the estimated fair value of the asset group. Assets that are held for sale are reported at the lower of their carrying amount or estimated fair value less cost to sell, with an impairment loss recognized for any write-down required.
 In the fourth quarter of 2024, due to the same factors discussed above, the Aluminum Extrusions' Clearfield reporting unit, which is also an asset group, required the Company to perform a recoverability test of its long-lived identifiable assets using the same projections used in the DCF Method by comparing the undiscounted future cash flows to the net carrying value of the asset group. As the undiscounted cash flows of the Clearfield asset group was greater than the carrying amount as of December 31, 2024, no long-lived impairment loss was recognized in 2024.
 As of December 31, 2024, no other events were identified that indicated long-lived assets may be impaired.
 In August 2023, the Company adopted a plan to close the PE Films technical center in Richmond, VA and reduce its efforts to develop and sell films supporting the semiconductor market. Research & development activities for PE Films are now being performed at the production facility in Pottsville, PA. PE Films continues to have new business opportunities primarily relating to surface protection films that protect components of flat panel and flexible displays. All activities ceased at the PE Films technical center in Richmond, VA as of the end of the first quarter of 2024. During 2023 the Company recognized a non-cash asset impairment of $3.5 million for Richmond Technical Center assets which went held for sale in the third quarter of 2023.
 Pension Costs and Postretirement Benefit Costs Other than Pensions. Pension costs and postretirement benefit costs other than pensions have been accrued over the period employees provided service to Tredegar. Liabilities and expenses for pension plans and other postretirement benefits are determined using actuarial methodologies and incorporate significant assumptions, including the rate used to discount the future estimated liability, the long-term rate of return on plan assets, and several assumptions relating to the employee workforce. The Company recognizes the funded status of its pension and other postretirement plans in the accompanying consolidated balance sheets. Tredegar's policy has been to fund its pension plans at amounts not less than the minimum requirements of the Employee Retirement Income Security Act ("ERISA") of 1974 and to fund postretirement benefits other than pensions when claims are incurred.
 In February 2022, Tredegar announced the initiation of a process to terminate and settle its frozen defined benefit pension plan through lump sum distributions and the purchase of annuity contracts. On November 3, 2023, the pension plan termination and settlement process for the Company was completed. For more information, see Note 8.
 Revenue Recognition. The Company's revenue is primarily generated from the sale of finished products to customers. Those sales predominantly contain a single performance obligation and revenue is recognized at the point in time when control of the product is transferred to customers, along with the title, risk of loss and rewards of ownership. Depending on the arrangement with the customer, these criteria are met either at the time the product is shipped or when the product is made available or delivered to the destination specified in the agreement with the customer.
 Sales revenue is recognized in an amount that reflects the consideration the Company expects to be entitled to in exchange for that finished product. The Company offers various discounts, rebates and allowances to customers, (collectively, "allowances"), all of which are considered when determining the transaction price. Certain allowances are fixed and

 determinable at the time of sale and are recorded at the time of sale as a reduction to revenues. Other allowances can vary depending on future outcomes such as sales returns and customer sales volume, thus representing variable consideration.
 Amounts billed to customers related to freight are classified as sales revenue and the cost of freight is classified as a separate line in the accompanying consolidated statements of income. Taxes assessed by a governmental authority that are both imposed on and concurrent with a specific revenue-producing transaction between Tredegar and its customers (such as value-added taxes) are accounted for on a net basis and therefore excluded from revenues. See Note 12 for disaggregation of revenue by segment and type.
 Revenue expected to be recognized in any future period related to remaining performance obligations, excluding (i) revenue pertaining to contracts that have an original expected duration of one year or less, (ii) contracts where revenue is recognized as invoiced and (iii) variable consideration related to unsatisfied performance obligations, is not expected to materially impact the Company's financial results.
 Research and Development ("R&D") Costs. R&D costs are expensed as incurred and include primarily salaries, wages, employee benefits, equipment depreciation, facility costs and the cost of materials consumed relating to R&D efforts. R&D costs include a reasonable allocation of indirect costs.
 Leases. At inception, the Company determines if an arrangement contains a lease and whether that lease meets the classification criteria of a finance or operating lease. The Company has elected to not record short-term leases with an original lease term of one year or less in the consolidated balance sheet. To the extent such leases contain renewal options that the Company intends to exercise, the related Right-of-Use ("ROU") asset and lease liability are included in the consolidated balance sheet. Some of the Company's lease arrangements contain lease components (e.g., minimum rent payments) and non-lease components (e.g., maintenance, labor charges, etc.). The Company generally accounts for the lease and non-lease components as a single lease component.
 Certain of the Company's lease agreements include rental payments that are adjusted periodically for an index or rate. The leases are initially measured using the projected payments adjusted for the index or rate in effect at the commencement date. The Company's lease agreements do not contain any material residual value guarantees or material restrictive covenants.
 Operating leases are included in "Right-of-use lease assets", "Lease liabilities - short-term" and "Lease liabilities - long-term" on the consolidated balance sheets. These assets and liabilities are recognized at the commencement date based on the present value of remaining lease payments over the lease term using the Company's secured incremental borrowing rates, adjusted for term and geographic location using country-based swap rates. As a result of the Company's review of new and existing lease contracts, there were no instances where the Company could readily determine a rate implicit in the lease.
 Lease expense for operating leases is recognized on a straight-line basis over the lease term. Variable lease expense is recognized in the period in which the obligation for those payments is incurred. Depending upon the specific use of the ROU asset, lease expense is included in the "Cost of goods sold", "Freight", "Selling, general and administrative", and "Research and development" line items on the consolidated statements of income. Lease income is not material to the results of operations for the years ended December 31, 2024, 2023 and 2022, respectively. Additional disclosure regarding Tredegar's leases is included in Note 4.
 Income Taxes. Income taxes are recognized during the period in which transactions enter into the determination of income for financial reporting purposes, with deferred income taxes being provided at enacted statutory tax rates on the differences between the financial reporting and tax bases of assets and liabilities (see Note 11). Tredegar's policy is to accrue U.S. federal income taxes to the extent required under GAAP on unremitted earnings of all foreign subsidiaries where required. However, Tredegar only records U.S. federal income taxes on unremitted earnings of its foreign subsidiaries where Tredegar cannot take steps to eliminate any potential tax on future distributions from its foreign subsidiaries.
 A valuation allowance is recorded in the period when the Company determines that it is more likely than not that all or a portion of deferred income tax assets may not be realized. The establishment and removal of a valuation allowance requires the Company to consider all positive and negative evidence and make a judgmental decision regarding the amount of valuation allowance required as of a reporting date. The benefit of an uncertain tax position is included in the accompanying financial statements when the Company determines that it is more likely than not that the position will be sustained, based on the technical merits of the position, if the taxing authority examines the position and the dispute is litigated. This determination is made on the basis of all the facts, circumstances and information available as of the reporting date.
 Earnings Per Share. Basic earnings per share is computed using the weighted average number of shares of common stock outstanding. Diluted earnings per share is computed using the weighted average common and potentially dilutive common equivalent shares outstanding, determined as follows:

 2024
 2023
 2022

 Weighted average shares outstanding used to compute basic earnings per share
 34,346,242
 34,133,078
 33,805,530

 Incremental shares attributable to stock options and restricted stock
 —
 —
 20,900

 Shares used to compute diluted earnings per share
 34,346,242
 34,133,078
 33,826,430

 Incremental shares attributable to stock options and restricted stock are computed under the treasury stock method using the average market price during the related period. The average out-of-the-money options to purchase shares that were excluded from the calculation of incremental shares attributable to stock options and restricted stock were 2,497,008 for the years ended December 31, 2024. The Company had a net loss from continuing operations for the year ended December 31, 2023, so there is no dilutive impact for such shares. If the Company had reported net income from continuing operations for the year ended December 31, 2023, average out-of-the-money options to purchase shares that were excluded from the calculation of incremental shares attributable to stock options and restricted stock would have been 2,925,091. The average out-of-the-money options to purchase shares that were excluded from the calculation of incremental shares attributable to stock options and restricted stock were 2,760,983 for the years ended December 31, 2022.
 Stock-Based Employee Compensation Plans. The cost of all share-based payments is recognized using the calculated fair value at the grant date, or the date of any later modification, over the requisite service period under the graded-vesting method. See Note 10 for additional information.
 Financial Instruments. Tredegar uses derivative financial instruments for the purpose of hedging aluminum price volatility. The Company's derivative financial instruments are designated as and qualify as cash flow hedges and are recognized in the accompanying balance sheet at fair value. A change in the fair value of the derivative that is highly effective and that is designated and qualifies as a cash flow hedge is recorded in other comprehensive income. Gains and losses reported in other comprehensive income (loss) are reclassified to earnings in the periods in which earnings are affected by the variability of cash flows of the hedged transaction. Such gains and losses are reported in the same line as the underlying hedged item, and the cash flows related to financial instruments are classified in the consolidated statements of cash flows in a manner consistent with those of the transactions being hedged.
 The Company's policy requires that it formally document all relationships between hedging instruments and hedged items, as well as its risk management objective and strategy for undertaking various hedge transactions. The Company also uses regression analysis, unless the hedge qualifies for other methods of assessing effectiveness, to formally assess (both at the hedge's inception and on an ongoing basis) whether the derivatives that are used in hedging transactions have been highly effective in offsetting changes in the fair value or cash flows of hedged items and whether those derivatives may be expected to remain highly effective in future periods. When it is determined that a derivative is not (or has ceased to be) highly effective as a hedge, the Company discontinues hedge accounting prospectively.
 As a policy, Tredegar does not engage in speculative or leveraged transactions, nor does it hold or issue financial instruments for trading purposes. Additional disclosure of the utilization of derivative hedging instruments is included in Note 9.
 Comprehensive Income (Loss). Comprehensive income (loss) is defined as net income or loss as adjusted by other comprehensive income or loss items. Other comprehensive income (loss) includes changes in foreign currency translation adjustments; realized and unrealized gains and losses on derivative financial instruments; prior service costs and net gains or losses from pension and other postretirement benefit plans arising during the period; and amortization of these prior service costs and net gain or loss adjustments; and during the period, realized net actuarial loss for pension settlement all recorded net of deferred income taxes.

 The changes in accumulated other comprehensive income (loss) by component are summarized as follows:

 Foreign Currency Translation
 Gain (Loss) on Derivative Financial Instruments
 Pension & Other Postretirement Benefit Adjust
 Total Accumulated Other Comprehensive Income (Loss)

 Balance at January 1, 2022
 $
 ( 85,792)
 $
 $
 ( 64,613)
 $
 ( 149,504)

 Other comprehensive income (loss)
 ( 1,256)
 ( 6,464)
 ( 7,717)

 ( 290)
 ( 374)
 1,400

 ( 1,630)
 ( 5,064)
 ( 6,981)

 Reclassification adjustment to net income (loss)
 —
 ( 2,461)
 13,606
 11,145

 —
 ( 2,965)
 ( 2,255)

 Reclassification adjustment to net income (loss), net of tax
 —
 ( 1,751)
 10,641
 8,890

 ( 3,381)
 5,577
 1,909

 Balance at December 31, 2022
 ( 86,079)
 ( 2,480)
 ( 59,036)
 ( 147,595)

 Other comprehensive income (loss)
 3,511
 11,794
 1,935
 17,240

 ( 469)
 ( 2,977)
 ( 422)
 ( 3,868)

 3,042
 8,817
 1,513
 13,372

 Reclassification adjustment to net income (loss)
 —
 ( 7,580)
 101,323
 93,743

 —
 2,044
 ( 43,261)
 ( 41,217)

 Reclassification adjustment to net income (loss), net of tax
 —
 ( 5,536)
 58,062
 52,526

 3,042
 3,281
 59,575
 65,898

 Balance at December 31, 2023
 ( 83,037)
 ( 81,697)

 Other comprehensive income (loss)

 —
 ( 72)
 ( 109)
 ( 181)

 Reclassification adjustment to net income (loss)
 89,038
 ( 1,881)
 ( 141)
 87,016

 ( 601)
 1,180

 Reclassification adjustment to net income (loss), net of tax
 88,437
 ( 701)
 ( 110)
 87,626

 88,142
 ( 533)
 87,896

 Balance at December 31, 2024
 $
 5,105
 $
 $
 $
 6,199

 The amounts reclassified out of accumulated other comprehensive income (loss) related to pension and other postretirement benefits are included in the computation of net periodic pension costs, see Note 8 for additional details. The amounts reclassified out of accumulated other comprehensive income (loss) related to foreign currency translation and derivative financial instruments are included in discontinued operations, see Note 16 for additional details.

 Recently Issued Accounting Standards.
 New accounting pronouncements adopted in 2024:
 In November 2023, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") 2023-07 to improve reportable segment disclosure and requirements, primarily through the enhanced disclosures about significant segment expenses. ASU 2023-07 expands public entities' segment disclosures by requiring disclosure of significant segment expenses that are regularly provided to the chief operating decision maker and included within each reported measure of segment profit or loss, an amount and description of its composition for other segment items, and interim disclosures of a reportable segment's profit or loss and assets. All disclosure requirements of ASU 2023-07 are required for entities with a single reportable segment. This ASU is effective for fiscal years beginning after December 15, 2023 and interim period beginning after December 15, 2024, with early adoption permitted. The amendments in this ASU are to be applied retrospectively to all prior periods presented in the financial statements. The Company adopted this ASU in fourth quarter of 2024. The adoption did not have a material impact on the Company's consolidated financial statements.
 Accounting standards not yet adopted:
 In October 2023, the FASB issued ASU 2023-06 to amend various paragraphs in the Accounting Standards Codification ("ASC") to primarily reflect the issuance of Securities and Exchange Commission ("SEC") Staff Bulletin No. 33-10532. ASU 2023-06 will impact various disclosure areas, including the statement of cash flows, accounting changes and error corrections, earnings per share, debt, equity, derivatives, and transfers of financial assets. The amendments in this ASU 2023-06 will be effective on the date the related disclosures are removed from Regulation S-X or Regulation S-K by the SEC and will no longer be effective if the SEC has not removed the applicable disclosure requirement by June 30, 2027. Early adoption is not permitted. The Company does not expect a material impact from the adoption of this standard on our consolidated financial statements and related disclosures.
 In December 2023, the FASB issued ASU 2023-09 to improve the income tax disclosures related to the rate reconciliation and income taxes paid information and to improve the effectiveness of income tax disclosures. The amendments in this ASU will require the Company to disclose specified additional information in its income tax rate reconciliation and provide additional information for reconciling items that meet a quantitative threshold. ASU 2023-09 will also require the Company to disaggregate its income taxes paid disclosure by federal, state and foreign taxes, with further disaggregation required for significant individual jurisdictions. This ASU is effective for annual periods beginning after December 15, 2024. Early adoption is permitted. The Company is currently evaluating the impact of this standard on our consolidated financial statements and related disclosures.
 In November 2024, the FASB issued ASU 2024-03 to improve the disclosures about public business entity's expenses and address requests from investors for more detailed information about the types of expenses in commonly presented expense captions. The amendments in this ASU will require the Company to disclose specified information about certain costs and expenses in the notes to the financial statements. This ASU is effective for annual periods beginning after December 15, 2026 and interim periods beginning after December 15, 2027. Early adoption is permitted. The Company is currently evaluating the impact of this standard on our consolidated financial statements and related disclosures.

 2. ACCOUNTS AND OTHER RECEIVABLES
 As of December 31, 2024 and 2023, accounts receivable and other receivables, net, include the following:

 2024
 2023

 Customer receivables
 $
 64,094
 $
 55,576

 Other receivables
 1,201

 Total accounts and other receivables
 65,046
 56,777

 Less: Allowance for bad debts
 ( 229)
 ( 1,162)

 Total accounts and other receivables, net
 $
 64,817
 $
 55,615

 A reconciliation of the beginning and ending balances of the allowance for doubtful accounts for the three years ended December 31, 2024 is as follows:

 2024
 2023
 2022

 Balance, beginning of year
 $
 1,162
 $
 2,068
 $
 1,142

 Charges to expense
 1,032

 Recoveries
 —
 —

 Write-offs and settlements
 ( 1,078)
 ( 1,313)
 ( 118)

 Balance, end of year
 $
 $
 1,162
 $
 2,068

 3. INVENTORIES
 Inventories consist of the following:

 2024
 2023

 Finished goods
 $
 15,051
 $
 15,770

 Work-in-process
 2,986
 2,082

 Raw materials
 12,158
 13,457

 Stores, supplies and other
 21,186
 18,345

 Total
 $
 51,381
 $
 49,654

 Inventories stated on the LIFO basis amounted to $ 6.7 million at December 31, 2024 and $ 7.2 million at December 31, 2023, which were below replacement costs by $ 13.8 million at December 31, 2024 and $ 13.2 million at December 31, 2023. Inventories stated on the weighted average cost basis were $ 14.3 million and $ 12.9 million at December 31, 2024 and 2023, respectively, while inventories stated on the FIFO method amounted to $ 30.4 million and $ 29.6 million at December 31, 2024 and 2023, respective ly.

 4. LEASES
 Tredegar has various operating lease agreements with remaining terms up to 19 years, including leases of real estate, office equipment and vehicles. As of December 31, 2024 and 2023, the Company had no finance lease agreements. Some leases include options to purchase the leased asset, terminate the agreement or extend the term of the agreement for one or more years. These options are included in the lease term when it is reasonably certain that the option will be exercised.
 The following table presents a maturity analysis of the Company's operating leases as of December 31, 2024:

 Future Lease Payments

 2025
 $
 3,121

 2026
 2,717

 2027
 2,316

 2028
 2,182

 2029
 2,205

 Thereafter
 5,704

 Total undiscounted operating lease payments
 18,245

 Less: Imputed interest
 2,799

 Present value of operating lease liabilities
 $
 15,446

 The following table summarizes lease costs, related cash flow and other information for the years ended December 31, 2024 and 2023. These costs are primarily related to long-term operating leases but also include amounts for variable leases and short-term leases.

 2024
 2023

 Operating lease expense
 $
 4,350
 $
 2,780

 Other Information:

 Weighted-average remaining lease term for operating leases
 10 years
 7 years

 Weighted-average discount rate for operating leases
 4.77
 %
 4.28
 %

 5. GOODWILL AND IDENTIFIABLE INTANGIBLE ASSETS
 A reconciliation of goodwill at December 31, 2024 and 2023 is as follows:

 Aluminum Extrusions(a)

 PE Films(a)

 Total

 Net carrying value of goodwill at December 31, 2022

 $
 $
 57,337
 $
 70,608

 —
 ( 34,891)
 ( 34,891)

 Net carrying value of goodwill at December 31, 2023

 22,446
 35,717

 ( 13,271)
 —
 ( 13,271)

 Net carrying value of goodwill at December 31, 2024

 $
 —
 $
 22,446
 $
 22,446

 (a) The goodwill of Aluminum Extrusions and PE Films is carried by the Clearfield and Surface Protection reporting units, respectively.

 A reconciliation of identifiable intangibles at December 31, 2024 and 2023 is as follows:

 Customer Relationships
 Proprietary Technology
 Trade Names
 Total

 Gross carrying value at December 31, 2023

 $
 25,900
 $
 3,400
 $
 11,500
 $
 40,800

 Accumulated amortization
 ( 16,795)
 ( 3,400)
 ( 11,500)
 ( 31,695)

 Net carrying value at December 31, 2023

 $
 9,105
 $
 —
 $
 —
 $
 9,105

 Gross carrying value at December 31, 2024

 $
 25,900
 $
 —
 $
 6,700
 $
 32,600

 Accumulated amortization
 ( 18,574)
 —
 ( 6,700)
 ( 25,274)

 Net carrying value at December 31, 2024

 $
 7,326
 $
 —
 $
 —
 $
 7,326

 Amortization expense over the next four years is expected to be $ 1.8 million per year and is expected to end in early 2029.

 6. ACCRUED EXPENSES
 Accrued expenses consist of the following:

 2024
 2023

 Payrolls, related taxes and medical and other benefits
 $
 6,812
 $
 5,688

 Incentive compensation
 6,434

 Workers' compensation and disabilities
 2,005
 2,178

 Vacation
 1,668
 1,370

 Environmental liabilities
 1,259
 1,560

 Accrued utilities
 1,164

 Customer rebates

 Accrued interest

 Accrued freight

 Derivative contract liability

 Group annuity contract premium liability
 —
 2,000

 Other
 1,762
 2,440

 Total
 $
 22,168
 $
 18,606

 7. DEBT AND CREDIT AGREEMENTS
 ABL Facility
 In December 2023, the Company entered into Amendment No. 3 to the Second Amended and Restated Credit Agreement ("the Credit Agreement"), which, prior to the ABL Adjustment Date (as defined below), provided the Company with a $ 180 million senior secured asset-based revolving credit facility. In April 2024, the Company entered into Amendment No. 4 to the Credit Agreement (as amended by Amendment No. 3 and Amendment No. 4, the "ABL Facility") that, among other items: (i) moved the ABL Adjustment Date (defined below) from March 31, 2025 to September 30, 2025 and (ii) required weekly reporting of the borrowing base financial covenant until the ABL Adjustment Date. The ABL Facility is secured by substantially all assets of the Company and its domestic subsidiaries, including equity in certain material first-tier foreign subsidiaries. Availability for borrowings under the ABL Facility is governed by a borrowing base, determined by the application of specified advance rates against eligible assets, including a portion of trade accounts receivable, inventory, cash and cash equivalents, owned real properties, and owned machinery and equipment. Upon the earlier of September 30, 2025 or the date the Company received the proceeds from the sale of Terphane (the "ABL Adjustment Date"), the $ 180 million ABL Facility was to be reduced to $ 125 million. On November 1, 2024, with the closing of the sale of Terphane, the ABL Adjustment Date occurred. The ABL Facility will expire on June 30, 2026. As of December 31, 2024, funds available to borrow under the ABL Facility was $ 43.8 million, or 35.0 % of the aggregate commitment of $125 million.
 Outstanding borrowings accrue interest at the rates elected by the Company depending on the type of loan and denomination of such borrowing. For the ABL Facility, the Company may elect interest rates at:
 • Alternate Base Rate ("ABR") Spread (as defined in the ABL Facility) is determined in accordance with an excess availability-based pricing grid. ABR is defined, in part, as the greater of (a) the Prime Rate in effect on such day, (b) the Federal Reserve Bank of New York Rate in effect on such day plus of 1% and (c) the Adjusted Term SOFR Rate (defined below) for a one-month period plus 1%; or
 • The Term Benchmark Spread (as defined in the ABL Facility) is determined in accordance with an excess availability-based pricing grid. Adjusted Term SOFR Rate is defined as the Term SOFR Rate plus 0.10%, subject to an initial Floor (as defined in the ABL Facility) of 0%.
 Based upon the quarterly average of daily availability under the ABL Facility, the interest rate pricing grid is as follows:

 Pricing under the ABL Facility (Basis Points)

 Quarter Average of Daily Availability
 Term Benchmark
Spread
 ABR
Spread
 Commitment
Fee

 > 66% of $125 million aggregate commitment
 225.0
 125.0
 40.0

 66% but > 33% of $125 million aggregate commitment
 250.0
 150.0
 40.0

 33% of $125 million aggregate commitment
 275.0
 175.0
 40.0

 The financial covenant is a minimum fixed charge coverage ratio (as defined in the ABL Facility) of 1.00:1.00 that will be triggered in the event that availability is less than 10 % of the $ 125 million commitment amount and continuing thereafter until availability is greater than 10 % of the $ 125 million commitment amount for 30 consecutive days.
 If at any time the availability under the ABL facility is less than 20 % of the maximum aggregate principal amount in effect at such time or an Event of Default occurs, the Company's current monthly reporting requirements to lenders changes to a weekly cadence until the Event of Default is waived, cured or the availability under the ABL facility is above 20 % of the maximum aggregate principal amount for 30 consecutive days.
 A Cash Dominion Period goes into effect if availability under the ABL Facility falls below 12.5 % of the aggregate commitment or an Event of Default (as defined in the ABL Facility) occurs. The Company would then be subject to the Cash Dominion Period until the Event of Default is waived or ABL Facility availability is above 12.5 % of the $ 125 million aggregate commitment for 30 consecutive days. During a Cash Dominion Period, receipts that have not yet been applied to the ABL Facility are classified as restricted cash in the Company's consolidated balance sheets.
 The ABL Facility has customary representations and warranties including, as a condition to each borrowing, that all such representations and warranties are true and correct in all material respects (including a representation that no Material
 Adverse Effect (as defined in the ABL Facility) has occurred since December 31, 2022). In the event that the Company cannot certify that all conditions to the borrowing have been met, the lenders can restrict the Company's future borrowings under the ABL Facility.
 As of November 1, 2024, the Company is no longer in a Cash Dominion Period. Because a Cash Dominion Period was in effect as of December 31, 2023 and the Company is required to represent that no Material Adverse Effect has occurred as a

 condition to borrowing, the outstanding debt under the ABL Facility (all contractual payments due on June 30, 2026) was classified as a current liability in the consolidated balance sheets as of December 31, 2023.
 In accordance with the ABL Facility, the lenders have been provided with the Company's financial statements, covenant compliance certificates and projections to facilitate their ongoing assessment of the Company. Accordingly, the Company believes the likelihood that lenders would exercise the subjective acceleration clause whereby prohibiting future borrowings is remote. As of December 31, 2024, the Company was in compliance with all debt covenants.
 PE Films Guangzhou Loan
 In June 2024, PE Films' business location in Guangzhou, China, Guangzhou Tredegar Film Products Co., Ltd.("Guangzhou Tredegar"), entered into a 9.5 million Chinese Yuan, which is equivalent to $ 1.3 million as of December 31, 2024, revolving loan with the Industrial and Commercial Bank of China. The loan matures on July 3, 2025. The interest rate is the one-year loan prime rate published by the National Interbank Funding Center for the working day immediately preceding the drawdown date, minus 0.45 %. As of December 31, 2024, the National Interbank Funding Center rate was 3.45 %. The revolving loan is secured by a mortgage contract listing the Guangzhou Tredegar factory building as collateral. The mortgage contract has a maximum value of 30 million Chinese Yuan and is effective from June 25, 2024 through May 31, 2027. This loan was presented as current debt on the consolidated balance sheet for the year ended December 31, 2024.

 8. RETIREMENT PLANS AND OTHER POSTRETIREMENT BENEFITS
 Tredegar sponsored a noncontributory defined benefit (pension) plan covering certain current and former U.S. employees. The plan for salaried and hourly employees was based on a formula using the participant's years of service and compensation or using the participant's years of service and a dollar amount. The plan is closed to new participants and pay for active plan participants for benefit calculations was frozen as of December 31, 2007. As of January 31, 2018, the plan no longer accrued benefits associated with crediting employees for service, thereby freezing all future benefits under the plan. On February 10, 2022, Tredegar announced the initiation of a process to terminate and settle its frozen defined benefit pension plan through lump sum distributions and the purchase of annuity contracts. In connection therewith, on February 9, 2022, the Company contributed $ 50 million to the pension plan.
 During the third quarter of 2023, the Company remeasured the pension plan, which resulted in a pre-tax pension settlement loss in the consolidated results of operation of $ 25.6 million. The remeasurement of the pension benefit obligation and plan assets was triggered by $ 64.5 million of lump sum distributions from the pension plan assets which exceeded the pension plan's service and interest cost.
 In September 2023, the Company borrowed $ 30 million under its prior credit agreement in anticipation of the final funding expected for terminating its defined benefit pension plan obligation. In October 2023, the Company used this cash to contribute $ 27.7 million to fully fund the pension plan with the amount necessary to purchase from Massachusetts Mutual Life Insurance Company a nonparticipating single premium group annuity contract for $ 157.5 million. In November 2023, the pension plan termination and settlement process was completed, and the Company's relevant pension plan obligation was transferred to Massachusetts Mutual Life Insurance Company. This completed the pension plan termination process that began in February 2022. As a result of the routine administrative process to transition the pension plan, the Company recognized a $ 2.0 million charge to adjust the initial purchase price of the nonparticipating single premium group annuity contract reported as part of Other income (expense), net on the Consolidated Statement of Income (Loss). During the fourth quarter of 2023, the Company recognized a pre-tax pension settlement loss of $ 66.7 million.
 Tredegar also has a non-qualified supplemental pension plan covering certain employees. Effective December 31, 2005, further participation in this plan was terminated and benefit accruals for existing participants were frozen. The plan was designed to restore all or a part of the pension benefits that would have been payable to designated participants from the principal pension plans if it were not for limitations imposed by income tax regulations. The projected benefit obligation relating to this unfunded plan was $ 1.5 million and $ 1.6 million at December 31, 2024 and December 31, 2023, respectively. Pension expense recognized for this plan was $ 0.1 million in 2024, 2023 and 2022. This information has been included in the pension benefit tables below.
 In addition to providing pension benefits, the Company provides postretirement life insurance and health care benefits for certain groups of employees. Tredegar and retirees share in the cost of postretirement health care benefits, with employees hired on or before January 1, 1993, receiving a fixed subsidy to cover a portion of their health care premiums. The Company eliminated prescription drug coverage for Medicare-eligible retirees as of January 1, 2006. Consequently, Tredegar is not eligible for any federal subsidies.

 The following tables reconcile the changes in benefit obligations and plan assets in 2024 and 2023, and reconcile the funded status to prepaid or accrued cost at December 31, 2024 and 2023:

 Pension Benefits
 Other Post-
Retirement Benefits

 2024
 2023
 2024
 2023

 Change in benefit obligation:

 Benefit obligation, beginning of year
 $
 1,600
 $
 248,114
 $
 5,712
 $
 5,726

 Service cost
 —
 —

 Interest cost
 9,623

 Effect of actuarial (gains) losses related to the following:

 Discount rate change
 ( 60)
 ( 10,751)
 ( 305)

 Other
 ( 6,459)
 ( 193)

 Plan participant contributions
 —
 —

 Benefits paid
 ( 184)
 ( 16,957)
 ( 875)
 ( 913)

 Settlement payments and annuity purchase
 —
 ( 221,970)
 —
 —

 Benefit obligation, end of year
 $
 1,478
 $
 1,600
 $
 5,078
 $
 5,712

 Change in plan assets:

 Plan assets at fair value, beginning of year
 $
 —
 $
 218,119
 $
 —
 $
 —

 Actual return on plan assets
 —
 ( 7,053)
 —
 —

 Employer contributions
 27,861

 Plan participant contributions
 —
 —

 Benefits paid
 ( 184)
 ( 16,957)
 ( 875)
 ( 913)

 Settlement payments and annuity purchase
 —
 ( 221,970)
 —
 —

 Plan assets at fair value, end of year
 $
 —
 $
 —
 $
 —
 $
 —

 Funded status of the plans
 $
 ( 1,478)
 $
 ( 1,600)
 $
 ( 5,078)
 $
 ( 5,712)

 Amounts recognized in the consolidated balance sheets:

 Accrued expenses (current)
 $
 $
 $
 $

 Pension and other postretirement benefit obligations, net
 1,317
 1,420
 4,597
 5,223

 Net amount recognized
 $
 1,478
 $
 1,600
 $
 5,078
 $
 5,712

 The following table sets forth the assumptions used in accounting for the pension and other post-retirement benefits, and the components of net periodic benefit cost:

 Pension Benefits
 Other Post-
Retirement Benefits

 2024
 2023
 2022
 2024
 2023
 2022

 Weighted-average assumptions used to determine benefit obligations:

 Discount rate
 5.49
 %
 4.89
 %
 5.07
 %
 5.63
 %
 4.98
 %
 5.17
 %

 Expected long-term return on plan assets
 n/a
 n/a
 4.99
 %
 n/a
 n/a
 n/a

 Weighted-average assumptions used to determine net periodic benefit cost:

 Discount rate(a)

 4.89
 %
 5.07 %/ 5.37 %

 2.90
 %
 4.98
 %
 5.17
 %
 2.86
 %

 Expected long-term return on plan assets
 n/a
 n/a
 3.05
 %
 n/a
 n/a
 n/a

 Components of net periodic benefit cost:

 Service cost
 $
 —
 $
 —
 $
 —
 $
 $
 $

 Interest cost
 9,623
 8,945

 Expected return on plan assets
 —
 ( 8,109)
 ( 8,174)
 —
 —
 —

 Amortization of prior service costs and gains or losses
 9,245
 13,746
 ( 162)
 ( 213)
 ( 140)

 Net periodic benefit cost
 $
 $
 10,759
 $
 14,517
 $
 $
 $

 —
 —
 —
 —
 —

 Total benefit cost
 $
 $
 103,050
 $
 14,517
 $
 $
 $

 (a) Prior to the pension lump sum distributions in August 2023, a discount rate of 5.07% was used to determine the net periodic benefit cost. Subsequent to August 2023, a discount rate of 5.37% was used to determine the net periodic benefit cost until the Company purchased a nonparticipating single premium group annuity contract in October 2023.

 Net periodic benefit cost is determined using assumptions at the beginning of each year. Funded status is determined using assumptions at the end of each year. The amount of the accumulated benefit obligation is the same as the projected benefit obligation. At December 31, 2024, the effect of a 1 % change in the health care cost trend rate assumptions would not impact the post-retirement obligation.
 Expected benefit payments over the next five years and in the aggregate for 2030—2034 are as follows:

 Pension Benefits
 Other Post-
Retirement
Benefits

 2025
 $
 $

 2026

 2027

 2028

 2029

 2030—2034
 1,890

 The pre-tax amounts recorded in 2024, 2023 and 2022 in accumulated other comprehensive income (loss) consist of:

 Pension Benefits
 Other Post-Retirement Benefits

 2024
 2023
 2022
 2024
 2023
 2022

 Net actuarial (gain) loss
 $
 $
 $
 103,998
 $
 ( 1,534)
 $
 ( 1,250)
 $
 ( 1,574)

 The amounts in accumulated other comprehensive income, before related deferred income taxes, which are expected to be recognized as components of net periodic cost during 2025 are approximately $ 0.3 million of benefit for other post-retirement plans.

 9. DERIVATIVES
 Tredegar uses derivative financial instruments for the purpose of hedging margin exposure from fixed-price forward sales contracts in Aluminum Extrusions. These derivative financial instruments are designated as and qualify as cash flow hedges

 and are recognized in the consolidated balance sheet at fair value. The fair value of derivative instruments recorded on the consolidated balance sheets is based upon Level 2 inputs. If individual derivative instruments with the same counterparty can be settled on a net basis, the Company records the corresponding derivative fair values as a net asset or net liability.
 In the normal course of business, Aluminum Extrusions enters into fixed-price forward sales contracts with certain customers for the future sale of fixed quantities of aluminum extrusions at scheduled intervals. In order to hedge margin exposure created from the fixing of future sales prices relative to volatile raw material (aluminum) costs, Aluminum Extrusions enters into a combination of forward purchase commitments and futures contracts to acquire or hedge aluminum, based on the scheduled purchases for the firm sales commitments. The fixed-price firm sales commitments and related hedging instruments generally have durations of not more than 12 months, and the notional amount of aluminum futures contracts that hedged future purchases of aluminum to meet fixed-price forward sales contract obligations was $ 4.3 million ( 3.1 million pounds of aluminum) at December 31, 2024 and $ 7.7 million ( 5.6 million pounds of aluminum) at December 31, 2023.
 The table below summarizes the location and gross amounts of aluminum derivative contract fair values (Level 2) in the consolidated balance sheets as of December 31, 2024 and 2023:

 December 31, 2024
 December 31, 2023

 Balance Sheet
Account
 Fair
Value
 Balance Sheet
Account
 Fair
Value

 Derivatives Designated as Hedging Instruments

 Asset derivatives:
Aluminum futures contracts
 Prepaid expenses & other
 $
 Prepaid expenses & other
 $
 —

 Liability derivatives:
Aluminum futures contracts
 Accrued expenses
 ( 57)
 Accrued expenses
 ( 483)

 Aluminum futures contracts
 Other non-current liabilities
 —
 Other non-current liabilities
 ( 9)

 Net asset (liability)
 $
 $
 ( 492)

 In the event that a counterparty to an aluminum fixed-price forward sales contract chooses not to take delivery of its aluminum extrusions, the customer is contractually obligated to compensate Aluminum Extrusions for any losses on the related aluminum futures and/or forward contracts through the date of cancellation.
 These derivative contracts involve elements of market risk that are not reflected on the consolidated balance sheet, including the risk of dealing with counterparties and their ability to meet the terms of the contracts. The counterparties to any forward purchase commitments are major aluminum brokers and suppliers, and the counterparties to any aluminum futures contracts are major financial institutions. Fixed-price forward sales contracts are only made available to the best and most creditworthy customers.
 The pre-tax effect on net income (loss) and other comprehensive income (loss) of derivative instruments classified as cash flow hedges and described in the previous paragraphs for years ended December 31, 2024, 2023, and 2022 is summarized in the table below:

 Cash Flow Derivative Hedges

 Aluminum Futures Contracts

 Years Ended December 31,
 2024
 2023
 2022

 Amount of pre-tax gain (loss) recognized in other comprehensive income
 $
 $
 7,598
 $
 ( 4,525)

 Location of gain (loss) reclassified from accumulated other comprehensive income into net income (effective portion)
 Cost of
goods sold
 Cost of
goods sold
 Cost of
goods sold

 Amount of pre-tax gain (loss) reclassified from accumulated other comprehensive income to net income (effective portion)
 $
 ( 612)
 $
 4,508
 $
 1,022

 As of December 31, 2024, the Company expects $ 0.1 million of unrealized after-tax net gains on aluminum derivative contracts reported in accumulated other comprehensive income (loss) to be reclassified to earnings within the next 12 months. For the years ended December 31, 2024, 2023 and 2022, net gains or losses realized, from previously unrealized net gains or losses on hedges that had been discontinued, were not material.

 10. STOCK OPTION AND STOCK AWARD PLANS
 As of December 31, 2024, the Company had one stock-based compensation plan that permits the grants of stock options, stock appreciation rights ("SARs"), stock, restricted stock, and stock unit awards. Awards available for grant totaled 725,154 shares at December 31, 2024. Stock options may be granted to purchase a specified number of shares of common stock at a price no lower than the fair market value on the date of grant and for a term not to exceed 10 years. Stock options exercisable totaled 2,327,655 and 3,019,333 shares at December 31, 2024 and 2023, respectively.

 A summary of stock options outstanding at December 31, 2024, 2023 and 2022, and changes during those years, is presented below:

 Option Exercise Price/Share

 Number of
Options
 Range
 Weighted
Average

 Outstanding at January 1, 2022
 3,125,944
 $
 10.75
 to
 $
 22.49
 $
 13.82

 ( 17,203)
 14.47
 to
 19.64
 15.33

 Outstanding at December 31, 2022

 3,108,741
 10.75
 to
 22.49
 13.81

 ( 89,408)
 13.78
 to
 19.64
 19.60

 Outstanding at December 31, 2023

 3,019,333
 10.75
 to
 22.49
 13.64

 ( 691,678)
 10.75
 to
 22.49
 14.15

 Outstanding at December 31, 2024
 2,327,655
 $
 10.75
 to
 $
 16.37
 $
 13.49

 No options were granted in 2024, 2023 or 2022.
 The following table summarizes additional information about stock options outstanding and exercisable at December 31, 2024:

 Options Outstanding at December 31, 2024
 Options Exercisable at December 31, 2024

 Weighted Average
 Aggregate Intrinsic Value

 Aggregate Intrinsic Value

 Range of
Exercise Prices
 Shares
 Remaining Contractual Life
 Exercise
Price
 Shares
 Weighted Average Exercise Price

 $
 10.75
 to
 $
 16.37
 2,327,655
 1.3 years
 $
 13.49
 $
 —
 2,327,655
 $
 13.49
 $
 —

 There were no stock options exercised in 2024, 2023 or 2022. The grant-date fair value of stock option-based awards vested in 2023 and 2022 was $ 2.2 million and $ 5.4 million, respectively. As of December 31, 2024, there was no unrecognized compensation cost related to stock option-based awards.

 Restricted stock grants ordinarily vest three years from the date of grant based upon continued employment. The fair value of restricted stock awards is estimated as of the grant date using the closing stock price on that date.
 Stock unit awards vest upon the achievement of certain performance targets.
 The following table summarizes additional information about unvested restricted stock awards and performance stock units awards outstanding at December 31, 2024, 2023 and 2022:

 Unvested Restricted Stock Awards
 Maximum Unvested Restricted Stock Units Issuable Upon Satisfaction of Certain Performance Criteria

 Number
of Shares
 Weighted Avg. Grant Date Fair Value/Share
 Grant Date
Fair Value
 Number
of Shares
 Weighted Avg. Grant Date Fair Value/Share
 Grant Date
Fair Value

 Outstanding at January 1, 2022
 335,800
 $
 16.30
 $
 5,473
 50,718
 $
 17.63
 $
 1,366

 Granted
 301,969
 11.88
 3,587
 —
 —
 —

 Vested
 ( 144,317)
 15.10
 ( 2,179)
 —
 —
 —

 Forfeited
 ( 18,474)
 14.94
 ( 276)
 ( 50,718)
 17.63
 ( 1,366)

 Outstanding at December 31, 2022
 474,978
 13.82
 6,564
 —
 —
 —

 Granted
 454,623
 7.67
 3,487
 —
 —
 —

 Vested
 ( 167,077)
 11.29
 ( 1,886)
 —
 —
 —

 Forfeited
 ( 26,445)
 11.60
 ( 307)
 —
 —
 —

 Outstanding at December 31, 2023
 736,079
 10.68
 7,861
 —
 —
 —

 Granted
 385,159
 7.25
 2,792
 —
 —
 —

 Vested
 ( 261,941)
 11.94
 ( 3,128)
 —
 —
 —

 Forfeited
 ( 87,181)
 8.51
 ( 742)
 —
 —
 —

 Outstanding at December 31, 2024
 772,116
 $
 8.79
 $
 6,787
 —
 $
 —
 $
 —

 As of December 31, 2024, the unrecognized compensation cost related to non-vested restricted stock awards was $ 3.4 million. This cost is expected to be recognized over the remaining weighted average period of 1.8 years.
 There were no SARs granted in 2024, 2023 or 2022. SARs may be settled in cash upon exercise and therefore are classified as liabilities and included in accrued expenses in the consolidated balance sheet. The fair value of these liability awards is remeasured at each reporting period until the date of settlement. Increases and decreases in stock-based compensation expense are recognized over the vesting period, or immediately, for vested awards.
 A summary of SARs outstanding at December 31, 2024, 2023 and 2022, and changes during those years, is presented below:

 Exercise Price/Share

 Number of
SARs
 Range
 Weighted
Average

 Outstanding at January 1, 2022
 521,601
 $
 10.75
 to
 $
 16.37
 $
 13.55

 ( 22,914)
 10.75
 to
 16.37
 14.83

 Outstanding at December 31, 2022
 498,687
 10.75
 to
 16.37
 13.49

 ( 53,969)
 10.75
 to
 16.37
 12.78

 Outstanding at December 31, 2023
 444,718
 10.75
 to
 16.37
 13.57

 ( 110,272)
 10.75
 to
 16.37
 13.85

 Outstanding at December 31, 2024
 334,446
 $
 10.75
 to
 $
 16.37
 $
 13.48

 The grant-date fair value of SARs awards vested in 2022 was $ 0.5 million. The grant-date fair value of SARs awards vested in 2024 and 2023 was immaterial. As of December 31, 2024, there was no unrecognized compensation cost related to SARs.

 11. INCOME TAXES
 Income (loss) from continuing operations before income taxes and income tax expense (benefit) from continuing operations are as follows:

 2024
 2023
 2022

 Income (loss) from continuing operations before income taxes:

 Domestic
 $
 ( 523)
 $
 ( 151,488)
 $
 8,250

 Foreign
 1,403
 1,023
 1,314

 Total
 $
 $
 ( 150,465)
 $
 9,564

 Current income tax expense (benefit):

 Federal
 $
 ( 106)
 $
 ( 39,929)
 $
 ( 346)

 State
 ( 39)

 Foreign

 Total
 ( 39,727)

 Deferred income tax expense (benefit):

 Federal
 ( 470)
 ( 11,758)
 ( 3,256)

 State
 ( 517)
 ( 513)

 Foreign
 ( 13)

 Total
 ( 886)
 ( 11,573)
 ( 3,723)

 Total income tax expense (benefit) for continuing operations
 $
 ( 165)
 $
 ( 51,300)
 $
 ( 3,021)

 The significant differences between the U.S. federal statutory rate and the effective income tax rate related to continuing operations are as follows:

 2024
 2023
 2022

 Amount
 %
 Amount
 %
 Amount
 %

 Income tax expense (benefit) at federal statutory rate
 $
 21.0
 $
 ( 31,598)
 21.0
 $
 1,992
 21.0

 Stock-based compensation
 46.5
 ( 0.1)
 ( 103)
 ( 1.1)

 Changes in estimates related to prior year tax provision
 37.0
 ( 0.4)
 ( 812)
 ( 8.5)

 Non-deductible other
 32.0
 ( 0.1)
 6.4

 Foreign rate differences
 6.5
 —
 0.5

 State taxes, net of federal income tax benefit
 3.2
 ( 0.1)
 0.4

 U.S. tax on foreign branch income
 —
 —
 1,693
 ( 1.1)
 ( 3,341)
 ( 35.1)

 Stranded taxes released with termination of pension
 —
 —
 ( 21,913)
 14.6
 —
 —

 Foreign derived intangible income deduction
 —
 —
 —
 —
 ( 259)
 ( 2.7)

 Tax contingency accruals and tax settlements
 ( 1)
 ( 0.1)
 —
 3.1

 Changes in federal valuation allowance
 ( 654)
 ( 74.3)
 ( 0.2)
 —
 —

 Research and development tax credit
 ( 797)
 ( 90.6)
 ( 766)
 0.5
 ( 1,489)
 ( 15.6)

 Income tax expense (benefit) at effective income tax rate
 $
 ( 165)
 ( 18.8)
 $
 ( 51,300)
 34.1
 $
 ( 3,021)
 ( 31.6)

 Provision (benefit) for income taxes for the year ended December 31, 2024 was $( 0.2) million compared to $( 51.3) million for the year ended December 31, 2023. The effective tax rates for the years ended December 31, 2024 and 2023 were ( 18.8)% and 34.1 %, respectively. The change in effective tax rate is primarily due to pre-tax income from continuing operations in 2024 versus a pre-tax loss from continuing operations in 2023. The tax rate in 2023 was significantly impacted by tax benefits previously recorded in other comprehensive income (loss) that were released in 2023 as a result of the pension plan termination. The stranded taxes released with the termination of the pension plan represent the effect of the change in federal and state tax rates on pension-related deferred tax items initially recorded in other comprehensive income. The related stranded taxes were released in full in 2023.
 The effective tax rate in 2022 was impacted by a large discrete benefit recorded in the first quarter of 2022, resulting from the implementation of new U.S. tax regulations associated with foreign tax credits published by the U.S. Treasury and Internal Revenue Service ("IRS") on January 4, 2022. These regulations overhauled various components of the foreign tax credit regime including the determination of creditable foreign taxes and limit the amount of foreign taxes that are creditable against U.S. income taxes. As the result of these regulations, future Brazilian income tax under Brazil tax law in place at that time

 would have been deductible, but not creditable, in the U.S. The accounting rules require a reduction of the U.S. deferred tax liability previously established related to anticipated future income from Brazil. The IRS released guidance in 2023 that provides temporary relief for tax years after 2021 from the regulations published by the IRS on January 4, 2022. As a result of the IRS guidance released in 2023, the reduction in the first quarter of 2022 of the U.S. deferred tax liability previously established related to anticipated future income from Brazil was reversed in 2023.
 Deferred income tax assets and deferred income tax liabilities for continuing operations at December 31, 2024 and 2023, are as follows:

 2024
 2023

 Deferred income tax assets:

 Pension and other postretirement obligations
 $
 —
 $

 Employee benefits
 6,381
 5,821

 Basis difference in capital assets
 1,150

 Inventory
 1,478

 Asset write-offs, divestitures and environmental accruals
 3,656
 1,025

 U.S. federal and state NOL and credit carryforwards
 38,706
 33,247

 Capitalized R&D expenditures
 8,169
 6,543

 Other
 2,805

 Lease liabilities
 3,419
 2,710

 Interest expense limitation
 2,592

 Foreign currency translation gain adjustment
 —

 Deferred income tax assets before valuation allowance
 63,003
 57,943

 Less: Valuation allowance
 15,220
 15,173

 Total deferred income tax assets
 47,783
 42,770

 Deferred income tax liabilities:

 Goodwill and identifiable intangibles
 $
 1,019
 $
 3,138

 Property, plant and equipment
 9,086
 11,386

 Foregone tax credits on foreign branch income
 —
 1,880

 Right-of-use leased assets
 3,210
 2,409

 Other
 2,020

 Total deferred income tax liabilities
 15,335
 19,615

 Net deferred income tax assets (liabilities)
 $
 32,448
 $
 23,155

 Amounts recognized in the consolidated balance sheets:

 Deferred income tax assets (noncurrent)
 $
 32,517
 $
 23,155

 Deferred income tax liabilities (noncurrent)
 —

 Net deferred income tax assets (liabilities)
 $
 32,448
 $
 23,155

 Except as noted below, the Company believes that it is more likely than not that future taxable income will exceed future tax-deductible amounts thereby resulting in the realization of deferred income tax assets. The Company had U.S. federal and state tax credits of $ 25.2 million, net operating loss carryforwards of $ 13.5 million and a deferred interest limitation of $0.5 million at December 31, 2024. The Company had U.S. federal and state tax credits of $ 16.7 million and net operating loss carryforwards of $ 16.5 million and a deferred interest limitation of $ 2.6 million at December 31, 2023. The U.S. deferred interest limitation can be carried forward indefinitely. The U.S. federal foreign tax credits will expire between 2026-2034 and the U.S. federal research and development tax credits will expire by 2045. The U.S. state carryforwards expire at different points over the next 20 years.
 Valuation allowances of $ 14.0 million, $ 12.1 million and $ 10.3 million at December 31, 2024, 2023 and 2022, respectively, are recorded against the tax benefit on U.S. federal and state tax credits and net operating loss carryforwards generated by domestic subsidiaries that may not be recoverable in the carryforward period. The Company had a valuation allowance of $ 0.8 million against U.S. federal tax credits at December 31, 2023. The valuation allowance for unrealized capital losses from investments and other related items was $ 0.2 million at December 31, 2024 and $ 0.7 million at December 31, 2022. As circumstances and events warrant, allowances will be reversed when it is more likely than not that future taxable income will exceed deductible amounts, thereby resulting in the realization of deferred income tax assets. Valuation allowances of

 $ 1.1 million, $ 2.2 million and $ 2.8 million at December 31, 2024, 2023 and 2022, respectively, were recorded against certain deferred state tax assets.
 A reconciliation of the Company's unrecognized uncertain tax positions since January 1, 2022, is shown below:

 Years Ended December 31,

 2024
 2023
 2022

 Balance at beginning of period
 $
 $
 $

 Increase (decrease) due to tax positions taken in:

 Current period

 Prior period

 Reductions due to lapse of statute of limitations
 ( 2)
 ( 17)
 ( 66)

 Balance at end of period
 $
 $
 $

 The Company records interest expense related to uncertain tax positions in income tax expense on the Consolidated Statements of Income (Loss) with the balance of accrued interest in other noncurrent liabilities on the Consolidated Balance Sheet. The Company accrued immaterial interest expense related to uncertain tax positions during 2024, 2023 and 2022, respectively.
 Tredegar, or one of its subsidiaries, files income tax returns in the U.S. federal jurisdiction, various states and jurisdictions outside the U.S. With few exceptions, Tredegar is no longer subject to U.S. federal, state or non-U.S. income tax examinations by tax authorities for years before 2021. The Company anticipates that it is reasonably possible that Federal and state income tax audits or statutes may settle or close within the next 12 months and are not expected to result in a material change in unrecognized tax positions, including any payments that may be made.

 12. BUSINESS SEGMENTS
 The Company's business segments are Aluminum Extrusions and PE Films. Aluminum Extrusions, also referred to as Bonnell Aluminum, produces high-quality, soft and medium strength alloyed aluminum extrusions, custom fabricated and finished, for the building and construction, automotive and transportation, consumer durables goods, machinery and equipment, electrical and renewable energy, and distribution markets. PE Films produces surface protection films, polyethylene overwrap films and films for other markets.
 The Company's reportable segments are based on its method of internal reporting, which is generally segregated by differences in products. Accounting standards for presentation of segments require an approach based on the way the Company organizes the segments for making operating decisions and how the chief operating decision maker ("CODM") assesses performance. EBITDA from ongoing operations is the key profitability measure used by the CODM (Tredegar's President and Chief Executive Officer) for purposes of assessing financial performance.
 EBITDA from ongoing operations used by the CODM excludes certain non-recurring items, such as restructuring costs, asset impairments and other items, which are reported separately. The CODM uses EBITDA from ongoing operations to evaluate the operating performance of Tredegar's ongoing operations, monitor budget versus actual results, establish management's compensation and allocate resources. EBITDA from ongoing operations is the primary measure of segment performance and is consistent with how the business is managed internally, in addition to being a key financial and analytic metric for borrowing capacity and estimated enterprise value.
 The Company uses sales less freight ("net sales") as its measure of revenues from external customers at the segment level. This measure is separately included in the financial information regularly provided to the CODM.
 Information by business segment and geographic area for the last three years is provided in the segment tables below. There were no accounting transactions between segments.

 Segment Revenue, Segment Profit (Loss), and Significant Expenses

 2024

 Total

 $
 471,815
 $
 105,199
 $
 577,014

 Reconciliation of revenue:

 Add back freight
 21,011

 Sales as shown in the consolidated statements of income (loss)
 $
 598,025

 Less:

 354,397
 50,289
 404,686

 1,234
 ( 174)
 1,060

 Manufacturing fixed costs (e)
 40,123
 13,248
 53,371

 Selling, general and administrative costs (e)
 33,638
 11,245
 44,883

 Other (f)
 1,066
 1,171

 $
 41,357
 $
 30,486
 $
 71,843

 Reconciliation of profit (loss):

 Depreciation and amortization
 22,922

 Plant shutdowns, asset impairments, restructurings and other (a)
 5,766

 4,664

 Gain on investment in kaleo, inc.

 Corporate expenses, net (d)
 24,520

 Income (loss) from continuing operations before income tax

 ( 165)

 1,045

 ( 65,610)

 $

 Refer to Notes to Financial Tables that follow these tables.

 Segment Revenue, Segment Profit (Loss), and Significant Expenses

 2023

 Total

 $
 $
 $
 551,566

 Reconciliation of revenue:

 Add back freight
 21,757

 Sales as shown in the consolidated statements of income (loss)
 $
 573,323

 Less:

 365,320
 40,824
 406,144

 ( 944)
 ( 1,333)
 ( 2,277)

 Manufacturing fixed costs (e)
 41,028
 13,793
 54,821

 Selling, general and administrative costs (e)
 29,725
 12,106
 41,831

 Other (f)
 1,698
 1,854

 $
 37,976
 $
 11,217
 $
 49,193

 Reconciliation of profit (loss):

 Depreciation and amortization
 24,449

 Plant shutdowns, asset impairments, restructurings and other (a)
 8,529

 34,891

 6,316

 Gain on investment in kaleo, inc.

 Stock option-based compensation expense

 Corporate expenses, net (d)
 33,727

 Income (loss) from continuing operations before income tax
 ( 150,465)

 ( 51,300)

 ( 99,165)

 ( 6,740)

 $

 Refer to Notes to Financial Tables that follow these tables.

 Segment Revenue, Segment Profit (Loss), and Significant Expenses

 2022

 Total

 $
 637,872
 $
 97,571
 $
 735,443

 Reconciliation of revenue:

 Add back freight
 26,542

 Sales as shown in the consolidated statements of income (loss)
 $
 761,985

 Less:

 503,374
 56,085
 559,459

 ( 5,402)
 ( 4,881)

 Manufacturing fixed costs (e)
 43,073
 15,216
 58,289

 Selling, general and administrative costs (e)
 31,641
 14,116
 45,757

 Other (f)
 ( 1,614)
 ( 316)
 ( 1,930)

 $
 66,800
 $
 11,949
 $
 78,749

 Reconciliation of profit (loss):

 Depreciation and amortization
 23,694

 Plant shutdowns, asset impairments, restructurings and other (a)

 4,141

 Gain on investment in kaleo, inc.
 1,406

 Stock option-based compensation expense
 1,414

 Corporate expenses, net (d)
 40,402

 Income (loss) from continuing operations before income tax
 9,564

 ( 3,021)

 12,585

 15,870

 $

 Refer to Notes to Financial Tables that follow these tables.

 Identifiable Assets

 2024
 2023

 $
 247,205
 $
 255,756

 55,081
 56,536

 Subtotal
 302,286
 312,292

 General corporate
 46,883
 36,652

 Cash, cash equivalents and restricted cash (b)
 7,062
 13,051

 84,466

 Total
 $
 356,357
 $
 446,461

 Depreciation and Amortization
 Capital Expenditures

 2024
 2023
 2022
 2024
 2023
 2022

 $
 17,722
 $
 17,927
 $
 17,414
 $
 10,097
 $
 20,339
 $
 23,664

 5,200
 6,522
 6,280
 1,761
 1,772
 3,289

 Subtotal
 22,922
 24,449
 23,694
 11,858
 22,111
 26,953

 General corporate (d)
 —
 1,771

 2,313
 2,865
 2,444
 2,489
 4,323
 8,151

 Total
 $
 25,537
 $
 27,683
 $
 26,402
 $
 14,347
 $
 26,446
 $
 36,875

 Net Sales by Geographic Area (c)

 2024
 2023
 2022

 United States
 $
 514,743
 $
 506,475
 $
 675,528

 Exports from the United States to:

 Asia
 46,724
 26,217
 41,841

 Canada
 9,541
 12,121
 10,477

 Europe
 1,384

 Latin America
 5,068
 6,192
 5,587

 Operations outside the United States:

 Asia

 Total
 $
 577,014
 $
 551,566
 $
 735,443

 Identifiable Assets
by Geographic Area (c)
 Property, Plant & Equipment,
Net by Geographic Area (c)

 2024
 2023
 2024
 2023

 United States
 $
 294,303
 $
 302,037
 $
 127,992
 $
 139,552

 Operations outside the United States:

 China
 7,983
 10,255
 7,217
 9,361

 General corporate
 46,883
 36,652
 1,823
 2,244

 Cash, cash equivalents and restricted cash (b)
 7,062
 13,051
 n/a
 n/a

 84,466
 —
 32,298

 Total
 $
 356,357
 $
 446,461
 $
 137,032
 $
 183,455

 Refer to Notes to Financial Tables that follow these tables.
 The Company's facilities in Pottsville, PA ("PV") and Guangzhou, China ("GZ") have a tolling arrangement whereby certain surface protection films are manufactured in GZ for a fee with raw materials supplied from PV that are then shipped by GZ directly to customers principally in the Asian market but paid by customers directly to PV. Amounts associated with this intercompany tolling arrangement are reported in the table above as export sales from the U.S. to Asia, and include net sales of $ 26.9 million in 2024, $ 15.9 million in 2023 and $ 20.1 million in 2022.

 Net Sales by Product Group

 2024
 2023
 2022

 Aluminum Extrusions:

 Nonresidential building & construction
 $
 265,496
 $
 273,648
 $
 350,377

 Consumer durables
 31,911
 37,257
 60,252

 Automotive
 39,283
 46,014
 49,330

 Machinery & equipment
 51,149
 41,908
 57,795

 Distribution
 11,750
 13,719
 28,533

 Residential building & construction
 36,303
 36,774
 61,815

 Electrical
 35,923
 25,483
 29,770

 Subtotal
 471,815
 637,872

 PE Films:

 Surface protection films
 75,909
 47,463
 68,140

 Packaging
 29,290
 29,300
 29,431

 Subtotal
 105,199
 97,571

 Total
 $
 577,014
 $
 551,566
 $
 735,443

 (a)See Note 1 for more information on losses associated with plant shutdowns, asset impairments and restructurings and other items.
 (b)Cash, cash equivalents and restricted cash includes funds held in locations outside the U.S. of $ 1.6 million and $ 0.8 million at December 31, 2024 and 2023, respectively.
 (c)Export sales relate primarily to PE Films.
 (d)Corporate depreciation and amortization are included in corporate expenses, net, on the Segment Revenue, Segment Profit (Loss), and Significant Expenses tables above.
 (e)Excludes related depreciation and amortization.
 (f) Other expenses include segment allocated employee compensation benefits expense.

 13. SAVINGS PLAN
 Tredegar has a savings plan that allows eligible employees to voluntarily contribute a percentage of their compensation, up to IRS limitations. Charges recognized for the savings plan were $ 3.7 million in 2024, $ 3.8 million in 2023 and $ 3.7 million in 2022. The provisions of the savings plan provided the following benefits for salaried and certain hourly employees:
 • The Company makes matching contributions to the savings plan of $ 1 for every $ 1 an employee contributes per pay period up to a maximum of 5 % of eligible compensation.
 • The savings plan includes immediate vesting of matching contributions and automatic enrollment at 3 % of eligible compensation unless the employee opts out or elects a different percentage.
 The Company also has a non-qualified plan that restores matching benefits for employees suspended from the savings plan due to certain limitations imposed by income tax regulations ("restoration plan"). The Company's liability under the restoration plan was $ 0.7 million at December 31, 2024 (consisting of 88,148 phantom shares of common stock) and $ 0.4 million at December 31, 2023 (consisting of 78,192 phantom shares of common stock) and valued at the closing market price on those dates. Charges recognized for the restoration plan were immaterial for the years 2024, 2023 and 2022.
 The Tredegar Corporation Benefits Plan Trust (the "Trust") purchased 7,200 shares of the Company's common stock in 1998 for $ 0.2 million and 46,671 shares of its common stock in 1997 for $ 1.0 million. There have been no shares purchased since 1998 except for re-invested dividends. The cost of the shares held by the Trust is shown as a reduction to shareholders' equity in the consolidated balance sheets.

 14. SUPPLY CHAIN FINANCING
 The Company had supply chain finance service agreements with third-party financial institutions to provide platforms that facilitate the ability of participating suppliers to finance payment obligations from the Company with third-party financial institutions. The Company's obligations to its suppliers, including amounts due and scheduled payment dates, were not affected by suppliers' decisions to finance amounts under the supply chain finance agreements. As of December 31, 2024, the Company is no longer participating in supply chain finance service agreements through third-party financial institutions. As of December 31, 2023, $ 1.0 million of the Company's accounts payable were financed by participating suppliers through third-party financial institutions.
 A reconciliation of the beginning and ending balances of the supply chain financing for the year ended December 31, 2024 is as follows:

 2024
 2023

 Balance, beginning of year
 $
 1,006
 $
 14,823

 New obligations entered
 —
 27,763

 Less payments made
 ( 1,006)
 ( 41,580)

 Balance, end of year
 $
 —
 $
 1,006

 15. CONTINGENCIES
 Tredegar is involved in various stages of investigation and remediation relating to environmental matters at certain current and former plant locations. Where the Company has determined the nature and scope of any required environmental remediation activity, estimates of cleanup costs have been obtained and accrued. As efforts to maintain compliance with applicable environmental laws and regulations continue, additional contingencies may be identified. If additional contingencies are identified in the future, the Company's practice is to determine at that time the nature and scope of those contingencies, obtain and accrue estimates of the cost of remediation, and perform remediation. While the Company believes it is currently adequately accrued for known environmental issues, it is possible that unexpected future costs for known or unknown environmental issues could have a material adverse effect on its financial condition, results of operations and cash flows at that time.
 The Company is involved in various other legal actions arising in the normal course of business. After taking into consideration the relevant information, the Company believes that it has sufficiently accrued for probable losses and that the actions will not have a material adverse effect on its financial position.
 From time to time, the Company enters into transactions with third parties in connection with the sale of assets or businesses in which it agrees to indemnify the buyers or third parties involved in the transaction, or in which the sellers or third parties involved in the transaction agree to indemnify Tredegar, for certain liabilities or risks related to the assets or business. Also, in the ordinary course of its business, the Company may enter into agreements with third parties for the sale of goods or services that may contain indemnification provisions. In the event that an indemnification claim is asserted, liability for indemnification would be subject to an assessment of the underlying facts and circumstances under the terms of the applicable agreement. For these reasons, Tredegar is unable to estimate the maximum amount of the potential future liability under the indemnity provisions of these agreements. The Company does, however, accrue for losses for any known contingent liability, including those that may arise from indemnification provisions, when future payment is probable and the amount is reasonably estimable. The Company discloses contingent liabilities if the probability of loss is reasonably possible and considered to be material.

 16. DIVESTITURES
 Flexible Packaging Films
 On September 1, 2023, the Company entered into an agreement to sell Terphane, headquartered in Brazil, to Oben for net cash-free and debt-free base consideration of $ 116 million.
 On November 1, 2024, Tredegar completed the sale of Terphane to Oben. At closing, Tredegar received $ 60 million in cash, which is net of Terphane debt assumed by Oben of $ 20 million and estimated Terphane cash retained by Oben of $ 2 million. The cash proceeds received by Tredegar at closing are after deducting net working capital adjustments and closing indebtedness ($ 20.5 million), escrow funds ($ 19.8 million), projected Brazil withholding taxes ($ 10.8 million), and transaction expenses ($ 4.4 million). On February 28, 2025, the Company received $ 9.8 million from post-closing settlement of the transaction, which was $ 2.8 million higher than expected mainly due to higher cash held at Terphane in Brazil than estimated at closing. The proceeds from the sale of Terphane were required to be used to pay down debt outstanding under the ABL Facility.

 Upon completion of the sale, the Company recognized a pre-tax loss of $ 74.9 million for the year ended December 31, 2024, which includes the realization of other comprehensive losses on foreign currency translation adjustments, net of gains on derivative financial instruments of $ 102.3 million previously reflected in accumulated other comprehensive income (loss).
 The following table summarizes the financial results of discontinued operations reflected in the Consolidated Statements of Income (Loss) for the years ended December 31, 2024, 2023 and 2022:

 Years Ended December 31,

 2024
 2023
 2022

 Revenue and other items

 Sales
 $
 118,382
 $
 131,502
 $
 176,579

 Other income (expense), net
 ( 51)

 118,390
 131,504
 176,528

 Costs and expenses

 Cost of goods sold
 97,919
 118,669
 133,493

 Freight
 5,598
 5,177
 8,440

 Selling, general and administrative
 7,608
 10,819
 9,179

 Research and development

 Amortization of intangibles

 Interest expense (a)
 7,532
 5,291

 Asset impairments and costs associated with exit and disposal activities, net of adjustments
 —
 —

 Loss on sale of business
 74,877
 —
 —

 Total
 194,267
 141,069
 153,248

 Income (loss) from discontinued operations before income tax
 ( 75,877)
 ( 9,565)
 23,280

 ( 10,267)
 ( 2,825)
 7,410

 $
 ( 65,610)
 $
 ( 6,740)
 $
 15,870

 (a) For the years ended December 31, 2024 and 2023, interest expense includes $ 1.9 million and $ 0.4 million, respectively, directly related to the $ 20 million of outstanding Terphane debt assumed by Oben.

 Interest expense allocated to discontinued operations was determined by applying the ABL Facility weighted-average interest rate to the Terphane sale proceeds, as the sale proceeds were required to be used to pay down debt outstanding under the ABL Facility.

 The assets and liabilities of the discontinued operations reflected in the Consolidated Balance Sheets as of December 31, 2024 and 2023, respectively were as follows:

 2024
 2023

 Assets

 Restricted cash
 $
 —
 $

 Accounts and other receivables, net
 —
 12,323

 Inventories
 —
 32,382

 Prepaid expenses and other
 —
 3,249

 Total current assets
 —
 48,358

 Property, plant and equipment, net
 —
 32,298

 Right-of-use leased assets
 —

 Identifiable intangible assets, net
 —

 Deferred income taxes (a)
 1,880

 Other assets
 —

 Total non-current assets
 36,108

 Total assets of discontinued operations
 $
 $
 84,466

 Liabilities

 Accounts payable (a)
 $
 $
 25,695

 Accrued expenses (a)
 5,836

 Lease liability, short-term
 —

 Income taxes payable
 —
 1,027

 Total current liabilities
 32,762

 Lease liability long-term
 —

 Long term debt
 —
 20,000

 Other non-current liabilities
 —

 Total non-current liabilities
 —
 20,803

 Total liabilities of discontinued operations
 $
 $
 53,565

 (a) The consolidated balance sheet of discontinued operations as of December 31, 2024 includes $ 0.1 million of deferred tax assets, $ 0.6 million of severance and $ 0.2 million of miscellaneous accrued expenses.

 The following table provides significant operating, investing and financing cash flow information for discontinued operations:

 Year Ended December 31,

 2024
 2023
 2022

 Operating activities:

 Depreciation and amortization
 $
 2,313
 $
 2,865
 $
 2,444

 Loss on the sale of divested business
 74,877
 —
 —

 Total
 $
 77,190
 $
 2,865
 $
 2,444

 Investing activities:

 Net proceeds on sale of divested business
 $
 54,631
 $
 —
 $
 —

 ( 2,489)
 ( 4,323)
 ( 8,151)

 Total
 $
 52,142
 $
 ( 4,323)
 $
 ( 8,151)

 Financing activities

 Borrowings
 $
 —
 $
 20,000
 $
 —

 Debt principal payments
 —
 —
 —

 Total
 $
 —
 $
 20,000
 $
 —

 17. SELECTED QUARTERLY FINANCIAL DATA
 (In thousands, except per-share amounts)
 (Unaudited)

 First Quarter
 Second Quarter
 Third Quarter
 Fourth Quarter

 For the year ended December 31, 2024

 Sales
 $
 143,972
 $
 153,940
 $
 146,064
 $
 154,049

 Gross profit
 23,851
 29,598
 18,125
 24,483

 Income (loss) from continuing operations, net of tax
 2,604
 9,170
 ( 3,389)
 ( 7,339)

 ( 378)
 ( 557)
 ( 65,359)

 $
 3,288
 $
 8,792
 $
 ( 3,946)
 $
 ( 72,698)

 Earnings (loss) per share:

 Basic:

 $
 0.08
 $
 0.27
 $
 ( 0.10)
 $
 ( 0.21)

 0.02
 ( 0.01)
 ( 0.01)
 ( 1.91)

 Basic
 $
 0.10
 $
 0.26
 $
 ( 0.11)
 $
 ( 2.12)

 Diluted:

 $
 0.08
 $
 0.27
 $
 ( 0.10)
 $
 ( 0.21)

 0.02
 ( 0.01)
 ( 0.01)
 ( 1.91)

 Diluted
 $
 0.10
 $
 0.26
 $
 ( 0.11)
 $
 ( 2.12)

 For the year ended December 31, 2023

 Sales
 $
 159,237
 $
 143,350
 $
 134,569
 $
 136,167

 Gross profit
 22,655
 15,987
 14,090
 18,394

 Income (loss) from continuing operations, net of tax
 ( 17)
 ( 15,918)
 ( 49,172)
 ( 34,057)

 ( 992)
 ( 3,004)
 ( 1,208)
 ( 1,534)

 $
 ( 1,009)
 $
 ( 18,922)
 $
 ( 50,380)
 $
 ( 35,591)

 Earnings (loss) per share:

 Basic:

 $
 —
 $
 ( 0.47)
 $
 ( 1.43)
 $
 ( 1.00)

 ( 0.03)
 ( 0.09)
 ( 0.04)
 ( 0.04)

 Basic
 $
 ( 0.03)
 $
 ( 0.56)
 $
 ( 1.47)
 $
 ( 1.04)

 Diluted:

 $
 —
 $
 ( 0.47)
 $
 ( 1.43)
 $
 ( 1.00)

 ( 0.03)
 ( 0.09)
 ( 0.04)
 ( 0.04)

 Diluted
 $
 ( 0.03)
 $
 ( 0.56)
 $
 ( 1.47)
 $
 ( 1.04)

 Due to rounding, the sum of quarterly amounts presented in the table above may not add up precisely to the corresponding full year amounts.

 Item 16. FORM 10-K SUMMARY
 Not Applicable.

 EXHIBIT INDEX

 2.1
 Purchase and Sale Agreement, dated as of September 1, 2023, by and among Packfilm US LLC, Film Trading Importacao e Representacao Ltda., Terphane LLC, Terphane Limitada, Tredegar Film Products (Latin America), Inc., Terphane Acquisition Corporation II, TAC Holdings, LLC, Tredegar Investments LLC, Tredegar Corporation and Oben Holding Group S.A.C. (filed as Exhibit 2.1 of Tredegar's Current Report on Form 8-K (File No. 1-10258), filed on September 5, 2023, and incorporated herein by reference)

 2.2
 First Amendment to Purchase and Sale Agreement, dated October 31, 2024, by and among Oben US, LLC (f/k/a Packfilm US, LLC), Film Trading Importa cao e Representa cao Ltda., Terphane LLC, Terphane Limitada, Tredegar Film Products (Latin America), Inc., Terphane Acquisition Corp. II, TAC Holdings, LLC, Tredegar Investments LLC, Oben Holding Group S.A.C. and Tredegar Corporation (filed as Exhibit 2.2 of Tredegar's Current Report on Form 8-K (File No. 1-10258), filed on November 6, 2024, and incorporated herein by reference)

 3.1
 Amended and Restated Articles of Incorporation of Tredegar (filed as Exhibit 3.1 to Tredegar's Annual Report on Form 10-K (File No. 1-10258) for the year ended December 31, 2004, and incorporated herein by reference)

 3.1.1
 Articles of Amendment to Amended and Restated Articles of Incorporation of Tredegar (filed as Exhibit 3.3 to Tredegar's Annual Report on Form 10-K (File No. 1-10258) for the year ended December 31, 2004, and incorporated herein by reference)

 3.1.2
 Articles of Amendment to Amended and Restated Articles of Incorporation of Tredegar, as of May 24, 2013 (filed as Exhibit 3.1 to Tredegar's Current Report on Form 8-K (File No. 1-10258), filed on May 29, 2013 and incorporated herein by reference)

 3.1.3
 Articles of Amendment to Amended and Restated Articles of Incorporation of Tredegar, as of May 4, 2016 (filed as Exhibit 3.1 to Tredegar's Current Report on Form 8-K (File No. 1-10258), filed on May 6, 2016, and incorporated herein by reference)

 3.2
 Amended and Restated Bylaws of Tredegar Corporation, as of August 4, 2023 (filed as Exhibit 3.1 of Tredegar's Current Report on Form 8-K (File No. 1-10258), filed on August 7, 2023, and incorporated herein by reference)

 4.1
 Description of Registered Securities (filed as Exhibit 4.1 to Tredegar's Annual Report on Form 10-K (File No 1-10258) for the year ended December 31, 2019, and incorporated herein by reference)

 10.1
 Second Amended and Restated Credit Agreement, dated as of June 29, 2022, among Tredegar, as borrower, the lenders named therein, JPMorgan Chase Bank N.A., as administrative agent, Citizens Bank N.A and PNC Bank, National Association, as co-syndication agents, and Bank of America, N.A., U.S. Bank National Association and Wells Fargo Bank, National Association, as co-documentation agents, and the other lenders party thereto (filed as Exhibit 4.1 to Tredegar's Current Report on Form 8-K (File No. 1-10258), filed on June 30, 2022, and incorporated herein by reference)

 10.1.1
 Second Amended and Restated Guaranty, dated as of June 29, 2022, by and among the subsidiaries of Tredegar listed on the signature pages thereto in favor of JPMorgan Chase Bank, N.A., as administrative agent, for the ratable benefit of the Holders of Guaranteed Obligations (as defined therein) (filed as Exhibit 4.2 to Tredegar's Current Report on Form 8-K (File No. 1-10258), filed on June 30, 2022, and incorporated herein by reference)

 10.1.2
 Second Amended and Restated Pledge Agreement, dated as of June 29, 2022, by and among Tredegar and the subsidiaries of Tredegar listed on the signature pages thereto and JPMorgan Chase Bank, N.A., as administrative agent, for the ratable benefit of the Secured Parties (as defined therein) (filed as Exhibit 4.3 to Tredegar's Current Report on Form 8-K (File No. 1-10258), filed on June 30, 2022, and incorporated herein by reference)

 10.1.3
 Amendment No. 1 to Second Amended and Restated Credit Agreement, dated as of November 29, 2022, among Tredegar Corporation, as borrower, the lenders named therein, JPMorgan Chase Bank, N.A., as administrative agent, Citizens Bank, N.A. and PNC Bank, National Association, as co-syndication agents, and Bank of America, N.A., U.S. Bank National Association and Wells Fargo Bank, National Association, as co-documentation agents, and the other lenders party thereto (filed as Exhibit 10.1 of Tredegar's Second Quarter 2023 Form 10-Q (File No. 1-10258), filed on August 9, 2023, and incorporated herein by reference)

 10.1.4
 Amendment No. 2 to Second Amended and Restated Credit Agreement, dated as of August 3, 2023, among Tredegar Corporation, as borrower, the lenders named therein, JPMorgan Chase Bank, N.A., as administrative agent, Citizens Bank, N.A. and PNC Bank, National Association, as co-syndication agents, and Bank of America, N.A., U.S. Bank National Association and Wells Fargo Bank, National Association, as co-documentation agents, and the other lenders party thereto (filed as Exhibit 10.2 of Tredegar's Second Quarter 2023 Form 10-Q (File No. 1-10258), filed on August 9, 2023, and incorporated herein by reference)

 10.1.5
 Amendment No. 3, dated December 27, 2023, to the Second Amended and Restated Credit Agreement, dated June 29, 2022, by and among Tredegar Corporation, as borrower, certain of Tredegar Corporation's material domestic subsidiaries, as guarantors, the lenders named therein, JPMorgan Chase Bank, N.A., as administrative agent, Citizens Bank, N.A. and PNC Bank, National Association, as co-syndication agents, and Bank of America, N.A., U.S. Bank National Association and Wells Fargo Bank, National Association, as co-documentation agents (filed as Exhibit 4.1 to Tredegar's Current Report on Form 8-K (File No. 1-10258), filed on December 28, 2023, and incorporated herein by reference)

 10.1.6
 Third Amended and Restated Pledge and Security Agreement, dated as of December 27, 2023, by and among Tredegar Corporation and the subsidiaries of Tredegar Corporation listed on the signature pages thereto and JPMorgan Chase Bank, N.A., as administrative agent, for the ratable benefit of the Secured Parties (as defined therein) (filed as Exhibit 4.1 to Tredegar's Current Report on Form 8-K (File No. 1-10258), filed on December 28, 2023, and incorporated herein by reference)

 10.1.7
 Amendment No. 4, dated April 16, 2024, to the Second Amended and Restated Credit Agreement, dated June 29, 2022, by and among Tredegar Corporation, as borrower, certain of Tredegar Corporation's material domestic subsidiaries, as guarantors, the lenders named therein, JPMorgan Chase Bank, N.A., as administrative agent, Citizens Bank, N.A. and PNC Bank, National Association, as co-syndication agents, and Bank of America, N.A., U.S. Bank National Association and Wells Fargo Bank, National Association, as co-documentation agents (filed as Exhibit 10.1 of Tredegar's Current Report on Form 8-K (File No. 1-10258), filed on April 22, 2024, and incorporated herein by reference)

 10.2
 Reorganization and Distribution Agreement, dated as of June 1, 1989, between Tredegar and Ethyl Corporation (filed as Exhibit 10.1 to Tredegar's Annual Report on Form 10-K (File No. 1-10258) for the year ended December 31, 2004, and incorporated herein by reference)

 *10.3
 Employee Benefits Agreement, dated as of June 1, 1989, between Tredegar and Ethyl Corporation (filed as Exhibit 10.2 to Tredegar's Annual Report on Form 10-K (File No. 1-10258) for the year ended December 31, 2004, and incorporated herein by reference)

 10.4
 Tax Sharing Agreement, dated as of June 1, 1989, between Tredegar and Ethyl Corporation (filed as Exhibit 10.3 to Tredegar's Annual Report on Form 10-K (File No. 1-10258) for the year ended December 31, 2004, and incorporated herein by reference)

 10.5
 Indemnification Agreement, dated as of June 1, 1989, between Tredegar and Ethyl Corporation (filed as Exhibit 10.4 to Tredegar's Annual Report on Form 10-K (File No. 1-10258) for the year ended December 31, 2004, and incorporated herein by reference)

 *10.6
 Tredegar Industries, Inc. Retirement Benefit Restoration Plan (filed as Exhibit 10.7 to Tredegar's Annual Report on Form 10-K (File No. 1-10258) for the year ended December 31, 2004, and incorporated herein by reference)

 *10.6.1
 Amendment to the Tredegar Industries, Inc. Retirement Benefit Restoration Plan (filed as Exhibit 10.7.1 to Tredegar's Annual Report on Form 10-K (File No. 1-10258) for the year ended December 31, 2004, and incorporated herein by reference)

 *10.7
 Tredegar Industries, Inc. Savings Plan Benefit Restoration Plan (filed as Exhibit 10.6 to Tredegar's Annual Report on Form 10-K (File No. 1-10258) for the year ended December 31, 2013, and incorporated herein by reference)

 *10.7.1
 Resolutions of the Executive Committee of the Board of Directors of Tredegar adopted on December 28, 2004 (effective as of December 31, 2004) amending the Tredegar Corporation Retirement Savings Plan Benefit Restoration Plan (filed as Exhibit 10.9.1 to Tredegar's Current Report on Form 8-K (File No. 1-10258), filed on December 30, 2004, and incorporated herein by reference)

 *10.8
 Tredegar 2004 Equity Incentive Plan as Amended and Restated Effective March 27, 2009 (filed as Annex 1 to Tredegar's Definitive Proxy Statement on Schedule 14A (File No. 1-10258) filed on April 14, 2009 and incorporated herein by reference)

 *10.9
 Form of Notice of Nonstatutory Stock Option Grant and Nonstatutory Stock Option Terms and Conditions (filed as Exhibit 10.3 to Tredegar's Current Report on Form 8-K (File No. 1-10258), filed on February 27, 2013, and incorporated herein by reference)

 *10.10
 Form of Notice of Stock Unit Award and Stock Unit Award Terms and Conditions (filed as Exhibit 10.1 to Tredegar's Current Report on Form 8-K (File No. 1-10258), filed on March 1, 2016, and incorporated herein by reference)

 *10.11
 Form of Notice of Stock Award and Stock Award Terms and Conditions (filed as Exhibit 10.2 to Tredegar's Current Report on Form 8-K (File No. 1-10258), filed on March 1, 2016, and incorporated herein by reference)

 *10.12
 Form of Notice of Stock Award and Stock Award Terms and Conditions (filed as Exhibit 10.18 to Tredegar's Quarterly Report on Form 10-Q (File No. 1-10258) for the quarterly period ended March 31, 2020, and incorporated herein by reference)

 *10.13
 Form of Notice of Stock Appreciation Right Grant and Stock Appreciation Right Terms and Conditions (filed as Exhibit 10.19 to Tredegar's Quarterly Report on Form 10-Q (File No. 1-10258) for the quarterly period ended March 31, 2020, and incorporated herein by reference)

 *10.14
 Form of Notice of Nonstatutory Stock Option Grant and Nonstatutory Stock Option Terms and Conditions (filed as Exhibit 10.20 to Tredegar's Quarterly Report on Form 10-Q (File No. 1-10258) for the quarterly period ended March 31, 2020, and incorporated herein by reference)

 *10.15
 Tredegar 2018 Equity Incentive Plan, as amended and restated (filed as Annex A to Tredegar's Definitive Proxy Statement on Schedule 14A (File No. 1-10258) filed on March 25, 2021, and incorporated herein by reference)

 *10.16
 Form of Notice of Nonstatutory Stock Option Grant and Nonstatutory Stock Option Terms and Conditions (filed as Exhibit 10.1 to Tredegar's Current Report on Form 8-K (File No. 1-10258), filed on May 7, 2018, and incorporated herein by reference)

 *10.17
 Form of Notice of Nonstatutory Stock Option Grant and Nonstatutory Stock Option Terms and Conditions (filed as Exhibit 10.3 to Tredegar Corporation's Registration Statement on Form S-8 (Registration No. 333-230386), filed on March 19, 2019, and incorporated herein by reference)

 *10.18
 Form of Executive Change-in-Control Severance Agreement (filed as Exhibit 10.1 of Tredegar's Current Report on Form 8-K (File No. 1-10258), filed on October 4, 2023, and incorporated herein by reference)

 10.19
 Standard Buyout Commitment Agreement, dated October 31, 2023, by and between Tredegar Corporation and Massachusetts Mutual Life Insurance Company (filed as Exhibit 10.1 of Tredegar's Current Report on Form 8-K (File No. 1-10258), filed on November 6, 2023, and incorporated herein by reference)

 *10.20
 Form of Notice of Phantom Stock Unit Award and Phantom Stock Unit Award Terms and Conditions (filed as Exhibit 10.2 to Tredegar's Quarterly Report on Form 10-Q (File No. 1-10258) for the quarterly period ended March 31, 2024, and incorporated herein by reference)

 +19
 Insider Trading Policy

 +21
 Subsidiaries of Tredegar

 +23
 Consent of KPMG LLP, Independent Registered Public Accounting Firm

 +31.1
 Certification of President and Chief Executive Officer (Principal Executive Officer) of Tredegar, pursuant to Rules 13a-14(a) and 15d-14(a) promulgated under the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

 +31.2
 Certification of Vice President and Chief Financial Officer (Principal Financial Officer) of Tredegar, pursuant to Rules 13a-14(a) and 15d-14(a) promulgated under the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

 +32.1
 Certification of President and Chief Executive Officer (Principal Executive Officer) of Tredegar, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

 +32.2
 Certification of Vice President and Chief Financial Officer (Principal Financial Officer) of Tredegar, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

 Executive Incentive-based Compensation Recoupment Policy (filed as exhibit 97 to Tredegar's Annual Report on Form 10-K (File no. 1-10258) for the year ended December 31, 2023, and incorporated her by reference)

 +101

 +104

 *
 Denotes compensatory plans or arrangements or management contracts.

 +
 Filed herewith

 SIGNATURES
 Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 TREDEGAR CORPORATION
(Registrant)

 Dated:
 March 12, 2025
 By

 /s/ John M. Steitz

 John M. Steitz

 President and Chief Executive Officer

 Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities indicated on March 12, 2025.

 Signature

 Title

 /s/
 John M. Steitz

 President, Chief Executive Officer and Director

 (John M. Steitz)
 (Principal Executive Officer)

 /s/
 D. Andrew Edwards

 Executive Vice President and Chief Financial Officer

 (D. Andrew Edwards)
 (Principal Financial Officer)

 /s/
 Frasier W. Brickhouse, II

 Corporate Treasurer and Controller

 (Frasier W. Brickhouse, II)
 (Principal Accounting Officer)

 /s/
 Gregory A. Pratt

 Chairman of the Board of Directors

 (Gregory A. Pratt)

 /s/
 George C. Freeman, III

 (George C. Freeman, III)

 /s/
 Kenneth R. Newsome

 (Kenneth R. Newsome)

 /s/
 Thomas G. Snead, Jr.

 (Thomas G. Snead, Jr.)

 /s/
 Carl E. Tack, III

 (Carl E. Tack, III)

 /s/
 Christine R. Vlahcevic

 (Christine R. Vlahcevic)